0001093557-19-000119.txt : 20190501 0001093557-19-000119.hdr.sgml : 20190501 20190501171315 ACCESSION NUMBER: 0001093557-19-000119 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190501 DATE AS OF CHANGE: 20190501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 19788633 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 10-Q 1 dxcm-2019x10qasof33119.htm 10-Q Document


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2019
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission file number 000-51222
DEXCOM, INC.
(Exact name of Registrant as specified in its charter)
 
 
 
Delaware
 
33-0857544
(State or Other Jurisdiction of Incorporation or Organization)
 
(I.R.S. Employer Identification No.)
 
 
6340 Sequence Drive
San Diego, California
 
92121
(Address of Principal Executive Offices)
 
(Zip Code)
(858) 200-0200
(Registrant’s Telephone Number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
 
Trading Symbol(s)
 
Name of Each Exchange on Which Registered
Common Stock, $0.001 Par Value Per Share
 
DXCM
 
Nasdaq Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check one):
Large Accelerated Filer
ý
 
Accelerated Filer
o
 
 
 
 
 
Non-Accelerated Filer
o
 
Smaller Reporting Company
o
 
 
 
 
 
Emerging Growth Company
o
 
 
 
 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 o
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  ý
As of April 25, 2019, there were 91,050,405 shares of the Registrant’s common stock outstanding.
 


DexCom, Inc.
Table of Contents
 
 
 
Page
Number
 
ITEM 1.
 
 
 
 
 
 
 
ITEM 2.
ITEM 3.
ITEM 4.
ITEM 1.
ITEM 1A.
ITEM 2.
ITEM 3.
ITEM 4.
ITEM 5.
ITEM 6.

2


PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
DexCom, Inc.
Consolidated Balance Sheets
(In millions, except par value and share data)
 

March 31, 2019

December 31, 2018
Assets
(Unaudited)


Current assets:



Cash and cash equivalents
$
1,285.1


$
1,137.0

Short-term marketable securities
72.9


248.6

Accounts receivable, net
204.7


226.7

Inventory
101.1


70.7

Prepaid and other current assets
27.0


16.5

Total current assets
1,690.8


1,699.5

Property and equipment, net
221.4


183.1

Operating lease right-of-use assets
27.7

 
—

Goodwill
18.6


18.7

Other assets
15.5


14.7

Total assets
$
1,974.0


$
1,916.0

Liabilities and Stockholders’ Equity



Current liabilities:



Accounts payable and accrued liabilities
$
169.1


$
147.1

Accrued payroll and related expenses
51.3


72.4

Operating lease liabilities, current portion
12.3

 
—

Deferred revenue
2.7


2.9

Total current liabilities
235.4


222.4

Long-term senior convertible notes
1,022.4

 
1,010.3

Operating lease liabilities, net of current portion
29.5

 
—

Other long-term liabilities
18.1


20.0

Total liabilities
1,305.4


1,252.7

Commitments and contingencies



Stockholders’ equity:



Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at March 31, 2019 and December 31, 2018
—


—

Common stock, $0.001 par value, 200.0 million shares authorized; 92.1 million and 91.0 million shares issued and outstanding, respectively, at March 31, 2019; and 91.1 million and 90.0 million shares issued and outstanding, respectively, at December 31, 2018
0.1


0.1

Additional paid-in capital
1,590.6


1,560.6

Accumulated other comprehensive income
1.6


1.5

Accumulated deficit
(823.7
)

(798.9
)
Treasury stock, at cost; 0.8 million shares at March 31, 2019 and December 31, 2018
(100.0
)
 
(100.0
)
Total stockholders’ equity
668.6


663.3

Total liabilities and stockholders’ equity
$
1,974.0


$
1,916.0

See accompanying notes

3

DexCom, Inc.
Consolidated Statements of Operations
(In millions, except per share data)
(Unaudited)


Three Months Ended 
 March 31,
 
2019
 
2018
 
 
 
 
Revenues
$
280.5

 
$
184.4

Cost of sales
111.7

 
65.5

Gross profit
168.8

 
118.9

Operating expenses:

 

Research and development
59.0

 
44.8

Selling, general and administrative
124.2

 
104.8

Total operating expenses
183.2

 
149.6

Operating loss
(14.4
)
 
(30.7
)
Interest expense
(14.9
)
 
(4.8
)
Income (loss) from equity investments
(4.2
)
 
7.4

Interest and other income (expense), net
6.9

 
4.1

Loss before income taxes
(26.6
)
 
(24.0
)
Income tax expense
0.3

 
0.2

Net loss
$
(26.9
)
 
$
(24.2
)
 
 
 
 
Basic and diluted net loss per share
$
(0.30
)
 
$
(0.28
)
Shares used to compute basic and diluted net loss per share
90.3

 
87.3

See accompanying notes

4

DexCom, Inc.
Consolidated Statements of Comprehensive Loss
(In millions)
(Unaudited)
 
 
Three Months Ended 
 March 31,
 
2019
 
2018
Net loss
$
(26.9
)
 
$
(24.2
)
Other comprehensive income (loss), net of income taxes:
 
 
 
Foreign currency translation loss
—

 
(2.3
)
Unrealized income on marketable debt securities
0.1

 
—

Total other comprehensive income (loss), net
0.1

 
(2.3
)
Comprehensive loss
$
(26.8
)
 
$
(26.5
)

See accompanying notes

5

DexCom, Inc.
Consolidated Statements of Stockholders’ Equity
(In millions)
(Unaudited)

 
 
Three Months Ended March 31, 2019
 
 
Common Stock
 
Additional
Paid-In
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Treasury Stock
 
Total
Stockholders’
Equity
Shares
 
Amount
 
Balance at December 31, 2018
 
90.0

 
$
0.1

 
$
1,560.6

 
$
1.5

 
$
(798.9
)
 
$
(100.0
)
 
$
663.3

Cumulative-effect adjustment from adoption of new lease accounting standard (Note 2)
 
—

 
—

 
—

 
—

 
2.1

 
—

 
2.1

Issuance of common stock under equity incentive plans
 
0.9

 
—

 
0.2

 
—

 
—

 
—

 
0.2

Issuance of common stock for Employee Stock Purchase Plan
 
0.1

 
—

 
4.8

 
—

 
—

 
—

 
4.8

Share-based compensation expense
 
—

 
—

 
25.0

 
—

 
—

 
—

 
25.0

Net loss
 
—

 
—

 
—

 
—

 
(26.9
)
 
—

 
(26.9
)
Other comprehensive income
 
—

 
—

 
—

 
0.1

 
—

 
—

 
0.1

Balance at March 31, 2019
 
91.0

 
$
0.1

 
$
1,590.6

 
$
1.6

 
$
(823.7
)
 
$
(100.0
)
 
$
668.6



 
 
Three Months Ended March 31, 2018
 
 
Common Stock
 
Additional
Paid-In
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Treasury Stock
 
Total
Stockholders’
Equity
Shares
 
Amount
 
Balance at December 31, 2017
 
87.0

 
$
0.1

 
$
1,093.7

 
$
(2.6
)
 
$
(671.8
)
 
$
—

 
$
419.4

Issuance of common stock under equity incentive plans
 
1.0

 
—

 
0.1

 
—

 
—

 
—

 
0.1

Issuance of common stock for Employee Stock Purchase Plan
 
0.1

 
—

 
4.1

 
—

 
—

 
—

 
4.1

Share-based compensation expense
 
—

 
—

 
24.6

 
—

 
—

 
—

 
24.6

Net loss
 
—

 
—

 
—

 
—

 
(24.2
)
 
—

 
(24.2
)
Other comprehensive loss
 
—

 
—

 
—

 
(2.3
)
 
—

 
—

 
(2.3
)
Balance at March 31, 2018
 
88.1

 
$
0.1

 
$
1,122.5

 
$
(4.9
)
 
$
(696.0
)
 
$
—

 
$
421.7


See accompanying notes


6

DexCom, Inc.
Consolidated Statements of Cash Flows
(In millions)
(Unaudited)
 
Three Months Ended
 
March 31,
 
2019
 
2018
Operating activities
 
 
 
Net loss
$
(26.9
)
 
$
(24.2
)
Adjustments to reconcile net loss to cash used in operating activities:
 
 
 
Depreciation and amortization
9.9

 
6.0

Share-based compensation
25.0

 
24.6

Non-cash interest expense
12.2

 
3.7

(Income) loss from equity investments
4.2

 
(7.4
)
Other non-cash income and expenses
0.3

 
(0.9
)
Changes in operating assets and liabilities:
 
 
 
Accounts receivable, net
21.5

 
10.7

Inventory
(30.4
)
 
(6.4
)
Prepaid and other assets
(5.4
)
 
(2.7
)
Accounts payable and accrued liabilities
25.5

 
2.2

Accrued payroll and related expenses
(21.1
)
 
(14.4
)
Deferred revenue, deferred rent, and other liabilities
(3.0
)
 
0.1

Net cash provided by (used in) operating activities
11.8

 
(8.7
)
Investing activities
 
 
 
Purchase of marketable securities
(50.7
)
 
(32.0
)
Proceeds from sale and maturity of marketable securities
222.5

 
32.9

Purchase of other equity investments
(1.2
)
 
(1.0
)
Purchase of property and equipment
(39.3
)
 
(15.3
)
Net cash provided by (used in) investing activities
131.3

 
(15.4
)
Financing activities
 
 
 
Net proceeds from issuance of common stock
5.0

 
4.2

Other financing activities
(0.1
)
 
—

Net cash provided by financing activities
4.9

 
4.2

Effect of exchange rate changes on cash, cash equivalents and restricted cash
0.6

 
(0.9
)
Increase (decrease) in cash, cash equivalents and restricted cash
148.6

 
(20.8
)
Cash, cash equivalents and restricted cash, beginning of period
1,137.1

 
441.5

Cash, cash equivalents and restricted cash, end of period
$
1,285.7

 
$
420.7

 
 
 
 
Reconciliation of cash, cash equivalents and restricted cash, end of period:
 
 
 
Cash and cash equivalents
$
1,285.1

 
$
420.4

Restricted cash
0.6

 
0.3

Total cash, cash equivalents and restricted cash
$
1,285.7

 
$
420.7

 
 
 
 
Supplemental disclosure of non-cash investing and financing transactions:
 
 
 
Acquisition of property and equipment included in accounts payable and accrued liabilities
$
10.1

 
$
4.3

Right-of-use assets obtained in exchange for lease liabilities
$
45.2

 
$
—

See accompanying notes

7

DexCom, Inc.
Notes to Consolidated Financial Statements
(Unaudited)
1. Organization and Significant Accounting Policies
Organization and Business
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.
Basis of Presentation and Principles of Consolidation
We have prepared the accompanying unaudited consolidated financial statements (the financial statements) in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.
Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We experience seasonality that is typical in our industry, with lower sales in the first quarter of each year compared to the fourth quarter.
These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2018 included in the Annual Report on Form 10-K that we filed with the SEC on February 21, 2019.
These financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.
Concentration of Credit Risk and Significant Customers
Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.
Two of our distributors are significant customers. Each of them accounted for more than 10% of revenue in each of the past three fiscal years and each of them accounted for more than 10% of accounts receivable as of the end of the past two fiscal years. Distributor A accounted for 15% and 13% of our revenues for the three months ended March 31, 2019 and 2018, respectively. Distributor B accounted for 11% and 14% of our revenues for the three months ended March 31, 2019 and 2018, respectively. Distributor A and Distributor B accounted for 17% and 11%, respectively, of our accounts receivable as of March 31, 2019 and for 19% and 15%, respectively, of our accounts receivable as of December 31, 2018.
Revenue Recognition
We generate our revenue from the sale of our durable CGM systems and disposable sensors (the Components). Our durable systems include a reusable transmitter and receiver. Disposable sensors are sold separately. We also provide free-of-charge software and mobile applications for use with our durable systems and disposable sensors. The initial durable system price is generally not dependent upon the subsequent purchase of any amount of disposable sensors.

8

We sell our durable systems and disposable sensors through two main sales channels: 1) directly to customers who use our products or organizations (the Direct Channel) and 2) to distribution partners who resell our products (the Distributor Channel).
In the Direct Channel, we sell the Components to customers and we receive payment directly from customers, organizations and third-party payors. Third-party payors primarily include commercial insurance companies and federal and state agencies (under Medicare and Medicaid programs).
Policy elections and ASC Topic 606 practical expedients taken
•
We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;
•
We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;
•
We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and
•
If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.
Contracts and performance obligations
We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. Components are individually priced and can be purchased separately or bundled in a contract. We also provide free-of-charge software, mobile applications and updates for our DexCom Share® remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are based on an expected cost plus a margin approach.
Transaction price
Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on contracted rates less any estimates of claim denials and historical reimbursement experience, which would include current and future expectations regarding reimbursement contracts, guidelines and payor mix, and less estimated variable consideration adjustments.
Variable consideration
Rebates. We estimate reductions to our revenues for rebates paid to payors, healthcare providers and distributors. Rebates are based on contractual arrangements or statutory requirements, which may vary by product, payor and individual payor plans. Our estimates are based on products sold, historical payor mix and, as available, known market events or trends and channel inventory data. We also take into consideration, as available, new information regarding changes in programs’ regulations and guidelines that would impact the amount of the actual rebates and/or our expectations regarding future payor mix for these programs.
Product Returns. We generally provide a “30-day money back guarantee” program whereby first-time end-user customers may return the durable system. In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. Our returns have historically been immaterial.
Revenue recognition
We recognize revenue when control is transferred to our customers. The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with the Components are satisfied at a point in time, which typically occurs at shipment. Terms of direct and distributor orders are generally Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer.
In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the durable system.
Our sales of the receiver and transmitter components of our CGM systems include an assurance-type warranty which is accounted for based on the cost accrual method recognized as expense when the products are sold and is not considered a separate performance obligation.

9

Contract balances
The timing of revenue recognition, billing and cash collections results in the recording of trade receivables and deferred revenue in our balance sheets. We recognize a receivable in the period in which our right to the consideration is unconditional. We generally do not have any contracts or performance obligations with a term of more than one year.
Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.
Accounts receivable as of March 31, 2019 and December 31, 2018 included unbilled accounts receivable of $4.7 million and $5.1 million. Unbilled accounts receivable consist of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months.
Substantially all of our deferred revenue as of March 31, 2019 is associated with certain of our free-of-charge software and mobile applications and will be recognized during 2019. During the three months ended March 31, 2019, we recognized revenue of $2.4 million that was recorded as deferred revenue as of December 31, 2018. During the three months ended March 31, 2018, we recognized revenue of $1.5 million that was recorded as deferred revenue as of December 31, 2017.
Deferred cost of sales
Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. These costs are recognized in cost of sales when the associated revenue is recognized. Deferred cost of sales are included in prepaid and other current assets in our balance sheets.
Incentive compensation costs
We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been one year or less. We record these costs in selling, general and administrative expense in our statement of operations.
Leases
We adopted Accounting Standards Codification Topic 842 (ASC 842) utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. Under ASC 842, we determine if an arrangement is a lease at inception. We record operating lease right-of-use assets and liabilities based on the present value of the lease payments over the lease term. In determining the present value of the lease payments, we use our incremental borrowing rate at the lease commencement date. We define the initial lease term to include the construction build-out period but to exclude lease extension periods when we are not reasonably certain to exercise our extension option. We record lease expense on a straight-line basis over the expected lease term. Lease costs which are variable and dependent on a rate, an index, or on usage of the asset are expensed in the period they are incurred.
We have facilities lease agreements with lease and non-lease components, such as common area maintenance. We generally account for the lease and non-lease components of these agreements as a single lease component.
We account for short-term lease expense on a straight-line basis over the lease term.
Net Income (Loss) Per Share
Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.
Common share equivalents that we calculate using the treasury stock method include outstanding stock options and unvested RSUs that are settleable in shares of common stock and potential common shares from convertible securities that we intend to settle using a combination of shares of our common stock and cash. Common share equivalents that we calculate using the if-converted method include potential common shares from convertible securities that we intend to settle using only shares of our common stock.
Because we reported net losses for the three months ended March 31, 2019 and 2018, all potentially dilutive common shares have been excluded from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.

10

Outstanding anti-dilutive securities not included in the diluted net loss per share attributable to common stockholders calculations were as follows:
 
Three Months Ended 
 March 31,
 (In millions)
2019
 
2018
Options outstanding to purchase common stock
—

 
0.4

Unvested restricted stock units
2.3

 
3.1

Senior convertible notes due 2022
4.0

 
4.0

Senior convertible notes due 2023
5.2

 
—

Warrants
5.2

 
—

Total
16.7

 
7.5


Recent Accounting Guidance
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) (ASU 2016-02), which requires a lessee to recognize most leases on the balance sheet as lease liabilities with corresponding right-of-use assets. We adopted ASU 2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. See Note 2, “Leases,” for more information on the impact of our adoption of ASU 2016-02 and related disclosures.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (ASU 2017-12), which is intended to more closely align hedge accounting with companies’ risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (ASU 2016-13), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. ASU 2016-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-14). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. ASU 2017-14 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other – Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-05). This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs

11

to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-05 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We are currently evaluating the impact that this guidance will have on our financial statements.


2. Leases
Impact of Adoption of ASC 842
We adopted ASU No. 2016-02, Leases (Topic 842) (ASU 2016-02) utilizing the modified retrospective transition method through a $2.1 million cumulative-effect adjustment to retained earnings at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards. We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019.
Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.
In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $26.7 million, finance lease right-of-use assets of $15.3 million, operating lease liabilities of $40.4 million and finance lease liabilities of $15.9 million at the beginning of the first quarter of 2019, with no material impact to our statement of operations.
Information About Our Leases
Our corporate headquarters and primary manufacturing facilities are located in San Diego, California. We lease approximately 219,000 square feet of space in San Diego under leases that expire in February and March 2022. We have the option to renew each of these leases for two additional five-year terms. In San Diego we also lease approximately 87,000 square feet of space under a lease that expires in February 2022 with no renewal options and approximately 132,600 square feet of space under a sublease that expires in January 2022. We lease approximately 148,800 square feet of space in Mesa, Arizona under a lease that expires in March 2028. We have the option to renew this lease for four additional five-year terms. We have also entered into other domestic and international operating lease agreements, primarily for office and warehouse space, that expire at various times through July 2026.
The components of lease expense for the three months ended March 31, 2019 were as follows:
(In millions)
Three Months Ended 
 March 31, 2019
Finance lease cost:
 
Amortization of right-of-use assets
$
0.3

Interest on lease liabilities
0.2

Operating lease cost
2.5

Short-term lease cost
1.3

Variable lease cost(1)
$
0.8

Total lease cost
$
5.1

(1) Variable lease costs represent payments that are dependent on a rate or index, or on usage of our facility leases and are primarily related to common area maintenance charges and property taxes.  


12

Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.
(Dollars in millions)
Three Months Ended 
 March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
4.6

Operating cash flows from finance leases
$
0.2

Financing cash flows from finance leases
$
0.1

Right-of-use assets obtained in exchange for lease liabilities:
 
Operating leases
$
29.9

Finance leases
$
15.3

Weighted average remaining lease term in years:
 
Operating leases
3.3

Finance leases
14.0

Weighted average discount rate:
 
Operating leases
5.0
%
Finance leases
5.0
%
Future minimum lease payments under non-cancellable leases as of March 31, 2019 were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of March 31, 2019.
(In millions)
Operating Leases
 
Finance Leases
2019
$
11.3

 
$
1.0

2020
14.2

 
1.3

2021
14.5

 
1.3

2022
3.7

 
1.4

2023
1.6

 
1.4

Thereafter
1.0

 
15.4

Total future lease cost
46.3

 
21.8

Less: Amount representing interest
(3.6
)
 
(6.1
)
Present value of future payments
42.7

 
15.7

Less: Short-term leases not recorded as a liability
(0.9
)
 
—

Revised present value of future lease payments
41.8
 
15.7

Less: Current portion
(12.3
)
 
(0.5
)
Long-term portion
$
29.5

 
$
15.2


3. Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.
We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark

13

yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market-related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.
The following table summarizes financial assets that we measured at fair value on a recurring basis as of March 31, 2019, classified in accordance with the fair value hierarchy. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.
 
Fair Value Measurements Using
(In millions)
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents
$
309.9

 
$
49.6

 
$
—

 
$
359.5

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
—

 
54.8

 
—

 
54.8

Commercial paper
—

 
3.0

 
—

 
3.0

Corporate debt
—

 
15.1

 
—

 
15.1

Total debt securities, available for sale
—

 
72.9

 
—

 
72.9

 
 
 
 
 
 
 
 
Total assets measured at fair value on a recurring basis
$
309.9

 
$
122.5

 
$
—

 
$
432.4

The following table summarizes financial assets that we measured at fair value on a recurring basis as of December 31, 2018, classified in accordance with the fair value hierarchy.
 
Fair Value Measurements Using
(In millions)
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents
$
199.3

 
$
66.7

 
$
—

 
$
266.0

 
 
 
 
 
 
 
 
Equity investment in Tandem Diabetes Care, Inc.
38.0

 
—

 
—

 
38.0

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
—

 
173.1

 
—

 
173.1

Commercial paper
—

 
36.2

 
—

 
36.2

Corporate debt
—

 
1.3

 
—

 
1.3

Total debt securities, available for sale
—

 
210.6

 
—

 
210.6

 
 
 
 
 
 
 
 
Total assets measured at fair value on a recurring basis
$
237.3

 
$
277.3

 
$
—

 
$
514.6

There were no transfers between Level 1 and Level 2 securities during the three months ended March 31, 2019 and 2018. There were no transfers into or out of Level 3 securities during the three months ended March 31, 2019 and 2018.
We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.
Financial liabilities whose fair values we measure on a recurring basis using Level 1 inputs consist of our outstanding 2022 Notes and 2023 Notes. We measure the fair value of the 2022 Notes and 2023 Notes based on their trading prices. The fair value of the 2022 Notes was $537.5 million as of March 31, 2019 and $540.2 million as of December 31, 2018. The fair value

14

of the 2023 Notes was $876.3 million as of March 31, 2019 and $859.6 million as of December 31, 2018. For more information on the carrying values and fair values of our 2022 Notes and 2023 Notes, see Note 5, “Debt.”
Foreign Currency and Derivative Financial Instruments
From time to time we engage in limited hedging transactions to reduce foreign currency risks on certain intercompany balances. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs. As of March 31, 2019, we had no outstanding currency hedging transactions.
 
4. Balance Sheet Details
Short-Term Marketable Securities
Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.
 
March 31, 2019
(In millions)
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
$
54.8

 
$
—

 
$
—

 
$
54.8

Commercial paper
3.0

 
—

 
—

 
3.0

Corporate debt
15.1

 
—

 
—

 
15.1

Total debt securities, available for sale
72.9

 
—

 
—

 
72.9

 
 
 
 
 
 
 
 
Total marketable securities
$
72.9

 
$
—

 
$
—

 
$
72.9


 
December 31, 2018
(In millions)
Cost or Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
Equity investment in Tandem Diabetes Care, Inc.
$
2.0

 
$
36.0

 
$
—

 
$
38.0

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
173.2

 
—

 
(0.1
)
 
173.1

Commercial paper
36.2

 
—

 
—

 
36.2

Corporate debt
1.3

 
—

 
—

 
1.3

Total debt securities, available for sale
210.7

 
—

 
(0.1
)
 
210.6

 
 
 
 
 
 
 
 
Total marketable securities
$
212.7

 
$
36.0

 
$
(0.1
)
 
$
248.6

As of March 31, 2019 and December 31, 2018, all of our debt securities had contractual maturities of less than 12 months. Gross realized gains and losses on sales of our debt securities during the three months ended March 31, 2019 and 2018 were not significant.
We periodically review our portfolio of debt securities to determine if any investment is other-than-temporarily impaired due to changes in credit risk or other potential valuation concerns. We believe that the investments we held at March 31, 2019 were not other-than-temporarily impaired. Unrealized losses on available-for-sale debt securities at that date were not significant and were due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.


15

Inventory
(In millions)
March 31, 2019
 
December 31, 2018
Raw materials
$
52.7

 
$
30.8

Work-in-process
10.0

 
11.2

Finished goods
38.4

 
28.7

Total inventory
$
101.1

 
$
70.7

During the three months ended March 31, 2019 we recorded excess and obsolete inventory charges of $1.6 million in cost of goods sold as a result of our ongoing assessment of sales demand and inventory on hand.
Property and Equipment
(In millions)
March 31, 2019
 
December 31, 2018
Building and land
$
15.3

 
$
6.0

Furniture and fixtures
9.1

 
9.0

Computer software and hardware
31.6

 
29.2

Machinery and equipment
82.5

 
80.7

Leasehold improvements
83.2

 
80.7

Construction in progress
88.1

 
57.3

Total cost
309.8

 
262.9

Less accumulated depreciation and amortization
(88.4
)
 
(79.8
)
Total property and equipment, net
$
221.4

 
$
183.1

Building and Land. Although we do not legally own these premises, under previous lease accounting standards we were deemed the owner of the construction project during the construction period of our manufacturing facility in Mesa, Arizona under a build-to-suit lease arrangement. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell that was included in Building in our balance sheet as of December 31, 2018 and the related lease liability and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019. See Note 2, “Leases,” for more information on our adoption of ASC 842.
Construction in Progress. The increase in construction in progress as of March 31, 2019 compared to December 31, 2018 is primarily due to continued investment in the expansion and automation of our production capabilities.
Accounts Payable and Accrued Liabilities
(In millions)
March 31, 2019
 
December 31, 2018
Accounts payable trade
$
90.3

 
$
75.5

Accrued tax, audit, and legal fees
12.3

 
11.7

Accrued rebates
40.9

 
36.1

Accrued warranty
6.0

 
6.8

Restructuring reserve
1.1

 
—

Other accrued liabilities
18.5

 
17.0

Total accounts payable and accrued liabilities
$
169.1

 
$
147.1

Restructuring Reserve. In February 2019, our Board of Directors approved a restructuring plan that will result in the transition of certain of our operations to the Philippines. We estimate that we will incur total pre-tax charges and costs of approximately $9 million, primarily for employee severance benefits under both ongoing and one-time benefit arrangements. We expect to incur these costs throughout 2019 but primarily in the first half of 2019, and we expect the restructuring activities to be substantially complete by the end of 2019.


16

Other Long-Term Liabilities
(In millions)
March 31, 2019
 
December 31, 2018
Finance lease liabilities
$
15.2

 
$
7.3

Deferred rent
—

 
9.4

Other liabilities
2.9

 
3.3

Total other long-term liabilities
$
18.1

 
$
20.0

Our adoption of ASC 842 during the first quarter of 2019 affected the balances of finance lease liabilities and deferred rent as of March 31, 2019. See Note 2, “Leases,” for more information.


5. Debt
Senior Convertible Notes
(In millions)
March 31, 2019
 
December 31, 2018
0.75% Senior Convertible Notes due 2022:
 
 
 
Principal amount
$
400.0

 
$
400.0

Unamortized debt discount
(47.7
)
 
(51.1
)
Unamortized debt issuance costs
(5.9
)
 
(6.3
)
Net carrying amount of Senior Convertible Notes due 2022
346.4

 
342.6

 
 
 
 
0.75% Senior Convertible Notes due 2023:
 
 
 
Principal amount
850.0

 
850.0

Unamortized debt discount
(164.0
)
 
(171.8
)
Unamortized debt issuance costs
(10.0
)
 
(10.5
)
Net carrying amount of Senior Convertible Notes due 2023
676.0

 
667.7

 
 
 
 
Total net carrying amount of senior convertible notes
$
1,022.4

 
$
1,010.3

 
 
 
 
Fair value of outstanding senior convertible notes:
 
 
 
Senior Convertible Notes due 2022
$
537.5

 
$
540.2

Senior Convertible Notes due 2023
876.3

 
859.6

Total fair value of outstanding senior convertible notes
$
1,413.8

 
$
1,399.8

 
 
 
 
Amount by which the notes' if-converted value exceeds their principal amount:
 
 
 
Senior Convertible Notes due 2022
$
121.7

 
$
125.4

Senior Convertible Notes due 2023
—

 
—

Total by which the notes' if-converted value exceeds their principal amount
$
121.7

 
$
125.4


0.75% Senior Convertible Notes due 2022
In June 2017, we completed an offering of $400.0 million aggregate principal amount of unsecured senior convertible senior notes with a stated interest rate of 0.75% and a maturity date of May 15, 2022 (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $389.0 million. The 2022 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all 2022 Notes conversions in shares of our common stock. The initial conversion rate of the 2022 Notes is 10.0918 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $99.09 per

17

share, subject to adjustments. We use the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.
Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders’ equity. As a result, we recognized $72.6 million in additional paid-in-capital during 2017.
The interest expense recognized on the 2022 Notes during the three months ended March 31, 2019 includes $0.7 million, $3.5 million and $0.4 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2022 Notes during the three months ended March 31, 2018 includes $0.8 million, $3.3 million and $0.4 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2022 Notes is 5.1%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. The discount on the 2022 Notes is amortized through May 15, 2022. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.
In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by DexCom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.
Prior to 5:00 p.m., New York City time, on the business day immediately preceding February 15, 2022, holders of the 2022 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:
(1)
during any calendar quarter commencing after September 30, 2017 (and only during such calendar quarter), if the last reported sale price of common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;
(2)
during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of common stock and the applicable conversion rate of the Notes on such trading day;
(3)
if we call any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or
(4)
upon the occurrence of specified corporate transactions.
 On or after February 15, 2022, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.
DexCom may not redeem the 2022 Notes prior to May 15, 2020. On or after May 15, 2020, DexCom may redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock has been at least 140% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.
No principal payments are due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes includes customary terms and covenants, including certain events of default after which the 2022 Notes may be due and payable immediately.
Circumstance (1) listed above occurred during the last 30 trading days of the quarter ended March 31, 2019. As a result, the 2022 Notes are convertible at the option of the holders from April 1, 2019 and will remain convertible until June 30, 2019. We continue to classify the carrying value of the liability component of the 2022 Notes as long-term debt, and the equity component of the 2022 Notes as permanent equity in our balance sheet as of March 31, 2019.
0.75% Senior Convertible Notes due 2023
In November 2018, we completed an offering of $850.0 million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.75% and a maturity date of December 1, 2023 (the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were

18

approximately $836.6 million. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all 2023 Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any note conversion value in excess of the principal amount in shares of our common stock. The initial conversion rate of the 2023 Notes is 6.0869 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $164.29 per share, subject to adjustments. We use the treasury stock method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes.
Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders’ equity. As a result, we recognized $174.4 million in additional paid-in capital during 2018.
The interest expense recognized on the 2023 Notes during the three months ended March 31, 2019 includes $1.6 million, $7.8 million and $0.5 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2023 Notes is 5.6%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. The discount on the 2023 Notes is being amortized through December 1, 2023. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.
Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by DexCom of a notice of redemption.
Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September 1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:
(1)
during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;
(2)
during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of common stock and the applicable conversion rate of the 2023 Notes on such trading day;
(3)
if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or
(4)
upon the occurrence of specified corporate transactions.
On or after September 1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.
DexCom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, DexCom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.
No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. As of the date of these financial statements, we are unaware of any current events or market conditions that would allow holders to convert the 2023 Notes.

19

2023 Note Hedge
In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to 5.2 million shares of our common stock at an initial price of $164.29 per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was $218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in additional paid-in capital during 2018. The 2023 Note Hedge will expire on December 1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge. The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.
2023 Warrants
In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to 5.2 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March 1, 2024. We received $183.8 million in cash proceeds from the sale of the 2023 Warrants, which we recorded in additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $198.38 per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.
Revolving Credit Agreement
In December 2018, we entered into a five-year $200.0 million revolving credit agreement (the Credit Agreement) with JPMorgan Chase Bank, NA, as administrative agent, Bank of America, Silicon Valley Bank, Union Bank and Bank of the West. The Credit Agreement provides a $50.0 million sublimit for borrowings in Canadian Dollars, Euros, British Pounds, Swedish Krona, Japanese Yen and any other currency that is subsequently approved by the lenders and a sub-facility of up to $10.0 million for letters of credit. Subject to customary conditions and the approval of any lender whose commitment would be increased, we have the option to increase the maximum principal amount available under the Credit Agreement by up to an additional $300.0 million, resulting in a maximum available principal amount of $500.0 million. However, at this time none of the lenders have committed to provide any such increase in their commitments.
Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from 0.375% to 1.000%. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from 1.375% to 2.000%. We will also pay a commitment fee of between 0.2% and 0.3%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.
The Credit Agreement requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of March 31, 2019.
We drew no loans under the Credit Agreement during the three months ended March 31, 2019. As of March 31, 2019, we had no outstanding borrowings, letters of credit totaling $4.4 million, and a total available balance of $195.6 million under the Credit Agreement.

6. Contingencies
Litigation
On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the United States District Court for the District of Oregon, asserting that certain of our products infringe certain patents held by AgaMatrix. On June 6, 2016, AgaMatrix filed a First Amended Complaint asserting the same three patents. On February 24, 2017, the Court granted AgaMatrix’s motion to substitute WaveForm Technologies, Inc., or WaveForm, as the new plaintiff following AgaMatrix’s transfer of the three patents to its newly formed entity. On August 25, 2016, we filed petitions for inter partes review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office seeking a determination that two of the three asserted patents are invalid under U.S. patent law and those petitions were granted on March 6, 2017. On

20

March 8, 2017, we filed a petition for inter partes review with the PTAB seeking a determination that the third of the three asserted patents is invalid under U.S. patent law. This petition was granted on September 15, 2017. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On April 3, 2019, the Federal Circuit affirmed the PTAB’s finding that certain claims were not unpatentable. The PTAB issued a Final Written Decision for the third patent on September 12, 2018, where the PTAB found all claims of the third patent asserted against us in the District of Oregon litigation unpatentable. WaveForm did not appeal this decision. Most activity in the patent infringement lawsuit against us in the District of Oregon was stayed until the PTAB completed the inter partes review proceedings. That stay was lifted on October 10, 2018. The remaining claims and counterclaims will continue with an estimated date of trial in February 2020. It is our position that Waveform’s assertions of infringement have no merit.
We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against Agamatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on April 15, 2019. AgaMatrix sought attorneys' fees for this lawsuit and as of March 31, 2019 we have accrued an immaterial amount for those fees. The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix’s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the Commission on April 4, 2019 with a finding of non-infringement. On September 14, 2018, AgaMatrix filed two petitions for inter partes review for each of the same two patents we asserted in the District of Delaware and the ITC. These petitions were denied.
Neither the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys’ fees described above, as of March 31, 2019 we have accrued no amounts for contingent losses associated with these suits.
We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not expect that the resolution of these matters would, or will, have a material adverse effect or material impact on our financial position or results of operations.

7. Income Taxes
Our effective tax rate for the three months ended March 31, 2019 and 2018 was a negative rate of 1%. The negative effective tax rate in the current period resulted from recording foreign income tax in jurisdictions with current taxable income. The negative effective tax rate in the prior period resulted from recording state income and foreign withholding taxes. In both periods, no income tax benefit was recorded on losses in jurisdictions where valuation allowances are recorded against net deferred tax assets.
We maintain a full valuation allowance against our net deferred tax assets as of March 31, 2019 based on our assessment that it is not more likely than not these future benefits will be realized before expiration.


21



8. Stockholders’ Equity

Share-Based Compensation Expense
The following table summarizes share-based compensation expense for the periods shown:
 
Three Months Ended 
 March 31,
(In millions)
2019
 
2018
Cost of sales
$
2.3

 
$
2.2

Research and development
8.5

 
8.5

Selling, general and administrative
14.2

 
13.9

Total share-based compensation expense included in net loss
$
25.0

 
$
24.6

As of March 31, 2019, unrecognized estimated compensation costs related to unvested restricted stock units, or RSUs, and performance stock units, or PSUs, totaled $188.3 million and is expected to be recognized through 2021.
Restricted Stock Units
A summary of our RSU and PSU activity for the three months ended March 31, 2019 is as follows:
 
 
 
Weighted
 
 
 
 
 
Average
 
Aggregate
 
 
 
Grant Date
 
Intrinsic
(In millions, except weighted average grant date fair values)
Shares
 
Fair Value
 
Value
Nonvested at December 31, 2018
2.7

 
$
69.19

 
$
319.0

Granted
0.6

 
143.24

 
 
Vested
(0.9
)
 
65.77

 
 
Forfeited
(0.1
)
 
95.68

 
 
Nonvested at March 31, 2019
2.3

 
$
89.57

 
$
277.4


The total vest date fair value of RSUs that vested during the three months ended March 31, 2019 was $132.3 million. No PSUs vested during that period.

9. Business Segment and Geographic Information
Reportable Segments
An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds.
We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.
Disaggregation of Revenue
DexCom is domiciled in the United States. We sell our durable systems and disposable sensors through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, Canada, Australia, New Zealand, and in some countries in Europe, Asia, Latin America, the Middle East and Africa. We disaggregate our revenue from contracts by major sales channel and geography as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors.

22

Revenues by geographic region
During the three months ended March 31, 2019 and 2018, no country outside of the United States generated revenue that represented more than 10% of our total revenue.
The following table sets forth revenues by our two primary geographical markets, United States and outside of the United States, based on the geographic location to which we deliver the product:
 
Three Months Ended 
 March 31, 2019
 
Three Months Ended 
 March 31, 2018
(In millions)
Amount
 
% of Total
 
Amount
 
% of Total
Revenues:
 
 
 
 
 
 
 
United States
$
210.5

 
75
%
 
$
145.4

 
79
%
Outside of the United States
70.0

 
25
%
 
39.0

 
21
%
Total
$
280.5

 
100
%
 
$
184.4

 
100
%
Revenues by customer sales channel
The following table sets forth revenues disaggregated by customer sales channel:
 
Three Months Ended 
 March 31, 2019
 
Three Months Ended 
 March 31, 2018
(In millions)
Amount
 
% of Total
 
Amount
 
% of Total
Revenues:
 
 
 
 
 
 
 
Distributor
$
187.8

 
67
%
 
$
118.3

 
64
%
Direct
92.7

 
33
%
 
66.1

 
36
%
Total
$
280.5

 
100
%
 
$
184.4

 
100
%


23


ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This document, including the following Management’s Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements that are not purely historical regarding DexCom’s or its management’s intentions, beliefs, expectations and strategies for the future. These forward-looking statements fall within the meaning of the federal securities laws that relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “intend,” “potential” or “continue” or the negative of these terms or other comparable terminology. Forward-looking statements are made as of the date of this report, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward-looking statements. The risks and uncertainties that could cause actual results to differ materially are more fully described under “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2018, elsewhere in this Quarterly Report, and in our other reports filed with the SEC. We assume no obligation to update any of the forward-looking statements after the date of this report or to conform these forward-looking statements to actual results. You should read the following discussion and analysis together with our financial statements and related notes in Part I, Item 1 of this Quarterly Report.
Overview
We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. We received approval from the Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation system, the DexCom G6® integrated Continuous Glucose Monitoring System, or G6, in 2018. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.
We sell our durable CGM systems and disposable sensors through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, Canada, Australia, New Zealand and some countries in Europe, Asia, Latin America, the Middle East and Africa.
We plan to develop future generations of technologies that are focused on improved performance and convenience and that will enable intelligent insulin administration. We also are aggressively exploring how to extend our offerings to other opportunities, including for people with Type 2 diabetes that are non-insulin using, people with pre-diabetes, people who are obese, people with gestational diabetes, and in the hospital setting. We will continue to develop a networked platform with open architecture, connectivity and transmitters capable of communicating with other devices and software systems. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.
Critical Accounting Policies and Estimates
The discussion and analysis of our financial condition and results of operations are based on our financial statements, which we have prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Our significant accounting policies are more fully described in Note 1 to the financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. The accounting policies and estimates which are most critical to a full understanding and evaluation of our reported financial results are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in Item 7 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. There were no material changes to our critical accounting policies during the three months ended March 31, 2019.


24

Results of Operations
Financial Overview
 
Three Months Ended March 31,
 
Q1 2019 - Q1 2018
(Dollars in millions, except per share amounts)
2019
 
2018
 
$ Change
 
% Change
Total revenues
$
280.5

 
$
184.4

 
$
96.1

 
52
 %
Gross profit
168.8

 
118.9

 
49.9

 
42
 %
Gross profit as a percent of total revenue
60
%
 
64
%
 
 
 
 
Operating loss
(14.4
)
 
(30.7
)
 
16.3

 
(53
)%
Net loss
(26.9
)
 
$
(24.2
)
 
(2.7
)
 
11
 %
Basic and diluted net loss per share
$
(0.30
)
 
$
(0.28
)
 
$
(0.02
)
 
7
 %

Revenue, Cost of Sales and Gross Profit
 
Three Months Ended March 31,
 
Q1 2019 - Q1 2018
(Dollars in millions)
2019
 
2018
 
$ Change
 
% Change
Total revenues
$
280.5

 
$
184.4

 
$
96.1

 
52
%
Cost of sales
111.7

 
65.5

 
46.2

 
71
%
Gross profit
$
168.8

 
$
118.9

 
$
49.9

 
42
%
Gross profit as a percent of total revenue
60
%
 
64
%
 
 
 
 
We sell our G4 PLATINUM, G5 Mobile and G6 durable CGM systems and disposable sensors through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, Canada, Australia, New Zealand and some countries in Europe, Asia, Latin America, the Middle East and Africa. Most of our distributors stock our products and fulfill orders for our products from their inventory.
We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.
Cost of sales includes direct labor and materials costs related to each product sold or produced, including assembly, test labor and scrap, as well as factory overhead supporting our manufacturing operations. Factory overhead includes facilities, material procurement and control, manufacturing engineering, quality assurance, supervision and management. These costs are primarily salary, fringe benefits, share-based compensation, facility expense, supplies and purchased services. A portion of our costs are currently fixed due to our moderate level of production volumes compared to our potential capacity. All of our manufacturing costs are included in cost of sales.
Quarter Ended March 31, 2019 Compared to Quarter Ended March 31, 2018
Revenues. Total revenues increased $96.1 million or 52% for the three months ended March 31, 2019 compared to the three months ended March 31, 2018. The 2019 revenue increase was primarily driven by increased sales volume of our disposable sensors and durable systems due to the continued growth of our installed base of customers, both in the United States and outside of the United States. Disposable sensor and other revenue comprised approximately 75% of total revenues and durable systems revenue comprised approximately 25% of total revenues for each of the three months ended March 31, 2019 and March 31, 2018. Total distributor revenue for the three months ended March 31, 2019 was approximately $187.8 million or 67% of our total revenues compared to $118.3 million or 64% of our total revenues for the three months ended March 31, 2018.
Cost of Sales. Cost of sales increased $46.2 million or 71% for the three months ended March 31, 2019 compared to the three months ended March 31, 2018 primarily due to increased sales volume. The gross profit of $168.8 million or 60% of total revenues for the three months ended March 31, 2019 increased $49.9 million compared to $118.9 million or 64% of total revenues for the same period in 2018. The first quarter 2019 increase in gross profit dollars was driven primarily by increased revenues, partially offset by higher freight and warranty costs compared with the first quarter of 2018. The first quarter 2019 decrease in gross margin percentage is primarily a function of the evolution of our channel strategy and product mix as we

25

launch new products and expand internationally. Our first quarter 2019 gross margin percentage was also impacted by investments to scale infrastructure as we drive significant production capacity expansion in 2019.
Operating Expenses
 
Three Months Ended March 31,
 
Q1 2019 - Q1 2018
(Dollars in millions)
2019
 
2018
 
$ Change
 
% Change
Research and development
$
59.0

 
$
44.8

 
$
14.2

 
32
%
as a % of total revenue
21
%
 
24
%
 
 
 
 
Selling, general and administrative
124.2

 
104.8

 
19.4

 
19
%
as a % of total revenue
44
%
 
57
%
 

 

Total operating expenses
$
183.2

 
$
149.6

 
$
33.6

 
22
%
as a % of total revenue
65
%
 
81
%
 
 
 
 
Our research and development expenses primarily consist of engineering and research expenses related to our continuous glucose monitoring technology, clinical trials, regulatory expenses, quality assurance programs, materials and products for clinical trials. Research and development expenses are primarily related to employee compensation, including salary, fringe benefits, share-based compensation, and temporary employee expenses. We also incur significant expenses to operate our clinical trials including clinical site reimbursement, clinical trial product and associated travel expenses. Our research and development expenses also include fees for design services, contractors and development materials.
Our selling, general and administrative expenses primarily consist of salary, fringe benefits and share-based compensation for our executive, financial, sales, marketing, information technology and administrative functions. Other significant expenses include commissions, marketing and advertising, IT software license costs, insurance, professional fees for our outside legal counsel and independent auditors, litigation expenses, patent application expenses and consulting expenses.
On February 21, 2019, we announced a restructuring plan that will result in the transition of certain of our operations to the Philippines. The restructuring plan is designed to reduce operating expenses in order to improve cost competitiveness, enable strategic flexibility, and increase the scalability of certain business functions. We expect the restructuring plan to impact approximately 350 full time employees, or approximately 13% of our total full time workforce as of December 31, 2018. We estimate that we will incur pre-tax charges and costs of approximately $9 million, primarily for employee severance benefits under both ongoing and one-time benefit arrangements. We expect to incur these costs throughout 2019 but primarily in the first half of 2019, and we expect the restructuring activities to be substantially complete by the end of 2019.
Quarter Ended March 31, 2019 Compared to Quarter Ended March 31, 2018
Research and Development. Research and development expense increased $14.2 million or 32% for the three months ended March 31, 2019 compared to the same period of 2018. The increase was primarily due to $9.3 million in additional salaries, bonus, and payroll-related costs and $1.2 million in additional facilities costs.
Selling, General and Administrative. Selling, general and administrative expense increased $19.4 million or 19% for the three months ended March 31, 2019 compared to the same period of 2018. The increase was primarily due to higher sales-related costs that were driven by increased headcount and marketing costs to support revenue growth and the continued commercialization of our products in both the United States and Europe. Significant elements of the increase in selling, general, and administrative expenses included $7.3 million in additional salaries, bonus and payroll-related costs, $3.2 million in restructuring charges, and $2.5 million in additional consulting fees.
Non-Operating Income and Expenses
Interest Expense
Interest expense is related to our 2022 Notes and 2023 Notes and to commitment fees for unused balances on our revolving Credit Agreement. Interest expense increased $10.1 million to $14.9 million for the three months ended March 31, 2019 compared to $4.8 million for the three months ended March 31, 2018. The increase was primarily due to an additional $9.9 million of interest expense for the 2023 Notes, which were issued in November 2018.

26

Income from Equity Investments
Loss from equity investments of $4.2 million for the three months ended March 31, 2019 and income from equity investments of $7.4 million for the three months ended March 31, 2018 consists solely of realized and unrealized gains and losses on our equity investment in Tandem Diabetes Care, Inc. As of March 31, 2019, we had sold all of our equity investment in Tandem.
Interest and Other Income (Expense), Net
Interest income was $7.3 million for the three months ended March 31, 2019 compared to $1.5 million for the three months ended March 31, 2018 and is related to our marketable debt securities portfolio. Average invested balances and average interest rates both increased during 2019 compared to 2018.
Other income (expense) for the three months ended March 31, 2019 and 2018 consists primarily of foreign currency transaction gains and losses due the effects of foreign currency fluctuations.
Income Tax Expense
Income tax expense of $0.3 million on a pre-tax loss of $26.6 million resulted in a negative effective tax rate of 1% for the three months ended March 31, 2019. Income tax expense of $0.2 million on a pre-tax loss of $24.0 million resulted in a negative effective tax rate of 1% for the three months ended March 31, 2018. The negative effective tax rate in the current period resulted from recording foreign income tax in jurisdictions with current taxable income. The negative effective tax rate in the prior period resulted from recording state income and foreign withholding taxes. In both periods, no income tax benefit was recorded on losses in jurisdictions where valuation allowances are recorded against net deferred tax assets.
We maintain a full valuation allowance against our net deferred tax assets as of March 31, 2019 based on our assessment that it is not more likely than not these future benefits will be realized before expiration. We analyze our ability to realize our deferred tax assets quarterly, weighing all available positive and negative evidence of future taxable income. A release of some or all of our valuation allowance will result in a material income tax benefit in our financial statements.

Liquidity and Capital Resources
Overview, Capital Resources, and Capital Requirements
Our principal sources of liquidity are our existing cash, cash equivalents and marketable securities, cash generated from operations, proceeds from our convertible notes issuances, and access to our revolving line of credit. Our primary uses of cash have been for research and development programs, selling and marketing activities, capital expenditures, acquisitions of businesses, and debt service costs. Historically we have not generated significant cash flows from operations. However, as we have grown our profitability profile has continued to improve.
We expect that cash provided by our operations may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, working capital requirements and capital deployment decisions. We have historically invested our cash primarily in U.S. dollar-denominated, investment grade, highly liquid obligations of U.S. government-sponsored enterprises, commercial paper, corporate debt, and money market funds. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.
Our future capital requirements will depend on many factors, including but not limited to:
•
the revenue generated by sales of our approved products and other future products;
•
the expenses we incur in manufacturing, developing, selling and marketing our products;
•
the quality levels of our products and services;
•
the third-party reimbursement of our products for our customers;
•
our ability to efficiently scale our operations to meet demand for our current and any future products;
•
the costs, timing and risks of delays of additional regulatory approvals;
•
the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;
•
the rate of progress and cost of our clinical trials and other development activities;
•
the success of our research and development efforts;
•
the emergence of competing or complementary technological developments;

27

•
the terms and timing of any collaborative, licensing and other arrangements that we may establish;
•
the acquisition of businesses, products and technologies and our ability to integrate and manage any acquired businesses, products and technologies; and
•
the evolution of the international expansion of our business.
We expect that existing cash and cash flows from our future operations will generally be sufficient to fund our ongoing core business. As current borrowing sources become due, we may be required to access the capital markets for additional funding. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. In the event that we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market in light of those earning levels.
A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. Accordingly, our assessment is that we have no material net exposure to foreign currency exchange rate fluctuations at this time. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the U.S. dollar and foreign currencies, primarily the British Pound, the Euro, and the Canadian Dollar, could adversely affect our financial results, including our revenues, revenue growth rates, gross margins, income and losses as well as assets and liabilities. We currently engage in limited hedging transactions to reduce foreign currency risks on certain intercompany balances. We will continue to monitor and manage our financial exposures due to exchange rate fluctuations as an integral part of our overall risk management program. As of March 31, 2019, the cash balance held by our foreign subsidiaries with currencies other than the U.S. dollar was approximately $23.2 million. We intend to reinvest a substantial portion of our foreign earnings in those businesses, and we currently do not anticipate that we will need funds generated by foreign operations to fund our domestic operations.
As of March 31, 2019, our cash, cash equivalents and short-term marketable securities totaled $1.358 billion, a decrease of $27.6 million from December 31, 2018 due to the factors described in “Cash Flows” below. We believe that our cash, cash equivalents, and marketable securities balances, projected cash contributions from our commercial operations, and our $200.0 million revolving line of credit, of which $195.6 million remains available, will be sufficient to meet our anticipated seasonal working capital needs, capital expenditure requirements, contractual obligations, commitments, debt service requirements, and other liquidity requirements associated with our operations for at least the next 12 months.
Revolving Credit Agreement
In December 2018, we entered into a five-year $200.0 million revolving Credit Agreement, including a sub-facility of up to $10.0 million for letters of credit. Subject to customary conditions and the approval of any lender whose commitment would be increased, we have the option to increase the maximum principal amount available under the Credit Agreement by up to an additional $300.0 million, resulting in a maximum available principal amount of $500.0 million. However, at this time none of the lenders have committed to provide any such increase in their commitments. Revolving loans under the Credit Agreement will be available for general corporate purposes, including working capital and capital expenditures. As of March 31, 2019, we had no outstanding borrowings, $4.4 million in outstanding letters of credit, and a total available balance of $195.6 million under the Credit Agreement. We monitor counterparty risk associated with the institutional lenders that are providing the credit facility. We currently believe that the credit facility will be available to us should we choose to borrow under it.
See Note 5 to the financial statements in Part I, Item 1 of this Quarterly Report for more information about the terms of the Credit Agreement.
Senior Convertible Notes
In June 2017, we completed an offering of $400.0 million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.75% and a maturity date of May 15, 2022 (the 2022 Notes). Holders may elect to convert the 2022 Notes any time on or after February 15, 2022 for shares of our common stock. The 2022 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.
In November 2018, we completed an offering of $850.0 million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.75% and a maturity date of December 1, 2023 (the 2023 Notes). Holders may elect to convert the 2023 Notes any time on or after September 1, 2023 for shares of our common stock. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at out discretion. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.

28

We used a portion of the net proceeds from the offering of the 2022 Notes to repay $75.0 million of borrowings under our previous credit facility in 2017. We used a portion of the net proceeds from the offering of the 2023 Notes to repurchase 0.8 million shares of our common stock for $100.0 million in 2018. The remainder of the net proceeds from the 2022 Notes and the 2023 Notes offerings are available for general corporate purposes and capital expenditures, including working capital needs. We may also use the net proceeds to expand our current business through in-licensing or acquisitions of, or investments in, other businesses, products or technologies; however, we do not have any significant commitments with respect to any such acquisitions or investments at this time.
2023 Note Hedge
In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions (the 2023 Note Hedge) with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to 5.2 million shares of our common stock at an initial price of $164.29 per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was $218.9 million and it will expire on December 1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge. The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge.
2023 Warrants
In November 2018, we also sold warrants (the 2023 Warrants) to the 2023 Counterparties to acquire up to 5.2 million shares of our common stock for cash proceeds of $183.8 million. The 2023 Warrants require net share settlement and a pro-rated number of warrants will expire on each of the 60 scheduled trading days starting on March 1, 2024.
See Note 5 to the financial statements in Part I, Item 1 of this Quarterly Report for more information about the 2022 Notes and the 2023 Notes, the 2023 Note Hedge, and the 2023 Warrants.
Cash Flows
The following table sets forth a summary of our cash flows for the periods indicated. See the financial statements in Part I, Item 1 of this Quarterly Report for complete statements of cash flows for these periods.
 
Three Months Ended 
 March 31,
 
 
(In millions)
2019
 
2018
 
Change
Net cash provided by (used in) operating activities
$
11.8

 
$
(8.7
)
 
$
20.5

Net cash provided by (used in) investing activities
131.3

 
(15.4
)
 
146.7

Net cash provided by financing activities
4.9

 
4.2

 
0.7

Effect of exchange rates on cash, cash equivalents and restricted cash
0.6

 
(0.9
)
 
1.5

Increase (decrease) in cash, cash equivalents and restricted cash
$
148.6

 
$
(20.8
)
 
$
169.4

As of March 31, 2019, we had $1.358 billion in cash, cash equivalents and short-term marketable securities, which is a decrease of $27.6 million compared to $1.386 billion as of December 31, 2018. The primary cash flows during the three months ended March 31, 2019 are described below.

Operating Cash Flows
Net cash provided by operating activities during the three months ended March 31, 2019 was comprised of a net loss of $26.9 million and changes in working capital balances of $12.9 million, offset by $51.6 million of net non-cash expenses. Net non-cash expenses were primarily related to share-based compensation, non-cash interest expense for our senior convertible notes, depreciation and amortization, and a loss on the sale of our remaining equity investment in Tandem Diabetes Care, Inc.
Net cash used in operating activities during the three months ended March 31, 2018 was comprised of a net loss of $24.2 million and changes in working capital balances of $10.5 million, partially offset by $26.0 million of net non-cash expenses. Net non-cash expenses were primarily related to share-based compensation, depreciation and amortization, non-cash interest expense for our senior convertible notes, and income on our equity investment in Tandem Diabetes Care, Inc.

29

Investing Cash Flows
Net cash provided by investing activities during the three months ended March 31, 2019 was primarily comprised of $170.6 million in net proceeds from sales of marketable securities partially offset by $39.3 million for capital expenditures.
Net cash used in investing activities during the three months ended March 31, 2018 was primarily comprised of $15.3 million for capital expenditures.
Financing Cash Flows
Net cash provided by financing activities during the three months ended March 31, 2019 was primarily comprised of $5.0 million from the issuance of common stock under our employee stock plans.
Net cash provided by financing activities during the three months ended March 31, 2018 was primarily comprised of $4.2 million from the issuance of common stock under our employee stock plans.

Contractual Obligations
We presented our contractual obligations as of December 31, 2018 in our Annual Report on Form 10-K for the year then ended. There were no significant changes to our contractual obligations during the three months ended March 31, 2019.
We adopted ASC 842, Leases, utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. As a result of our adoption of ASC 842, we recorded operating lease right-of-use assets of $26.7 million and operating lease liabilities of $40.4 million in our balance sheet. See Note 2 to the financial statements in Part I, Item 1 of this Quarterly Report for more information.

Off-Balance Sheet Arrangements
As of March 31, 2019, we did not have any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.
Recent Accounting Pronouncements
For a description of recent accounting pronouncements and the potential impact of these pronouncements on our financial statements, see Note 1 to the financial statements in Part I, Item 1 of this Quarterly Report.


30


ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk
The primary objective of our investment activities is to preserve our capital for the purpose of funding operations while at the same time maximizing the income we receive from our investments without significantly increasing risk. To achieve these objectives, our investment policy allows us to maintain a portfolio of cash equivalents and short-term investments in a variety of securities, including money market funds, U.S. Treasury debt and corporate debt securities. We also may borrow funds through our credit facility that exposes our cash flow to interest rate risk. These borrowings are short term in nature and are reset based on market indices. Due to the short-term nature of our investments and borrowings, we believe that we have no material exposure to interest rate risk.
Market Price Sensitive Instruments
In order to reduce potential equity dilution, in connection with the issuance of the 2023 Notes, we entered into the 2023 Hedge which entitles us to purchase shares of our common stock. Upon conversion of the 2023 Notes, the 2023 Hedge is expected to reduce the equity dilution if the daily volume-weighted average price per share of our common stock exceeds the strike price of the hedge. We also entered into warrant transactions with the counterparties of the 2023 Hedge entitling them to acquire shares of our common stock. The warrant transactions could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given quarterly or annual measurement period exceeds the strike price of the warrants. See Note 5 to the financial statements in Part I, Item 1 of this Quarterly Report for more information.
Foreign Currency Risk
A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in United States dollars. Accordingly, our assessment is that we do not have any material net exposure to foreign currency exchange rate fluctuations at this time. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the U.S. dollar and foreign currencies, primarily the British Pound, the Euro, and the Canadian Dollar, could adversely affect our financial results, including our revenues, revenue growth rates, gross margins, income and losses as well as assets and liabilities.
We translate the financial statements of our foreign subsidiaries with functional currencies other than the U.S. dollar into the U.S. dollar for consolidation using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. We record net gains or losses resulting from the translation of foreign financial statements and the effect of exchange rate changes on intercompany receivables and payables of a long-term nature as a separate component of stockholders’ equity. These adjustments will affect net income only upon sale or liquidation of the underlying investment in foreign subsidiaries.
We record exchange rate fluctuations resulting from the translation of the short-term intercompany balances between domestic entities and our foreign subsidiaries as foreign currency transaction gains or losses and include them in interest and other income (expense), net in our statement of operations. From time to time we enter into foreign currency forward contracts for certain intercompany balances in order to partially offset the impact from fluctuation of the foreign currency rates. We record derivative instruments in other current assets or other current liabilities in our balance sheets consistent with the nature of the instrument at period end. As of March 31, 2019, we had no outstanding currency hedging transactions.
Notional principal amounts provide one measure of the transaction volume outstanding as of period end, but they do not represent the amount of our exposure to market loss. Estimates of fair value are based on applicable and commonly used pricing models using prevailing financial market information. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. We monitor and manage our financial exposures due to exchange rate fluctuations as an integral part of our overall risk management program, which recognizes the unpredictability of financial markets and seeks to reduce potentially adverse effects on our financial results.


31


ITEM 4.
CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Regulations under the Securities Exchange Act of 1934 require public companies to maintain “disclosure controls and procedures,” which are defined to mean a company’s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and timely communicated to management, including our Chief Executive Officer and Chief Financial Officer, recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Our management, including our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation as of the end of the period covered by this report of the effectiveness of our disclosure controls and procedures. Based on their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective for this purpose.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.
Limitation on Effectiveness of Controls
It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. The design of any control system is based, in part, upon the benefits of the control system relative to its costs. Control systems can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. In addition, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

32

PART II. OTHER INFORMATION 

ITEM 1.
LEGAL PROCEEDINGS
On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the United States District Court for the District of Oregon, asserting that certain of our products infringe certain patents held by AgaMatrix. On June 6, 2016, AgaMatrix filed a First Amended Complaint asserting the same three patents. On February 24, 2017, the Court granted AgaMatrix’s motion to substitute WaveForm Technologies, Inc., or WaveForm, as the new plaintiff following AgaMatrix’s transfer of the three patents to its newly formed entity. On August 25, 2016, we filed petitions for inter partes review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office seeking a determination that two of the three asserted patents are invalid under U.S. patent law and those petitions were granted on March 6, 2017. On March 8, 2017, we filed a petition for inter partes review with the PTAB seeking a determination that the third of the three asserted patents is invalid under U.S. patent law. This petition was granted on September 15, 2017. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On April 3, 2019, the Federal Circuit affirmed the PTAB’s finding that certain claims were not unpatentable. The PTAB issued a Final Written Decision for the third patent on September 12, 2018, where the PTAB found all claims of the third patent asserted against us in the District of Oregon litigation unpatentable. WaveForm did not appeal this decision. Most activity in the patent infringement lawsuit against us in the District of Oregon was stayed until the PTAB completed the inter partes review proceedings. That stay was lifted on October 10, 2018. The remaining claims and counterclaims will continue with an estimated date of trial in February 2020. It is our position that Waveform’s assertions of infringement have no merit.
We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against Agamatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on April 15, 2019. AgaMatrix sought attorneys' fees for this lawsuit and as of March 31, 2019 we have accrued an immaterial amount for those fees. The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix’s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the Commission on April 4, 2019 with a finding of non-infringement. On September 14, 2018, AgaMatrix filed two petitions for inter partes review for each of the same two patents we asserted in the District of Delaware and the ITC. These petitions were denied.
Neither the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys’ fees described above, as of March 31, 2019 we have accrued no amounts for contingent losses associate with these suits.
We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not believe we are party to any currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.


ITEM 1A.
RISK FACTORS

Our short and long-term success is subject to numerous risks and uncertainties, many of which involve factors that are difficult to predict or beyond our control. Before making a decision to invest in, hold or sell our common stock, stockholders and potential stockholders should carefully consider the risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 31, 2018, in addition to the other information contained in or incorporated by reference into this Quarterly Report on Form 10-Q, as well as the other information we file with the Securities and Exchange Commission. If any of the risks described in that Annual Report are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that case, the value of our common stock could decline and stockholders may

33

lose all or part of their investment. Furthermore, additional risks and uncertainties of which we are currently unaware, or which we currently consider to be immaterial, could have a material adverse effect on our business, financial condition or results of operations. Refer to our disclaimer regarding forward-looking statements at the beginning of Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part I, Item 2 of this Quarterly Report.


ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.


ITEM 3.
DEFAULTS UPON SENIOR SECURITIES
None.


ITEM 4.
MINE SAFETY DISCLOSURES
None. 


ITEM 5.
OTHER INFORMATION
None.




34


ITEM 6.
EXHIBITS
The following exhibits are filed as a part of this report.
 
 
  
 
Incorporated by Reference
Exhibit
Number
  
Exhibit Description
 
Form
 
  
 
File
No.
 
 
Date of
First
Filing
 
 
Exhibit
Number
 
 
Provided
Herewith
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
—  
  
  
 
—  
  
 
—  
  
 
—  
  
 
X
 
 
 
 
 
 
 
  
 
—  
  
  
 
—  
  
 
—  
  
 
—  
  
 
X
 
 
 
 
 
 
 
  
 
—  
  
  
 
—  
  
 
—  
  
 
—  
  
 
X
 
 
 
 
 
 
 
  
 
—  
  
  
 
—  
  
 
—  
  
 
—  
  
 
X
 
 
 
 
 
 
 
101.INS
  
XBRL Instance Document
 
 
 
  
 
 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
101.SCH
  
XBRL Taxonomy Extension Schema Document
 
 
 
  
 
 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
101.CAL
  
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
  
 
 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
101.DEF
  
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
  
 
 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
101.LAB
  
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
  
 
 
 
 
 
 
 
 
 
 
X
 
 
 
 
 
 
 
101.PRE
  
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
  
 
 
 
 
 
 
 
 
 
 
X
 
 
 
*
This certification is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that DexCom specifically incorporates it by reference.
 
 
 

35

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
 
 
 
DEXCOM, INC.
(Registrant)
 
 
 
Dated: May 1, 2019
 
By:
 
/s/ KEVIN R. SAYER
 
 
 
 
Kevin R. Sayer,
Chairman of the Board of Directors,
President and Chief Executive Officer (Principal Executive Officer)
 
 
 
Dated: May 1, 2019
 
By:
 
/s/ QUENTIN S. BLACKFORD
 
 
 
 
Quentin S. Blackford,
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

36
 EX-31.01 2 dxcm3312019exhibit3101.htm EXHIBIT 31.01 Exhibit


Exhibit 31.01
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Kevin R. Sayer, certify that:
1. I have reviewed this quarterly report on Form 10-Q of DexCom, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 

 
 
 
 
May 1, 2019
By:
 
/s/ Kevin R. Sayer
 
 
 
Kevin R. Sayer
 
 
 
Chairman of the Board of Directors, President and
 
 
 
Chief Executive Officer
 
 
 
(Principal Executive Officer)


 EX-31.02 3 dxcm3312019exhibit3102.htm EXHIBIT 31.02 Exhibit


Exhibit 31.02
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Quentin S. Blackford, certify that:
1. I have reviewed this quarterly report on Form 10-Q of DexCom, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including any consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
 
 
 
May 1, 2019
By:
 
/s/ Quentin S. Blackford
 
 
 
Quentin S. Blackford
 
 
 
Executive Vice President and Chief Financial Officer     
 
 
 
(Principal Financial and Accounting Officer)


 EX-32.01 4 dxcm3312019exhibit3201.htm EXHIBIT 32.01 Exhibit


Exhibit 32.01
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C SECTION 1350
The undersigned, Kevin R. Sayer, the President and Chief Executive Officer of DexCom, Inc. (the “Company”), pursuant to 18 U.S.C. §1350, hereby certifies that:
(i) the quarterly Report on Form 10-Q for the period ended March 31, 2019 of the Company (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 1, 2019
 
 
/s/ Kevin R. Sayer
Kevin R. Sayer
Chairman of the Board of Directors, President and
Chief Executive Officer
(Principal Executive Officer)


 EX-32.02 5 dxcm3312019exhibit3202.htm EXHIBIT 32.02 Exhibit


Exhibit 32.02
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350
The undersigned, Quentin S. Blackford, Chief Financial Officer of DexCom, Inc. (the “Company”), pursuant to 18 U.S.C. §1350, hereby certifies:
(i) the quarterly Report on Form 10-Q for the period ended March 31, 2019 of the Company (the “Report”) fully complies with the requirements of Section 13(a) and 15(d) of the Securities Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: May 1, 2019
 
 
/s/ Quentin S. Blackford
Quentin S. Blackford
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)



 EX-101.INS 6 dxcm-20190331.xml XBRL INSTANCE DOCUMENT 0001093557 2019-01-01 2019-03-31 0001093557 2019-04-25 0001093557 2018-12-31 0001093557 2019-03-31 0001093557 2018-01-01 2018-03-31 0001093557 us-gaap:RetainedEarningsMember 2018-12-31 0001093557 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001093557 us-gaap:CommonStockMember 2019-03-31 0001093557 us-gaap:TreasuryStockMember 2019-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001093557 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001093557 us-gaap:CommonStockMember 2018-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001093557 us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001093557 us-gaap:TreasuryStockMember 2018-12-31 0001093557 us-gaap:RetainedEarningsMember 2019-03-31 0001093557 us-gaap:RetainedEarningsMember 2017-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001093557 us-gaap:CommonStockMember 2017-12-31 0001093557 2018-03-31 0001093557 us-gaap:TreasuryStockMember 2018-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001093557 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001093557 us-gaap:RetainedEarningsMember 2018-03-31 0001093557 us-gaap:CommonStockMember 2018-03-31 0001093557 us-gaap:TreasuryStockMember 2017-12-31 0001093557 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001093557 2017-12-31 0001093557 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001093557 us-gaap:WarrantMember 2018-01-01 2018-03-31 0001093557 us-gaap:WarrantMember 2019-01-01 2019-03-31 0001093557 us-gaap:ConvertibleDebtSecuritiesMember dxcm:ConvertibleNotesdue2023Member 2019-01-01 2019-03-31 0001093557 us-gaap:ConvertibleDebtSecuritiesMember dxcm:ConvertibleNotesdue2022Member 2019-01-01 2019-03-31 0001093557 us-gaap:ConvertibleDebtSecuritiesMember dxcm:ConvertibleNotesdue2022Member 2018-01-01 2018-03-31 0001093557 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001093557 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0001093557 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0001093557 us-gaap:ConvertibleDebtSecuritiesMember dxcm:ConvertibleNotesdue2023Member 2018-01-01 2018-03-31 0001093557 dxcm:EdgeparkMember 2018-12-31 0001093557 dxcm:ByramMember 2018-01-01 2018-03-31 0001093557 dxcm:EdgeparkMember 2019-01-01 2019-03-31 0001093557 dxcm:ByramMember 2019-03-31 0001093557 dxcm:ByramMember 2019-01-01 2019-03-31 0001093557 dxcm:EdgeparkMember 2018-01-01 2018-03-31 0001093557 dxcm:ByramMember 2018-12-31 0001093557 dxcm:EdgeparkMember 2019-03-31 0001093557 dxcm:LeasedBuildings232SouthDobsonRoadMember 2019-01-01 2019-03-31 0001093557 us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2019-01-01 0001093557 2019-01-01 0001093557 dxcm:LeasedBuildings232SouthDobsonRoadMember 2019-03-31 0001093557 us-gaap:BuildingMember 2019-03-31 0001093557 us-gaap:BuildingMember 2019-01-01 2019-03-31 0001093557 dxcm:LeasedBuildings6340SequenceDrive6310SequenceDrive6290SequencedriveMember 2019-01-01 2019-03-31 0001093557 dxcm:LeasedBuildings6340SequenceDrive6310SequenceDrive6290SequencedriveMember 2019-03-31 0001093557 dxcm:LeasedBuildings6350SequenceMember 2019-03-31 0001093557 dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2019-03-31 0001093557 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-03-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2019-03-31 0001093557 dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2018-12-31 0001093557 us-gaap:CommercialPaperMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel2Member 2019-03-31 0001093557 us-gaap:FairValueInputsLevel3Member 2019-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001093557 us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialPaperMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialPaperMember 2019-03-31 0001093557 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel1Member 2019-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2019-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel2Member 2018-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialPaperMember 2018-03-31 0001093557 dxcm:TandemDiabetesCareIncMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel3Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialPaperMember 2018-03-31 0001093557 dxcm:TandemDiabetesCareIncMember us-gaap:FairValueInputsLevel2Member 2018-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialPaperMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel1Member 2018-03-31 0001093557 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel3Member 2018-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2018-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-03-31 0001093557 dxcm:TandemDiabetesCareIncMember us-gaap:FairValueInputsLevel1Member 2018-03-31 0001093557 us-gaap:FairValueMeasurementsRecurringMember 2018-03-31 0001093557 us-gaap:CommercialPaperMember 2018-03-31 0001093557 us-gaap:CorporateDebtSecuritiesMember 2018-03-31 0001093557 dxcm:TandemDiabetesCareIncMember us-gaap:FairValueInputsLevel3Member 2018-03-31 0001093557 us-gaap:FairValueInputsLevel2Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2018-03-31 0001093557 2019-02-01 2019-02-28 0001093557 dxcm:ReceiverProductComponentMember 2019-01-01 2019-03-31 0001093557 us-gaap:CommercialPaperMember 2018-12-31 0001093557 2018-01-01 2018-12-31 0001093557 dxcm:TandemDiabetesCareIncMember 2018-01-01 2018-12-31 0001093557 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001093557 dxcm:TandemDiabetesCareIncMember 2018-12-31 0001093557 us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2018-12-31 0001093557 us-gaap:ConstructionInProgressMember 2019-03-31 0001093557 us-gaap:EquipmentMember 2018-12-31 0001093557 us-gaap:LeaseholdImprovementsMember 2019-03-31 0001093557 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001093557 us-gaap:ComputerEquipmentMember 2019-03-31 0001093557 us-gaap:EquipmentMember 2019-03-31 0001093557 us-gaap:FurnitureAndFixturesMember 2019-03-31 0001093557 us-gaap:BuildingMember 2019-03-31 0001093557 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001093557 us-gaap:BuildingMember 2018-12-31 0001093557 us-gaap:ComputerEquipmentMember 2018-12-31 0001093557 us-gaap:ConstructionInProgressMember 2018-12-31 0001093557 dxcm:DebtInstrumentConversionTermTwoMember srt:MaximumMember dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 us-gaap:LetterOfCreditMember dxcm:ForeignCurrencyLineofCreditMember 2018-12-31 0001093557 us-gaap:LineOfCreditMember 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 dxcm:DebtInstrumentConversionTermOneMember srt:MaximumMember dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2017-06-30 0001093557 dxcm:DebtInstrumentConversionTermTwoMember dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 dxcm:DebtInstrumentConversionTermOneMember srt:MinimumMember dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2018-12-31 0001093557 srt:MaximumMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-12-01 2018-12-31 0001093557 srt:MinimumMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-12-01 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2018-11-01 2018-11-30 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2018-11-30 0001093557 dxcm:DebtInstrumentConversionTermTwoMember srt:MaximumMember dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 srt:MaximumMember us-gaap:LineOfCreditMember 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2017-06-01 2017-06-30 0001093557 dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember 2018-01-01 2018-03-31 0001093557 us-gaap:LineOfCreditMember 2018-12-01 2018-12-31 0001093557 srt:MinimumMember us-gaap:LineOfCreditMember 2018-12-01 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2018-11-01 2018-11-30 0001093557 us-gaap:LetterOfCreditMember 2019-03-31 0001093557 dxcm:ConvertibleNotesdue2022Member us-gaap:SeniorNotesMember us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001093557 srt:MaximumMember us-gaap:LineOfCreditMember 2018-12-01 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2018-11-30 0001093557 dxcm:DebtInstrumentConversionTermTwoMember dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 dxcm:DebtInstrumentConversionTermOneMember srt:MinimumMember dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 srt:MinimumMember us-gaap:LineOfCreditMember 2018-12-31 0001093557 dxcm:DebtInstrumentConversionTermOneMember srt:MaximumMember dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 dxcm:ZeroPointSevenFivePercentSeniorConvertibleNotesMember us-gaap:SeniorNotesMember 2018-12-31 0001093557 dxcm:ZeroPointSevenFivePercentSeniorConvertibleNotesMember us-gaap:SeniorNotesMember 2019-03-31 0001093557 us-gaap:SeniorNotesMember 2018-12-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2018-01-01 2018-03-31 0001093557 us-gaap:SeniorNotesMember 2018-01-01 2018-03-31 0001093557 us-gaap:SeniorNotesMember 2019-01-01 2019-03-31 0001093557 us-gaap:SeniorNotesMember 2019-03-31 0001093557 dxcm:ConvertibleNotesdue2023Member us-gaap:SeniorNotesMember 2017-06-01 2017-06-30 0001093557 dxcm:AgaMatrixMember 2017-09-15 2017-09-15 0001093557 dxcm:WaveFormTechnologiesInc.Member 2017-03-08 2017-03-08 0001093557 dxcm:AgaMatrixMember 2016-06-06 2016-06-06 0001093557 dxcm:AgaMatrixMember 2018-09-14 2018-09-14 0001093557 dxcm:WaveFormTechnologiesInc.Member 2018-03-30 2018-03-30 0001093557 dxcm:WaveFormTechnologiesInc.Member 2017-02-24 2017-02-24 0001093557 2018-09-14 2018-09-14 0001093557 dxcm:WaveFormTechnologiesInc.Member 2018-02-28 2018-02-28 0001093557 dxcm:WaveFormTechnologiesInc.Member 2016-08-25 2016-08-25 0001093557 us-gaap:PerformanceSharesMember 2019-01-01 2019-03-31 0001093557 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001093557 dxcm:SellingGeneralAndAdministrativeMember 2019-01-01 2019-03-31 0001093557 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-03-31 0001093557 us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0001093557 dxcm:SellingGeneralAndAdministrativeMember 2018-01-01 2018-03-31 0001093557 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-03-31 0001093557 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0001093557 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001093557 us-gaap:RestrictedStockUnitsRSUMember 2019-03-31 0001093557 country:US 2018-01-01 2018-03-31 0001093557 country:US 2019-01-01 2019-03-31 0001093557 us-gaap:NonUsMember 2018-01-01 2018-03-31 0001093557 us-gaap:NonUsMember 2019-01-01 2019-03-31 0001093557 us-gaap:SalesChannelThroughIntermediaryMember 2018-01-01 2018-03-31 0001093557 us-gaap:SalesChannelDirectlyToConsumerMember 2018-01-01 2018-03-31 0001093557 us-gaap:SalesChannelThroughIntermediaryMember 2019-01-01 2019-03-31 0001093557 us-gaap:SalesChannelDirectlyToConsumerMember 2019-01-01 2019-03-31 xbrli:pure utreg:sqft dxcm:customer xbrli:shares dxcm:number_patents iso4217:USD xbrli:shares utreg:D iso4217:USD dxcm:Petition dxcm:segment dxcm:renewal_term false --12-31 Q1 2019 2019-03-31 10-Q 0001093557 91050405 false Large Accelerated Filer DEXCOM INC false DXCM 11700000 12300000 P1Y 0.15 0.19 0.1 0.11 0.17 2 5173865 1000 1000 1 1 1.4 1.3 248600000 72900000 36000000 100000 212700000 0 0 0 15700000 7300000 15200000 148800 219000 132600 87000 4 2 0 -900000 300000000 2 3 2 2 2 2 3 41800000 36100000 40900000 1 0.79 0.21 0.36 0.64 1 0.75 0.25 0.33 0.67 P30D 45200000 0 147100000 169100000 75500000 90300000 226700000 204700000 79800000 88400000 1500000 1600000 1560600000 1590600000 218900000 24600000 24600000 25000000 25000000 24600000 13900000 2200000 8500000 25000000 14200000 2300000 8500000 3700000 3300000 12200000 3500000 7800000 400000 400000 500000 7500000 4000000 0 400000 3100000 0 16700000 4000000 5200000 0 2300000 5200000 1916000000 1974000000 1699500000 1690800000 237300000 277300000 0 514600000 309900000 122500000 0 432400000 0 0 0 0 0 0 0 0 100000 0 0 100000 0 0 0 0 210700000 36200000 1300000 173200000 72900000 3000000 15100000 54800000 210600000 0 0 0 0 210600000 36200000 1300000 173100000 0 0 0 0 36200000 1300000 173100000 210600000 36200000 1300000 173100000 72900000 0 0 0 0 72900000 3000000 15100000 54800000 0 0 0 0 3000000 15100000 54800000 420400000 1137000000 1285100000 441500000 420700000 1137100000 1285700000 -20800000 148600000 266000000 199300000 66700000 0 359500000 309900000 49600000 0 198.3840 0.001 0.001 200000000 200000000 91100000 92100000 90000000 91000000 100000 100000 -26500000 -26800000 0.14 0.13 0.1 0.11 0.15 2900000 2700000 1500000 2400000 540200000 859600000 1399800000 537500000 876300000 1413800000 1010300000 342600000 667700000 1022400000 346400000 676000000 65500000 111700000 -2100000 0 7400000 -4200000 5200000 0.02 0.01375 99.09 164.29 0.0100918 0.0060869 125400000 0 125400000 121700000 0 121700000 60 30 30 20 20 5 5 5 5 1.3 1.3 0.98 0.98 400000000.0 400000000.0 850000000.0 400000000.0 850000000.0 850000000 0.0514 0.0563 0.0075 0.01 0.00375 0.0075 1 1 P5Y 51100000 171800000 47700000 164000000 9400000 0 6000000 9900000 -0.28 -0.30 -900000 600000 -0.01 72600000 174400000 72400000 51300000 188300000 7400000 -4200000 38000000 2000000 36000000 0 0 0 200000 200000 15700000 15900000 500000 15200000 21800000 15400000 1400000 1400000 1300000 1300000 1000000 6100000 100000 15300000 300000 0.050 P14Y 2 18700000 18600000 118900000 168800000 -24000000 -26600000 200000 300000 2200000 25500000 -10700000 -21500000 -14400000 -21100000 6400000 30400000 100000 -3000000 2700000 5400000 4800000 14900000 800000 700000 1600000 28700000 38400000 70700000 101100000 30800000 52700000 11200000 10000000 1600000 4100000 6900000 38000000 38000000 0 0 5100000 46300000 1000000 1600000 3700000 14500000 14200000 11300000 3600000 P5Y 1252700000 1305400000 1916000000 1974000000 222400000 235400000 200000000 4400000 50000000 10000000 500000000 195600000 0.003 0.0020 0 0 1010300000 1022400000 0 3 4200000 4900000 -15400000 131300000 -8700000 11800000 -24200000 -24200000 -26900000 -26900000 2100000 2100000 4300000 10100000 1 149600000 183200000 -30700000 -14400000 2500000 42700000 40400000 0 12300000 0 29500000 4600000 0 27700000 26700000 0.050 P3Y4M2D 17000000 18500000 14700000 15500000 -2300000 0 -2300000 100000 -2300000 -2300000 100000 100000 0 100000 20000000 18100000 900000 -300000 3300000 2900000 32000000 50700000 1000000 1200000 15300000 39300000 0.001 0.001 5000000 5000000 0 0 0 0 0 0 16500000 27000000 389000000 836600000 4200000 5000000 183800000 0 -100000 32900000 222500000 262900000 6000000 29200000 57300000 80700000 9000000 80700000 309800000 15300000 31600000 88100000 82500000 9100000 83200000 183100000 221400000 44800000 59000000 300000 600000 9000000 0 1100000 -798900000 -823700000 184400000 145400000 39000000 66100000 118300000 280500000 210500000 70000000 92700000 187800000 15300000 29900000 104800000 124200000 24600000 25000000 100000 95.68 600000 143.24 2700000 2300000 69.19 89.57 900000 0 132300000 65.77 319000000 277400000 87000000 88100000 90000000 91000000 1300000 6800000 6000000 1000000 900000 100000 100000 100000 100000 200000 200000 4100000 4100000 4800000 4800000 419400000 -2600000 1093700000 100000 -671800000 0 421700000 -4900000 1122500000 100000 -696000000 0 663300000 1500000 1560600000 100000 -798900000 -100000000 668600000 1600000 1590600000 100000 -823700000 -100000000 800000 800000 100000000 100000000 6300000 10500000 5900000 10000000 5100000 4700000 800000 87300000 90300000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet Details </font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Short-Term Marketable Securities </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total marketable securities </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost or Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">248.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:20px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, all of our debt securities had contractual maturities of less than </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;"> months. Gross realized gains and losses on sales of our debt securities during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> were not significant.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We periodically review our portfolio of debt securities to determine if any investment is other-than-temporarily impaired due to changes in credit risk or other potential valuation concerns. We believe that the investments we held at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> were not other-than-temporarily impaired. Unrealized losses on available-for-sale debt securities at that date were not significant and were due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventory</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> we recorded excess and obsolete inventory charges of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> in cost of goods sold as a result of our ongoing assessment of sales demand and inventory on hand. </font></div><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property and Equipment</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and hardware</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Building and Land. </font><font style="font-family:inherit;font-size:10pt;">Although we do not legally own these premises, under previous lease accounting standards we were deemed the owner of the construction project during the construction period of our manufacturing facility in Mesa, Arizona under a build-to-suit lease arrangement. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell that was included in Building in our balance sheet as of December 31, 2018 and the related lease liability and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019. See Note 2, &#8220;Leases,&#8221; for more information on our adoption of ASC 842.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Construction in Progress. </font><font style="font-family:inherit;font-size:10pt;">The increase in construction in progress as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> compared to </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> is primarily due to continued investment in the expansion and automation of our production capabilities. </font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Payable and Accrued Liabilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable trade</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued tax, audit, and legal fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued rebates</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued warranty</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring reserve</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring Reserve.</font><font style="font-family:inherit;font-size:10pt;"> In February 2019, our Board of Directors approved a restructuring plan that will result in the transition of certain of our operations to the Philippines. We estimate that we will incur total pre-tax charges and costs of approximately </font><font style="font-family:inherit;font-size:10pt;">$9 million</font><font style="font-family:inherit;font-size:10pt;">, primarily for employee severance benefits under both ongoing and one-time benefit arrangements. We expect to incur these costs throughout 2019 but primarily in the first half of 2019, and we expect the restructuring activities to be substantially complete by the end of 2019. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred rent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our adoption of ASC 842 during the first quarter of 2019 affected the balances of finance lease liabilities and deferred rent as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. See Note 2, &#8220;Leases,&#8221; for more information.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Organization and Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of</font><font style="font-family:inherit;font-size:10pt;"> continuous glucose monitoring, or CGM,</font><font style="font-family:inherit;font-size:10pt;"> systems for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have prepared the accompanying unaudited consolidated financial statements (the financial statements) in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the year ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We experience seasonality that is typical in our industry, with lower sales in the first quarter of each year compared to the fourth quarter.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> included in the Annual Report on Form 10-K that we filed with the SEC on </font><font style="font-family:inherit;font-size:10pt;">February&#160;21, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Litigation </font></div><div style="line-height:120%;padding-top:5px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the United States District Court for the District of Oregon, asserting that certain of our products infringe certain patents held by AgaMatrix. On June 6, 2016, AgaMatrix filed a First Amended Complaint asserting the same three patents. On February 24, 2017, the Court granted AgaMatrix&#8217;s motion to substitute WaveForm Technologies, Inc., or WaveForm, as the new plaintiff following AgaMatrix&#8217;s transfer of the three patents to its newly formed entity. On August 25, 2016, we filed petitions for </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter partes</font><font style="font-family:inherit;font-size:10pt;"> review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office seeking a determination that two of the three asserted patents are invalid under U.S. patent law and those petitions were granted on March 6, 2017. On March 8, 2017, we filed a petition for </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter partes</font><font style="font-family:inherit;font-size:10pt;"> review with the PTAB seeking a determination that the third of the three asserted patents is invalid under U.S. patent law. This petition was granted on September 15, 2017. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On April 3, 2019, the Federal Circuit affirmed the PTAB&#8217;s finding that certain claims were not unpatentable. The PTAB issued a Final Written Decision for the third patent on September 12, 2018, where the PTAB found all claims of the third patent asserted against us in the District of Oregon litigation unpatentable. WaveForm did not appeal this decision. Most activity in the patent infringement lawsuit against us in the District of Oregon was stayed until the PTAB completed the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter partes</font><font style="font-family:inherit;font-size:10pt;"> review proceedings. That stay was lifted on October 10, 2018. The remaining claims and counterclaims will continue with an estimated date of trial in February 2020. It is our position that Waveform&#8217;s assertions of infringement have no merit.</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-top:5px;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against Agamatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on April 15, 2019. AgaMatrix sought attorneys' fees for this lawsuit and as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> we have accrued an immaterial amount for those fees. The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix&#8217;s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the Commission on April 4, 2019 with a finding of non-infringement. On September 14, 2018, AgaMatrix filed two petitions for </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter partes</font><font style="font-family:inherit;font-size:10pt;"> review for each of the same two patents we asserted in the District of Delaware and the ITC. These petitions were denied. </font></div><div style="line-height:120%;padding-top:5px;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Neither&#160;the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys&#8217; fees described above, as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> we have accrued </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> amounts for contingent losses associated with these suits.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. </font><font style="font-family:inherit;font-size:10pt;">We do not expect that the resolution of these matters would, or will, have a material adverse effect or material impact on our financial position or results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have prepared the accompanying unaudited consolidated financial statements (the financial statements) in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the year ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We experience seasonality that is typical in our industry, with lower sales in the first quarter of each year compared to the fourth quarter.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> included in the Annual Report on Form 10-K that we filed with the SEC on </font><font style="font-family:inherit;font-size:10pt;">February&#160;21, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Senior Convertible Notes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt discount</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">346.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal amount</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">850.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">850.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt discount</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(164.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2023</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">676.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net carrying amount of senior convertible notes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,022.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,010.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of outstanding senior convertible notes:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">540.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">876.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">859.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total fair value of outstanding senior convertible notes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,413.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,399.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount by which the notes' if-converted value exceeds their principal amount:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total by which the notes' if-converted value exceeds their principal amount</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75%</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Senior Convertible Notes due 2022</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2017, we completed an offering of </font><font style="font-family:inherit;font-size:10pt;">$400.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of unsecured senior convertible senior notes with a stated interest rate of </font><font style="font-family:inherit;font-size:10pt;">0.75%</font><font style="font-family:inherit;font-size:10pt;"> and a maturity date of </font><font style="font-family:inherit;font-size:10pt;">May&#160;15, 2022</font><font style="font-family:inherit;font-size:10pt;"> (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately </font><font style="font-family:inherit;font-size:10pt;">$389.0 million</font><font style="font-family:inherit;font-size:10pt;">. The 2022 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all 2022 Notes conversions in shares of our common stock. The initial conversion rate of the 2022 Notes is </font><font style="font-family:inherit;font-size:10pt;">10.0918</font><font style="font-family:inherit;font-size:10pt;"> shares per </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount of notes, which is equivalent to a conversion price of approximately </font><font style="font-family:inherit;font-size:10pt;">$99.09</font><font style="font-family:inherit;font-size:10pt;"> per share, subject to adjustments. We use the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized </font><font style="font-family:inherit;font-size:10pt;">$72.6 million</font><font style="font-family:inherit;font-size:10pt;"> in additional paid-in-capital during 2017.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interest expense recognized on the 2022 Notes during the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> includes </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2022 Notes during the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> includes </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2022 Notes is </font><font style="font-family:inherit;font-size:10pt;">5.1%</font><font style="font-family:inherit;font-size:10pt;">, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. The discount on the 2022 Notes is amortized through May 15, 2022. </font><font style="font-family:inherit;font-size:10pt;">Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by DexCom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior to 5:00 p.m., New York City time, on the business day immediately preceding February&#160;15, 2022, holders of the 2022 Notes may convert all or a portion of their notes, in multiples of $</font><font style="font-family:inherit;font-size:10pt;">1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount, only under the following circumstances:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;padding-left:12px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;text-indent:-12px;"><font style="font-family:inherit;font-size:10pt;">during any calendar quarter commencing after September&#160;30, 2017 (and only during such calendar quarter), if the last reported sale price of common stock for at least </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during the period of </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to </font><font style="font-family:inherit;font-size:10pt;">130%</font><font style="font-family:inherit;font-size:10pt;"> of the applicable conversion price of the Notes on each such trading day;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">during the </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> business day period after any </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading day period in which the trading price per $</font><font style="font-family:inherit;font-size:10pt;">1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount of the Notes for each day of that </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> day consecutive trading day period was less than </font><font style="font-family:inherit;font-size:10pt;">98%</font><font style="font-family:inherit;font-size:10pt;"> of the product of the last reported sale price of common stock and the applicable conversion rate of the Notes on such trading day;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if we call any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">upon the occurrence of specified corporate transactions.</font></div></td></tr></table><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;On or after </font><font style="font-family:inherit;font-size:10pt;">February&#160;15, 2022</font><font style="font-family:inherit;font-size:10pt;">, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom may not redeem the 2022 Notes prior to May 15, 2020. On or after May 15, 2020, DexCom may redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock has been at least </font><font style="font-family:inherit;font-size:10pt;">140%</font><font style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for at least </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No principal payments are due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes includes customary terms and covenants, including certain events of default after which the 2022 Notes may be due and payable immediately. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Circumstance (1) listed above occurred during the last </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> trading days of the quarter ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. As a result, the 2022 Notes are convertible at the option of the holders from April 1, 2019 and will remain convertible until June 30, 2019. We continue to classify the carrying value of the liability component of the 2022 Notes as long-term debt, and the equity component of the 2022 Notes as permanent equity in our balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:174%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">0.75%</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Senior Convertible Notes due 2023</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2018, we completed an offering of&#160;</font><font style="font-family:inherit;font-size:10pt;">$850.0 million</font><font style="font-family:inherit;font-size:10pt;">&#160;aggregate principal amount of unsecured senior convertible notes with a stated interest rate of&#160;</font><font style="font-family:inherit;font-size:10pt;">0.75%</font><font style="font-family:inherit;font-size:10pt;">&#160;and a maturity date of&#160;</font><font style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</font><font style="font-family:inherit;font-size:10pt;">&#160;(the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers&#8217; discounts and costs directly related to the offering, were approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">$836.6 million</font><font style="font-family:inherit;font-size:10pt;">. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all 2023 Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any note conversion value in excess of the principal amount in shares of our common stock. The initial conversion rate of the 2023 Notes is&#160;</font><font style="font-family:inherit;font-size:10pt;">6.0869</font><font style="font-family:inherit;font-size:10pt;">&#160;shares per&#160;</font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount of notes, which is equivalent to a conversion price of approximately&#160;</font><font style="font-family:inherit;font-size:10pt;">$164.29</font><font style="font-family:inherit;font-size:10pt;">&#160;per share, subject to adjustments. We use the treasury stock method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders&#8217; equity. As a result, we recognized </font><font style="font-family:inherit;font-size:10pt;">$174.4 million</font><font style="font-family:inherit;font-size:10pt;"> in additional paid-in capital during 2018.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interest expense recognized on the 2023 Notes during the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended&#160;</font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">&#160;includes&#160;</font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$7.8 million</font><font style="font-family:inherit;font-size:10pt;"> and&#160;</font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#160;for the contractual&#160;coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively.&#160;The effective interest rate on the 2023 Notes is </font><font style="font-family:inherit;font-size:10pt;">5.6%</font><font style="font-family:inherit;font-size:10pt;">, which includes the interest on the notes, amortization of the&#160;debt discount and debt issuance costs. The discount on the 2023 Notes is being amortized through </font><font style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;">Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by DexCom of a notice of redemption.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September&#160;1, 2023, in multiples of </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount, only under the following circumstances:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of common stock for at least </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during the period of </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to </font><font style="font-family:inherit;font-size:10pt;">130%</font><font style="font-family:inherit;font-size:10pt;"> of the applicable conversion price of the 2023 Notes on each such trading day;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">during the </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> business day period after any </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading day period in which the trading price per </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> principal amount of the 2023 Notes for each day of that </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-day consecutive trading day period was less than </font><font style="font-family:inherit;font-size:10pt;">98%</font><font style="font-family:inherit;font-size:10pt;"> of the product of the last reported sale price of common stock and the applicable conversion rate of the 2023 Notes on such trading day;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">upon the occurrence of specified corporate transactions.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On or after </font><font style="font-family:inherit;font-size:10pt;">September&#160;1, 2023</font><font style="font-family:inherit;font-size:10pt;">, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, DexCom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least </font><font style="font-family:inherit;font-size:10pt;">130%</font><font style="font-family:inherit;font-size:10pt;"> of the conversion price then in effect for at least </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> trading days (whether or not consecutive) during any </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. As of the date of these financial statements, we are unaware of any current events or market conditions that would allow holders to convert the 2023 Notes.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Note Hedge</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to&#160;</font><font style="font-family:inherit;font-size:10pt;">5.2 million</font><font style="font-family:inherit;font-size:10pt;">&#160;shares of our common stock at an initial price of&#160;</font><font style="font-family:inherit;font-size:10pt;">$164.29</font><font style="font-family:inherit;font-size:10pt;">&#160;per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was&#160;</font><font style="font-family:inherit;font-size:10pt;">$218.9 million</font><font style="font-family:inherit;font-size:10pt;"> and we accounted for it as an equity instrument by recognizing </font><font style="font-family:inherit;font-size:10pt;">$218.9 million</font><font style="font-family:inherit;font-size:10pt;"> in&#160;additional paid-in capital&#160;during 2018. The 2023 Note Hedge will expire on </font><font style="font-family:inherit;font-size:10pt;">December&#160;1, 2023</font><font style="font-family:inherit;font-size:10pt;">. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge.&#160;The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2023 Warrants</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to&#160;</font><font style="font-family:inherit;font-size:10pt;">5.2 million</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> scheduled trading days starting on </font><font style="font-family:inherit;font-size:10pt;">March&#160;1, 2024</font><font style="font-family:inherit;font-size:10pt;">. We received&#160;</font><font style="font-family:inherit;font-size:10pt;">$183.8 million</font><font style="font-family:inherit;font-size:10pt;">&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially </font><font style="font-family:inherit;font-size:10pt;">$198.38</font><font style="font-family:inherit;font-size:10pt;"> per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</font></div><div style="line-height:120%;padding-top:18px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revolving Credit Agreement</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2018, we entered into a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> revolving credit agreement (the Credit Agreement) with JPMorgan Chase Bank, NA, as administrative agent, Bank of America, Silicon Valley Bank, Union Bank and Bank of the West. The Credit Agreement provides a </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> sublimit for borrowings in Canadian Dollars, Euros, British Pounds, Swedish Krona, Japanese Yen and any other currency that is subsequently approved by the lenders and a sub-facility of up to </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;"> for letters of credit. Subject to customary conditions and the approval of any lender whose commitment would be increased, we have the option to increase the maximum principal amount available under the Credit Agreement by up to an additional </font><font style="font-family:inherit;font-size:10pt;">$300.0 million</font><font style="font-family:inherit;font-size:10pt;">, resulting in a maximum available principal amount of </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;">. However, at this time none of the lenders have committed to provide any such increase in their commitments. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from </font><font style="font-family:inherit;font-size:10pt;">0.375%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.000%</font><font style="font-family:inherit;font-size:10pt;">. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from </font><font style="font-family:inherit;font-size:10pt;">1.375%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">2.000%</font><font style="font-family:inherit;font-size:10pt;">. We will also pay a commitment fee of between </font><font style="font-family:inherit;font-size:10pt;">0.2%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.3%</font><font style="font-family:inherit;font-size:10pt;">, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We drew no loans under the Credit Agreement during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding borrowings, letters of credit totaling </font><font style="font-family:inherit;font-size:10pt;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;">, and a total available balance of </font><font style="font-family:inherit;font-size:10pt;">$195.6 million</font><font style="font-family:inherit;font-size:10pt;"> under the Credit Agreement. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Short-Term Marketable Securities </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total marketable securities </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost or Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Market</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">248.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth revenues disaggregated by customer sales channel:</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders&#8217; Equity</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation Expense</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes share-based compensation expense for the periods shown:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense included in net loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, unrecognized estimated compensation costs related to unvested restricted stock units, or RSUs, and performance stock units, or PSUs, totaled </font><font style="font-family:inherit;font-size:10pt;">$188.3 million</font><font style="font-family:inherit;font-size:10pt;"> and is expected to be recognized through 2021.</font></div><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Stock Units</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of our RSU and PSU activity for the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions, except weighted average grant date fair values)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total vest date fair value of RSUs that vested during the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$132.3 million</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> PSUs vested during that period.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Net Income (Loss) Per Share</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common share equivalents that we calculate using the treasury stock method include outstanding stock options and unvested RSUs that are settleable in shares of common stock and potential common shares from convertible securities that we intend to settle using a combination of shares of our common stock and cash. Common share equivalents that we calculate using the if-converted method include potential common shares from convertible securities that we intend to settle using only shares of our common stock.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because we reported net losses for the three months ended March 31, 2019 and 2018, all potentially dilutive common shares have been excluded from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.</font></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:24px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">514.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Fair Value Measurements</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Assets and Liabilities Measured at Fair Value on a Recurring Basis</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market-related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.</font></div><div style="line-height:120%;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">359.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">122.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">432.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:24px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes financial assets that we measured at fair value on a recurring basis as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, classified in accordance with the fair value hierarchy.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Measurements Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity investment in Tandem Diabetes Care, Inc.</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt securities, available for sale:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government agencies</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial paper</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt securities, available for sale</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets measured at fair value on a recurring basis</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">514.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:20px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> transfers between Level 1 and Level 2 securities during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> transfers into or out of Level 3 securities during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial liabilities whose fair values we measure on a recurring basis using Level 1 inputs consist of our outstanding 2022 Notes and 2023 Notes. We measure the fair value of the 2022 Notes and 2023 Notes based on their trading prices. The fair value of the 2022 Notes was </font><font style="font-family:inherit;font-size:10pt;">$537.5 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$540.2 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. The fair value of the 2023 Notes was </font><font style="font-family:inherit;font-size:10pt;">$876.3 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$859.6 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. For more information on the carrying values and fair values of our 2022 Notes and 2023 Notes, see Note 5, &#8220;Debt.&#8221;</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency and Derivative Financial Instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time we engage in limited hedging transactions to reduce foreign currency risks on certain intercompany balances. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs. As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding currency hedging transactions.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">Future minimum lease payments under non-cancellable leases as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total future lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Present value of future payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> was a negative rate of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;">. The negative effective tax rate in the current period resulted from recording foreign income tax in jurisdictions with current taxable income. The negative effective tax rate in the prior period resulted from recording state income and foreign withholding taxes. In both periods, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> income tax benefit was recorded on losses in jurisdictions where valuation allowances are recorded against net deferred tax assets.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain a full valuation allowance against our net deferred tax assets as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> based on our assessment that it is not more likely than not these future benefits will be realized before expiration. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financing cash flows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term in years:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">The components of lease expense for the </font><font style="font-family:inherit;font-size:10pt;color:#252525;">three months</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance lease cost:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of right-of-use assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on lease liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Variable lease cost</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;color:#252525;"> </font><font style="font-family:inherit;font-size:10pt;">Variable lease costs represent payments that are dependent on a rate or index, or on usage of our facility leases and are primarily related to common area maintenance charges and property taxes. &#160;</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-top:12px;text-indent:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Impact of Adoption of ASC 842</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">We adopted </font><font style="font-family:inherit;font-size:10pt;">ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;"> (ASU 2016-02)</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> utilizing the modified retrospective transition method through a </font><font style="font-family:inherit;font-size:10pt;color:#252525;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> cumulative-effect adjustment to retained earnings at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards. </font><font style="font-family:inherit;font-size:10pt;">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$26.7 million</font><font style="font-family:inherit;font-size:10pt;">, finance lease right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$15.3 million</font><font style="font-family:inherit;font-size:10pt;">, operating lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$40.4 million</font><font style="font-family:inherit;font-size:10pt;"> and finance lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$15.9 million</font><font style="font-family:inherit;font-size:10pt;"> at the beginning of the first quarter of 2019, with no material impact to our statement of operations. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Information About Our Leases</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our corporate headquarters and primary manufacturing facilities are located in San Diego, California. We lease approximately </font><font style="font-family:inherit;font-size:10pt;">219,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of space in San Diego under leases that expire in February and March 2022. We have the option to renew each of these leases for </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> additional </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year terms. In San Diego we also lease approximately </font><font style="font-family:inherit;font-size:10pt;">87,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of space under a lease that expires in February 2022 with </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> renewal options and approximately </font><font style="font-family:inherit;font-size:10pt;">132,600</font><font style="font-family:inherit;font-size:10pt;"> square feet of space under a sublease that expires in January 2022. We lease approximately </font><font style="font-family:inherit;font-size:10pt;">148,800</font><font style="font-family:inherit;font-size:10pt;"> square feet of space in Mesa, Arizona under a lease that expires in March 2028. We have the option to renew this lease for </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> additional </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year terms. We have also entered into other domestic and international operating lease agreements, primarily for office and warehouse space, that expire at various times through July 2026. </font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">The components of lease expense for the </font><font style="font-family:inherit;font-size:10pt;color:#252525;">three months</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance lease cost:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of right-of-use assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on lease liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Variable lease cost</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;color:#252525;"> </font><font style="font-family:inherit;font-size:10pt;">Variable lease costs represent payments that are dependent on a rate or index, or on usage of our facility leases and are primarily related to common area maintenance charges and property taxes. &#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financing cash flows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term in years:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:20px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">Future minimum lease payments under non-cancellable leases as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total future lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Present value of future payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">We adopted Accounting Standards Codification Topic 842 (ASC 842) utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. Under ASC 842, w</font><font style="font-family:inherit;font-size:10pt;">e determine if an arrangement is a lease at inception. We record operating lease right-of-use assets and liabilities based on the present value of the lease payments over the lease term. In determining the present value of the lease payments, we use our incremental borrowing rate at the lease commencement date. We define the initial lease term to include the construction build-out period but to exclude lease extension periods when we are not reasonably certain to exercise our extension option. We record lease expense on a straight-line basis over the expected lease term. Lease costs which are variable and dependent on a rate, an index, or on usage of the asset are expensed in the period they are incurred.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have facilities lease agreements with lease and non-lease components, such as common area maintenance. We generally account for the lease and non-lease components of these agreements as a single lease component. </font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We account for short-term lease expense on a straight-line basis over the lease term.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">Future minimum lease payments under non-cancellable leases as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total future lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Present value of future payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Leases</font></div><div style="line-height:120%;padding-top:12px;text-indent:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Impact of Adoption of ASC 842</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">We adopted </font><font style="font-family:inherit;font-size:10pt;">ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;"> (ASU 2016-02)</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> utilizing the modified retrospective transition method through a </font><font style="font-family:inherit;font-size:10pt;color:#252525;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> cumulative-effect adjustment to retained earnings at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards. </font><font style="font-family:inherit;font-size:10pt;">We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$26.7 million</font><font style="font-family:inherit;font-size:10pt;">, finance lease right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$15.3 million</font><font style="font-family:inherit;font-size:10pt;">, operating lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$40.4 million</font><font style="font-family:inherit;font-size:10pt;"> and finance lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$15.9 million</font><font style="font-family:inherit;font-size:10pt;"> at the beginning of the first quarter of 2019, with no material impact to our statement of operations. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Information About Our Leases</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our corporate headquarters and primary manufacturing facilities are located in San Diego, California. We lease approximately </font><font style="font-family:inherit;font-size:10pt;">219,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of space in San Diego under leases that expire in February and March 2022. We have the option to renew each of these leases for </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> additional </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year terms. In San Diego we also lease approximately </font><font style="font-family:inherit;font-size:10pt;">87,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of space under a lease that expires in February 2022 with </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> renewal options and approximately </font><font style="font-family:inherit;font-size:10pt;">132,600</font><font style="font-family:inherit;font-size:10pt;"> square feet of space under a sublease that expires in January 2022. We lease approximately </font><font style="font-family:inherit;font-size:10pt;">148,800</font><font style="font-family:inherit;font-size:10pt;"> square feet of space in Mesa, Arizona under a lease that expires in March 2028. We have the option to renew this lease for </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> additional </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year terms. We have also entered into other domestic and international operating lease agreements, primarily for office and warehouse space, that expire at various times through July 2026. </font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">The components of lease expense for the </font><font style="font-family:inherit;font-size:10pt;color:#252525;">three months</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> ended </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> were as follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance lease cost:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of right-of-use assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on lease liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Variable lease cost</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total lease cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;color:#252525;"> </font><font style="font-family:inherit;font-size:10pt;">Variable lease costs represent payments that are dependent on a rate or index, or on usage of our facility leases and are primarily related to common area maintenance charges and property taxes. &#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:88%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(Dollars in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash paid for amounts included in the measurement of lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating cash flows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financing cash flows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Right-of-use assets obtained in exchange for lease liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average remaining lease term in years:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average discount rate:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:20px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">Future minimum lease payments under non-cancellable leases as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of </font><font style="font-family:inherit;font-size:10pt;color:#252525;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;color:#252525;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total future lease cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Amount representing interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Present value of future payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Short-term leases not recorded as a liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revised present value of future lease payments</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Guidance</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;"> (ASU 2016-02), which requires a lessee to recognize most leases on the balance sheet as lease liabilities with corresponding right-of-use assets. </font><font style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASU&#160;2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. </font><font style="font-family:inherit;font-size:10pt;">See Note 2, &#8220;Leases,&#8221; for more information on the impact of our adoption of ASU 2016-02 and related disclosures.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In August 2017, the FASB issued ASU No. 2017-12, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Derivatives and Hedging </font><font style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-12), which is intended to more closely align hedge accounting with companies&#8217; risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our financial statements. </font></div><div style="line-height:120%;padding-bottom:13px;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In June 2016, the FASB issued ASU No. 2016-13, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Financial Instruments &#8211; Credit Losses </font><font style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2016-13), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. ASU 2016-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </font><font style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-14). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-14 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement: Disclosure Framework </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">&#8211;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Changes to the Disclosure Requirements for Fair Value Measurement </font><font style="font-family:inherit;font-size:10pt;">(ASU 2018-13), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;</font><font style="font-family:inherit;font-size:10pt;color:#252525;">We are currently evaluating the impact that this guidance will have on our financial statements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In August 2018, the FASB issued ASU No. 2018-15, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles - Goodwill and Other &#8211; Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> (ASU 2018-05). This new guidance </font><font style="font-family:inherit;font-size:10pt;">requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. </font><font style="font-family:inherit;font-size:10pt;color:#252525;">ASU 2018-05 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We are currently evaluating the impact that this guidance will have on our financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Organization and Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of</font><font style="font-family:inherit;font-size:10pt;"> continuous glucose monitoring, or CGM,</font><font style="font-family:inherit;font-size:10pt;"> systems for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;DexCom&#8221; refer to DexCom, Inc. and its subsidiaries.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation and Principles of Consolidation</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have prepared the accompanying unaudited consolidated financial statements (the financial statements) in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results that may be expected for the year ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">. We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We experience seasonality that is typical in our industry, with lower sales in the first quarter of each year compared to the fourth quarter.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> included in the Annual Report on Form 10-K that we filed with the SEC on </font><font style="font-family:inherit;font-size:10pt;">February&#160;21, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with </font><font style="font-family:inherit;font-size:10pt;">GAAP</font><font style="font-family:inherit;font-size:10pt;"> requires us to make estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates. </font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Two</font><font style="font-family:inherit;font-size:10pt;"> of our distributors are significant customers. Each of them accounted for more than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of revenue in each of the past three fiscal years and each of them accounted for more than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable as of the end of the past two fiscal years. Distributor A accounted for </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> of our revenues for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. Distributor B accounted for </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">14%</font><font style="font-family:inherit;font-size:10pt;"> of our revenues for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. Distributor A and Distributor B accounted for </font><font style="font-family:inherit;font-size:10pt;">17%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of our accounts receivable as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and for </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of our accounts receivable as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We generate our revenue from the sale of our durable CGM systems and disposable sensors (the Components). Our durable systems include a reusable transmitter and receiver. Disposable sensors are sold separately. We also provide free-of-charge software and mobile applications for use with our durable systems and disposable sensors. The initial durable system price is generally not dependent upon the subsequent purchase of any amount of disposable sensors.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sell our durable systems and disposable sensors through two main sales channels: 1) directly to customers who use our products or organizations (the Direct Channel) and 2) to distribution partners who resell our products (the Distributor Channel).</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the Direct Channel, we sell the Components to customers and we receive payment directly from customers, organizations and third-party payors. Third-party payors primarily include commercial insurance companies and federal and state agencies (under Medicare and Medicaid programs).</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Policy elections and ASC Topic 606 practical expedients taken</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contracts and performance obligations</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. Components are individually priced and can be purchased separately or bundled in a contract. We also provide free-of-charge software, mobile applications and updates for our DexCom Share</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are based on an expected cost plus a margin approach.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Transaction price</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on contracted rates less any estimates of claim denials and historical reimbursement experience, which would include current and future expectations regarding reimbursement contracts, guidelines and payor mix, and less estimated variable consideration adjustments.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Variable consideration</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Rebates.</font><font style="font-family:inherit;font-size:10pt;"> We estimate reductions to our revenues for rebates paid to payors, healthcare providers and distributors. Rebates are based on contractual arrangements or statutory requirements, which may vary by product, payor and individual payor plans. Our estimates are based on products sold, historical payor mix and, as available, known market events or trends and channel inventory data. We also take into consideration, as available, new information regarding changes in programs&#8217; regulations and guidelines that would impact the amount of the actual rebates and/or our expectations regarding future payor mix for these programs.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Returns.</font><font style="font-family:inherit;font-size:10pt;"> We generally provide a &#8220;</font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;">-day money back guarantee&#8221; program whereby first-time end-user customers may return the durable system. In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. Our returns have historically been immaterial. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue recognition</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize revenue when control is transferred to our customers. The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with the Components are satisfied at a point in time, which typically occurs at shipment. Terms of direct and distributor orders are generally</font><font style="font-family:inherit;font-size:10pt;color:#ee2724;"> </font><font style="font-family:inherit;font-size:10pt;">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the durable system.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our sales of the receiver and transmitter components of our CGM systems include an assurance-type warranty which is accounted for based on the cost accrual method recognized as expense when the products are sold and is not considered a separate performance obligation.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract balances</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The timing of revenue recognition, billing and cash collections results in the recording of trade receivables and deferred revenue in our balance sheets. We recognize a receivable in the period in which our right to the consideration is unconditional. We generally do not have any contracts or performance obligations with a term of more than one year.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> included unbilled accounts receivable of </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;">. Unbilled accounts receivable consist of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Substantially all of our deferred revenue as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> is associated with certain of our free-of-charge software and mobile applications and will be recognized during </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">. During the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we recognized revenue of </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> that was recorded as deferred revenue as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. During the three months ended March 31, 2018, we recognized revenue of&#160;</font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">&#160;that was recorded as deferred revenue as of December 31, 2017.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred cost of sales</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. These costs are recognized in cost of sales when the associated revenue is recognized. Deferred cost of sales are included in prepaid and other current assets in our balance sheets.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Incentive compensation costs</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been </font><font style="font-family:inherit;font-size:10pt;">one year</font><font style="font-family:inherit;font-size:10pt;"> or less. We record these costs in selling, general and administrative expense in our statement of operations.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">We adopted Accounting Standards Codification Topic 842 (ASC 842) utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. Under ASC 842, w</font><font style="font-family:inherit;font-size:10pt;">e determine if an arrangement is a lease at inception. We record operating lease right-of-use assets and liabilities based on the present value of the lease payments over the lease term. In determining the present value of the lease payments, we use our incremental borrowing rate at the lease commencement date. We define the initial lease term to include the construction build-out period but to exclude lease extension periods when we are not reasonably certain to exercise our extension option. We record lease expense on a straight-line basis over the expected lease term. Lease costs which are variable and dependent on a rate, an index, or on usage of the asset are expensed in the period they are incurred.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have facilities lease agreements with lease and non-lease components, such as common area maintenance. We generally account for the lease and non-lease components of these agreements as a single lease component. </font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We account for short-term lease expense on a straight-line basis over the lease term.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Net Income (Loss) Per Share</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common share equivalents that we calculate using the treasury stock method include outstanding stock options and unvested RSUs that are settleable in shares of common stock and potential common shares from convertible securities that we intend to settle using a combination of shares of our common stock and cash. Common share equivalents that we calculate using the if-converted method include potential common shares from convertible securities that we intend to settle using only shares of our common stock.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because we reported net losses for the three months ended March 31, 2019 and 2018, all potentially dilutive common shares have been excluded from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding anti-dilutive securities not included in the diluted net loss per share attributable to common stockholders calculations were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#160;(In millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options outstanding to purchase common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Guidance</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;"> (ASU 2016-02), which requires a lessee to recognize most leases on the balance sheet as lease liabilities with corresponding right-of-use assets. </font><font style="font-family:inherit;font-size:10pt;color:#252525;">We adopted ASU&#160;2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. </font><font style="font-family:inherit;font-size:10pt;">See Note 2, &#8220;Leases,&#8221; for more information on the impact of our adoption of ASU 2016-02 and related disclosures.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In August 2017, the FASB issued ASU No. 2017-12, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Derivatives and Hedging </font><font style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-12), which is intended to more closely align hedge accounting with companies&#8217; risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our financial statements. </font></div><div style="line-height:120%;padding-bottom:13px;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In June 2016, the FASB issued ASU No. 2016-13, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Financial Instruments &#8211; Credit Losses </font><font style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2016-13), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. ASU 2016-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </font><font style="font-family:inherit;font-size:10pt;color:#252525;">(ASU 2017-14). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit&#8217;s carrying amount over its fair value. ASU 2017-14 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement: Disclosure Framework </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">&#8211;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Changes to the Disclosure Requirements for Fair Value Measurement </font><font style="font-family:inherit;font-size:10pt;">(ASU 2018-13), which&#160;adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance,&#160;entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December&#160;15, 2019, including interim periods within those fiscal years, and early adoption is permitted.&#160;</font><font style="font-family:inherit;font-size:10pt;color:#252525;">We are currently evaluating the impact that this guidance will have on our financial statements.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">In August 2018, the FASB issued ASU No. 2018-15, </font><font style="font-family:inherit;font-size:10pt;color:#252525;font-style:italic;">Intangibles - Goodwill and Other &#8211; Internal-Use Software: Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</font><font style="font-family:inherit;font-size:10pt;color:#252525;"> (ASU 2018-05). This new guidance </font><font style="font-family:inherit;font-size:10pt;">requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. </font><font style="font-family:inherit;font-size:10pt;color:#252525;">ASU 2018-05 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We are currently evaluating the impact that this guidance will have on our financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property and Equipment</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and land</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and hardware</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">309.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(88.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total property and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">183.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We generate our revenue from the sale of our durable CGM systems and disposable sensors (the Components). Our durable systems include a reusable transmitter and receiver. Disposable sensors are sold separately. We also provide free-of-charge software and mobile applications for use with our durable systems and disposable sensors. The initial durable system price is generally not dependent upon the subsequent purchase of any amount of disposable sensors.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sell our durable systems and disposable sensors through two main sales channels: 1) directly to customers who use our products or organizations (the Direct Channel) and 2) to distribution partners who resell our products (the Distributor Channel).</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the Direct Channel, we sell the Components to customers and we receive payment directly from customers, organizations and third-party payors. Third-party payors primarily include commercial insurance companies and federal and state agencies (under Medicare and Medicaid programs).</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Policy elections and ASC Topic 606 practical expedients taken</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contracts and performance obligations</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. Components are individually priced and can be purchased separately or bundled in a contract. We also provide free-of-charge software, mobile applications and updates for our DexCom Share</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;">remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are based on an expected cost plus a margin approach.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Transaction price</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on contracted rates less any estimates of claim denials and historical reimbursement experience, which would include current and future expectations regarding reimbursement contracts, guidelines and payor mix, and less estimated variable consideration adjustments.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Variable consideration</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Rebates.</font><font style="font-family:inherit;font-size:10pt;"> We estimate reductions to our revenues for rebates paid to payors, healthcare providers and distributors. Rebates are based on contractual arrangements or statutory requirements, which may vary by product, payor and individual payor plans. Our estimates are based on products sold, historical payor mix and, as available, known market events or trends and channel inventory data. We also take into consideration, as available, new information regarding changes in programs&#8217; regulations and guidelines that would impact the amount of the actual rebates and/or our expectations regarding future payor mix for these programs.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Returns.</font><font style="font-family:inherit;font-size:10pt;"> We generally provide a &#8220;</font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;">-day money back guarantee&#8221; program whereby first-time end-user customers may return the durable system. In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. Our returns have historically been immaterial. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue recognition</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize revenue when control is transferred to our customers. The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with the Components are satisfied at a point in time, which typically occurs at shipment. Terms of direct and distributor orders are generally</font><font style="font-family:inherit;font-size:10pt;color:#ee2724;"> </font><font style="font-family:inherit;font-size:10pt;">Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the durable system.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our sales of the receiver and transmitter components of our CGM systems include an assurance-type warranty which is accounted for based on the cost accrual method recognized as expense when the products are sold and is not considered a separate performance obligation.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract balances</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The timing of revenue recognition, billing and cash collections results in the recording of trade receivables and deferred revenue in our balance sheets. We recognize a receivable in the period in which our right to the consideration is unconditional. We generally do not have any contracts or performance obligations with a term of more than one year.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> included unbilled accounts receivable of </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;">. Unbilled accounts receivable consist of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Substantially all of our deferred revenue as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> is associated with certain of our free-of-charge software and mobile applications and will be recognized during </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">. During the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">, we recognized revenue of </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> that was recorded as deferred revenue as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. During the three months ended March 31, 2018, we recognized revenue of&#160;</font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">&#160;that was recorded as deferred revenue as of December 31, 2017.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred cost of sales</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. These costs are recognized in cost of sales when the associated revenue is recognized. Deferred cost of sales are included in prepaid and other current assets in our balance sheets.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Incentive compensation costs</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been </font><font style="font-family:inherit;font-size:10pt;">one year</font><font style="font-family:inherit;font-size:10pt;"> or less. We record these costs in selling, general and administrative expense in our statement of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth revenues by our two primary geographical markets, United States and outside of the United States, based on the geographic location to which we deliver the product:</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outside of the United States</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Payable and Accrued Liabilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable trade</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued tax, audit, and legal fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued rebates</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued warranty</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring reserve</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accounts payable and accrued liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding anti-dilutive securities not included in the diluted net loss per share attributable to common stockholders calculations were as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#160;(In millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options outstanding to purchase common stock</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2022</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior convertible notes due 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warrants</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2022:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt discount</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(47.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">346.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75% Senior Convertible Notes due 2023:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal amount</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">850.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">850.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt discount</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(164.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net carrying amount of Senior Convertible Notes due 2023</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">676.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total net carrying amount of senior convertible notes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,022.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,010.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of outstanding senior convertible notes:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">537.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">540.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">876.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">859.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total fair value of outstanding senior convertible notes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,413.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,399.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount by which the notes' if-converted value exceeds their principal amount:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Convertible Notes due 2023</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total by which the notes' if-converted value exceeds their principal amount</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Share-Based Compensation Expense</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes share-based compensation expense for the periods shown:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total share-based compensation expense included in net loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventory</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.2</font></div></td><td style="vertical-align:bottom;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted Stock Units</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of our RSU and PSU activity for the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Grant Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions, except weighted average grant date fair values)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143.24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested at March 31, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.42184557438794%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred rent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other long-term liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Segment and Geographic Information</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reportable Segments </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently consider our operations to be, and manage our business globally within, </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Disaggregation of Revenue </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom is domiciled in the United States. We sell our durable systems and disposable sensors through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, Canada, Australia, New Zealand, and in some countries in Europe, Asia, Latin America, the Middle East and Africa. We disaggregate our revenue from contracts by major sales channel and geography as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors. </font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues by geographic region</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, no country outside of the United States generated revenue that represented more than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of our total revenue. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth revenues by our two primary geographical markets, United States and outside of the United States, based on the geographic location to which we deliver the product:</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">210.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outside of the United States</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenues by customer sales channel</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth revenues disaggregated by customer sales channel:</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;March 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Total</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with </font><font style="font-family:inherit;font-size:10pt;">GAAP</font><font style="font-family:inherit;font-size:10pt;"> requires us to make estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates. </font></div></div> EX-101.SCH 7 dxcm-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2104100 - Disclosure - Balance Sheet Details link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Balance Sheet Details - Inventory (Detail) link:presentationLink link:calculationLink link:definitionLink 2404406 - Disclosure - Balance Sheet Details - Other Long-Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Balance Sheet Details - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Balance Sheet Details - Short Term Marketable Securities, Available for Sale (Detail) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Balance Sheet Details (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Business Segment and Geographic Information link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Business Segment and Geographic Information - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Business Segment and Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2406401 - Disclosure - Contingencies Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Debt 0.75% Senior convertible notes (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Debt Revolving Credit Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Debt Schedule of senior convertible notes (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2407401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Leases - Components of lease expense (Details) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - Leases - Future minimum lease payments under non-cancellable leases (Details) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - Leases - Future minimum lease payments under non-cancellable leases (Details) link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - Leases - Other information related to leases (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Organization and Significant Accounting Policies Anti-dilutive securities not included in calculation of net loss per share (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Stockholders' Equity Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Stockholders' Equity Share-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 dxcm-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 dxcm-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 dxcm-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Organization, Consolidation and Presentation of Financial Statements [Abstract] Accounts Payable and Accrued Liabilities [Abstract] Accounts Payable and Accrued Liabilities [Abstract] Accounts payable trade Accounts Payable, Trade, Current Accrued tax, audit, and legal fees Accrued Tax Audit And Legal Fees Carrying value as of the balance sheet date of accrued current tax, audit and legal fees. Accrued rebates Pharmacy Rebates Pharmacy Rebates Accrued warranty Standard Product Warranty Accrual Restructuring reserve Restructuring Reserve Other accrued liabilities Other Accrued Liabilities, Current Total accounts payable and accrued liabilities Accounts Payable and Other Accrued Liabilities, Current Restructuring charges Restructuring Charges Document Documentand Entity Information [Abstract] Document Documentand Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Commitments and Contingencies Disclosure [Abstract] Contingencies Commitments and Contingencies Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property Subject to or Available for Operating Lease [Axis] Property Subject to or Available for Operating Lease [Axis] Property Subject to or Available for Operating Lease [Domain] Property Subject to or Available for Operating Lease [Domain] Leased Buildings -232 South Dobson Road Leased Buildings -232 South Dobson Road [Member] Leased Buildings -232 South Dobson Road [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Building Building [Member] Furniture and fixtures Furniture and Fixtures [Member] Computer software and hardware Computer Equipment [Member] Machinery and equipment Equipment [Member] Leasehold improvements Leasehold Improvements [Member] Construction in progress Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, plant and equipment, gross Property, Plant and Equipment, Gross Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property and equipment, net Property, Plant and Equipment, Net Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share based compensation expense Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Restricted Stock Units Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Leases [Abstract] Leases Lessee, Operating Leases [Text Block] Leases Lessee, Finance Leases [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Reclassification Reclassification, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Concentration of Credit Risk and Significant Customers Concentration Risk, Credit Risk, Policy [Policy Text Block] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Net Income (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Recent Accounting Guidance New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Unvested restricted stock units Restricted Stock Units (RSUs) [Member] Performance Shares [Member] Performance Shares [Member] Class of Stock [Line Items] Class of Stock [Line Items] Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Nonvested beginning balance, shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Nonvested ending balance, shares Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted average grant date fair value, in dollars per share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested Total vest date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Debt Disclosure [Abstract] Schedule of Carrying Values and Estimated Fair Values of Debt Instruments Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Finance lease liabilities Financing Lease Obligation Financing Lease Obligation Deferred rent Deferred Rent Credit, Noncurrent Other liabilities Other Sundry Liabilities, Noncurrent Total other long-term liabilities Other Liabilities, Noncurrent Balance Sheet Details Additional Financial Information Disclosure [Text Block] Stockholder's Equity Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Segment Reporting [Abstract] Business Segment and Geographic Information Segment Reporting Disclosure [Text Block] Financial Statement Details [Table] Financial Statement Details [Table] Financial Statement Details [Table] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Equity investment in Tandem Diabetes Care, Inc Tandem Diabetes Care Inc [Member] Tandem Diabetes Care, Inc [Member]. Financial Instrument [Axis] Financial Instrument [Axis] Financial Instruments [Domain] Financial Instruments [Domain] U.S. government agencies US Government Corporations and Agencies Securities [Member] Commercial paper Commercial Paper [Member] Corporate debt Corporate Debt Securities [Member] Financial Statement Details [Line Items] Financial Statement Details [Line Items] Financial Statement Details [Line Items] Equity investment in Tandem Diabetes Care, Inc. Equity Securities, FV-NI, Gain (Loss) [Abstract] Cost or Amortized Cost Equity Securities, FV-NI, Cost Gross Unrealized Gains Equity Securities, FV-NI, Unrealized Gain Gross Unrealized Losses Equity Securities, FV-NI, Unrealized Loss Estimated Market Value Equity Securities, FV-NI Debt securities, available for sale: Debt Securities, Available-for-sale [Abstract] Amortized Cost Debt Securities, Available-for-sale, Amortized Cost Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Estimated Market Value Debt Securities, Available-for-sale Total marketable securities Marketable Securities [Abstract] Cost or Amortized Cost Debt Securities, Available-for-sale and Equity Securities, Amortized Cost Debt Securities, Available-for-sale and Equity Securities, Amortized Cost Gross Unrealized Gains Debt Securities, Available-For-Sale and Equity Securities, Unrealized Gain Debt Securities, Available-For-Sale and Equity Securities, Unrealized Gain Gross Unrealized Losses Debt Securities, Available-For-Sale and Equity Securities, Unrealized Loss Debt Securities, Available-For-Sale and Equity Securities, Unrealized Loss Estimated Market Value Debt Securities, Available-For-Sale and Equity Securities Debt Securities, Available-For-Sale and Equity Securities Equity Securities Net Gain Debt and Equity Securities, Gain (Loss) [Abstract] Net gains recognized during the period on equity securities Debt and Equity Securities, Gain (Loss) Statement of Comprehensive Income [Abstract] Net loss Net Income (Loss) Attributable to Parent Other comprehensive income (loss), net of income taxes: Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation loss Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Unrealized income on marketable debt securities Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax Total other comprehensive income (loss), net Other Comprehensive Income (Loss), Net of Tax Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Loss Contingencies [Table] Loss Contingencies [Table] Name of Defendant [Axis] Name of Defendant [Axis] Name of Defendant [Axis] Name of Defendant [Domain] Name of Defendant [Domain] [Domain] for Name of Defendant [Axis] AgaMatrix AgaMatrix [Member] AgaMatrix [Member] Name of Plaintiff [Axis] Name of Plaintiff [Axis] Name of Plaintiff [Axis] Name of Plaintiff [Domain] Name of Plaintiff [Domain] [Domain] for Name of Plaintiff [Axis] WaveForm Technologies, Inc. WaveForm Technologies, Inc. [Member] WaveForm Technologies, Inc. [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Loss contingency, patents allegedly infringed, number Loss Contingency, Patents Allegedly Infringed, Number Loss contingency, patents allegedly infringed, number transferred to new plaintiff Loss Contingency, Patents Allegedly Infringed, Number Transferred to New Plaintiff Loss Contingency, Patents Allegedly Infringed, Number Transferred to New Plaintiff Loss contingencies, patents allegedly infringed, number of inter partes review requested Loss Contingencies, Patents Allegedly Infringed, Number of inter partes review requested Loss Contingencies, Patents Allegedly Infringed, Number of inter partes reviews requested Gain contingency, patents allegedly infringed upon, number Gain Contingency, Patents Allegedly Infringed upon, Number Loss contingency accrual Loss Contingency Accrual Estimated litigation liability Estimated Litigation Liability Outstanding anti-dilutive securities not included in diluted net loss per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Income Statement [Abstract] Revenues Revenue from Contract with Customer, Excluding Assessed Tax Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Total operating expenses Operating Expenses Operating loss Operating Income (Loss) Interest expense Interest Expense Income (loss) from equity investments Interest and other income (expense), net Investment Income, Interest Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income tax expense Income Tax Expense (Benefit) Net loss Basic and diluted net loss per share Earnings Per Share, Basic and Diluted Shares used to compute basic and diluted net loss per share Weighted Average Number of Shares Outstanding, Basic and Diluted Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Accumulated Deficit Retained Earnings [Member] Treasury Stock Treasury Stock [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-02 Accounting Standards Update 2016-02 [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance (in shares) Shares, Outstanding Beginning Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Issuance of common stock under equity incentive plans (in shares) Stock Issued During Period, Shares, Employee Benefit Plan Issuance of common stock under equity incentive plans Stock Issued During Period, Value, Employee Benefit Plan Issuance of common stock for Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock for Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Share-based compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Cumulative-effect adjustment from adoption of new lease accounting standard (Note 2) New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification Net loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Ending Balance (in shares) Ending Balance Operating Leases Operating Lease Liabilities, Payments Due [Abstract] 2019 Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total future lease cost Lessee, Operating Lease, Liability, Payments, Due Less: Amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Present value of future payments Operating Lease, Liability Less: Short-term leases not recorded as a liability Lessee, Operating Leases, Short Term Lease Payments Due Lessee, Operating Leases, Short Term Lease Payments Due Revised present value of future lease payments Operating Lease, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability Operating Lease, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability Less: Current portion Operating Lease, Liability, Current Long-term portion Operating Lease, Liability, Noncurrent Finance Leases Finance Lease Liabilities, Payments, Due [Abstract] 2019 Finance Lease, Liability, Payments, Remainder of Fiscal Year 2020 Finance Lease, Liability, Payments, Due Year Two 2021 Finance Lease, Liability, Payments, Due Year Three 2022 Finance Lease, Liability, Payments, Due Year Four 2023 Finance Lease, Liability, Payments, Due Year Five Thereafter Finance Lease, Liability, Payments, Due after Year Five Total future lease cost Finance Lease, Liability, Payments, Due Less: Amount representing interest Finance Lease, Liability, Undiscounted Excess Amount Present value of future payments Finance Lease, Liability Less: Short-term leases not recorded as a liability Finance Lease, Short Term Leases, Payments Due Finance Lease, Short Term Leases, Payments Due Revised present value of future lease payments Finance Leases, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability Finance Leases, Liability, Less Payments Due On Short Term Leases Not Recorded As A Liability Less: Current portion Finance Lease, Liability, Current Long-term portion Finance Lease, Liability, Noncurrent Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Customer Notification Related Inventory Reserve Receiver Product Component [Member] Receiver Product Component [Member] Raw materials Inventory, Raw Materials, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventory Inventory, Net Inventory write-down Inventory Write-down Line of Credit Facility [Table] Line of Credit Facility [Table] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Foreign Currency Line of Credit Foreign Currency Line of Credit [Member] Foreign Currency Line of Credit [Member] Line of Credit Line of Credit [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Letter of Credit Letter of Credit [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Debt Instrument, Term Debt Instrument, Term Long-term line of credit Long-term Line of Credit Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Amount of option to increase the maximum available principal Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Margin on variable rate Debt Instrument, Basis Spread on Variable Rate Line of credit facility, unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Line of credit, current Line of Credit, Current Line of credit facility, remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign Exchange Forward Foreign Exchange Forward [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior convertible notes due 2023 Convertible Notes due 2023 [Member] Convertible Notes due 2023 [Member] Senior convertible notes due 2022 Convertible Notes due 2022 [Member] Convertible Notes due 2022 [Member] Senior Notes Senior Notes [Member] Investment [Axis] Investment [Axis] Investment [Domain] Investment [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Cash equivalents Cash Equivalents, at Carrying Value Debt securities, available-for-sale Equity investment in Tandem Diabetes Care, Inc. Investments, Fair Value Disclosure Total assets measured at fair value on a recurring basis Assets, Fair Value Disclosure Transfers between Level 1 and Level 2 securities Fair Value, Assets, Level 1 to Level 2 Transfers, Amount Transfers into or out of Level 3 securities Fair Value, Assets, Level 3 Transfers, Amount Fair Value, Assets, Level 3 Transfers, Amount Fair value of outstanding senior convertible notes: Convertible Debt, Fair Value Disclosures Outstanding currency hedging transactions Derivative, Notional Amount Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Options outstanding to purchase common stock Employee Stock Option [Member] Senior convertible notes Convertible Debt Securities [Member] Warrants Warrant [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Operating Lease, Payments Operating Lease, Payments Finance Lease, Interest Payment on Liability Finance Lease, Interest Payment on Liability Finance Lease, Principal Payments Finance Lease, Principal Payments Right-of-use assets obtained in exchange for lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Finance Lease, Right-of-Use Asset Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Operating Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Remaining Lease Term Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Weighted Average Remaining Lease Term Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Weighted Average Discount Rate, Percent Finance Lease, Weighted Average Discount Rate, Percent Finance Lease, Weighted Average Discount Rate, Percent Fair Value Hierarchy for Financial Assets Fair Value, Assets Measured on Recurring Basis [Table Text Block] Organization And Summary Of Significant Accounting Policies [Table] Organization And Summary Of Significant Accounting Policies [Table] Organization And Summary Of Significant Accounting Policies [Table] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Distributor A Edgepark [Member] Edgepark [Member] Distributor B Byram [Member] Byram [Member] Organization And Summary Of Significant Accounting Policies [Line Items] Organization And Summary Of Significant Accounting Policies [Line Items] Organization And Summary Of Significant Accounting Policies [Line Items] Number of customers Customer Concentration, Number Of Customers Customer Concentration, Number Of Customers Percentage of revenue Concentration Risk, Percentage Percentage of accounts receivable Concentration Risk, Percentage of Accounts Receivable attributable to customer Concentration Risk, Percentage of Accounts Receivable attributable to customer Sales returns coverage period Revenue Recognition, Sales Returns, Coverage Period Revenue Recognition, Sales Returns, Coverage Period Unbilled accounts receivable Unbilled Contracts Receivable Deferred revenue recognized Contract with Customer, Liability, Revenue Recognized Amortization period for incentive compensation costs Amortization Period for Incentive Compensation Costs Amortization Period for Incentive Compensation Costs Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Contract with Customer, Sales Channel [Axis] Contract with Customer, Sales Channel [Axis] Contract with Customer, Sales Channel [Domain] Contract with Customer, Sales Channel [Domain] Distributor Sales Channel, Through Intermediary [Member] Direct Sales Channel, Directly to Consumer [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States UNITED STATES Outside of the United States Non-US [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Number of Reportable Segments Number of Reportable Segments Revenue, Percentage Revenue, Percentage Revenue, Percentage Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of Sales Cost of Sales [Member] Research and Development Expense Research and Development Expense [Member] Selling General And Administrative Selling General And Administrative [Member] The allocation of expenses to selling, general and administrative Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Unrecognized estimated compensation costs Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Allocated Share-based Compensation Expense Allocated Share-based Compensation Expense Effective tax rate Effective Income Tax Rate Reconciliation, Percent Tax benefit for refunds of foreign withholding tax, partially offset by state and foreign tax expense Current Foreign Tax Expense (Benefit) Fair Value Measurement Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Finance lease cost: Finance Lease, Cost [Abstract] Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Interest on lease liabilities Finance Lease, Interest Expense Operating lease cost Operating Lease, Cost Short-term lease cost Short-term Lease, Cost Variable lease cost(1) Variable Lease, Cost Total lease cost Lease, Cost New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Name of Property [Axis] Name of Property [Axis] Name of Property [Domain] Name of Property [Domain] Leased Buildings -6350 Sequence Drive Leased Buildings - 6350 Sequence [Member] Leased Buildings - 6350 Sequence [Member] Leased Buildings -6340 Sequence Drive, 6310 Sequence Drive, 6290 Sequence drive Leased Buildings -6340 Sequence Drive, 6310 Sequence Drive, 6290 Sequence drive [Member] Leased Buildings -6340 Sequence Drive, 6310 Sequence Drive, 6290 Sequence drive [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Cumulative-effect adjustment to retained earnings Cumulative Effect of New Accounting Principle in Period of Adoption Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Finance lease right-of-use asset Finance Lease, Right-of-Use Asset Operating lease liabilities Finance lease liability Leased square footage Leased Square Footage Leased Square Footage Lessee leasing arrangements, operating leases, number of renewal terms Lessee Leasing Arrangements, Operating Leases, Number of Renewal Term Lessee Leasing Arrangements, Operating Leases, Number of Renewal Term Lessee, operating lease, renewal term Lessee, Operating Lease, Renewal Term Short Term Marketable Securities, Available for Sale Debt Securities, Available-for-sale [Table Text Block] Inventory Schedule of Inventory, Current [Table Text Block] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Other Liabilities Schedule of Other Assets and Other Liabilities [Table Text Block] Statement of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Short-term marketable securities Accounts receivable, net Accounts Receivable, Net, Current Inventory Prepaid and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Goodwill Goodwill Other assets Other Assets, Noncurrent Total assets Assets Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable and accrued liabilities Accrued payroll and related expenses Employee-related Liabilities, Current Short-term portion of operating lease liabilities Deferred revenue Contract with Customer, Liability, Current Total current liabilities Liabilities, Current Long-term senior convertible notes Convertible Notes Payable, Noncurrent Operating lease liabilities, net of current portion Other long-term liabilities Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at March 31, 2019 and December 31, 2018 Preferred Stock, Value, Outstanding Common stock, $0.001 par value, 200.0 million shares authorized; 92.1 million and 91.0 million shares issued and outstanding, respectively, at March 31, 2019; and 91.1 million and 90.0 million shares issued and outstanding, respectively, at December 31, 2018 Common Stock, Value, Outstanding Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated deficit Retained Earnings (Accumulated Deficit) Treasury stock, at cost; 0.8 million shares at March 31, 2019 and December 31, 2018 Treasury Stock, Value Total stockholders’ equity Total liabilities and stockholders’ equity Liabilities and Equity Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Common Stock, Shares, Outstanding Treasury Stock, Shares Treasury Stock, Shares Debt Debt Disclosure [Text Block] Statement of Cash Flows [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Share-based compensation Share-based Compensation Non-cash interest expense Amortization of Debt Discount (Premium) Income (loss) from equity investments Equity Method Investment, Realized Gain (Loss) on Disposal Other non-cash income and expenses Other Noncash Income (Expense) Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable, net Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Prepaid and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Accrued payroll and related expenses Increase (Decrease) in Employee Related Liabilities Deferred revenue, deferred rent, and other liabilities Increase (Decrease) in Other Deferred Liability Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Purchase of marketable securities Payments to Acquire Debt Securities, Available-for-sale Proceeds from sale and maturity of marketable securities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale Purchase of other equity investments Payments to Acquire Other Investments Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Other financing activities Proceeds from (Payments for) Other Financing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash, beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash, end of period Reconciliation of cash, cash equivalents and restricted cash, end of period: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] Cash and cash equivalents Restricted cash Restricted Cash Supplemental disclosure of non-cash investing and financing transactions: Supplemental Cash Flow Information [Abstract] Acquisition of property and equipment included in accounts payable and accrued liabilities Noncash or Part Noncash Acquisition, Fixed Assets Acquired Right-of-use assets obtained in exchange for lease liabilities Right-of-Use Asset Obtained in Exchange for Lease Liabilities Right-of-Use Asset Obtained in Exchange for Lease Liabilities Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Zero Point Seven Five Percent Senior Convertible Notes Zero Point Seven Five Percent Senior Convertible Notes [Member] Zero Point Seven Five Percent Senior Convertible Notes [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Senior Notes [Abstract] Senior Notes [Abstract] Principal amount Debt Instrument, Face Amount Unamortized debt discount Debt Instrument, Unamortized Discount Unamortized debt issuance costs Unamortized Debt Issuance Expense Net carrying amount of Senior Convertible Notes due 2022 Total net carrying amount of senior convertible notes Long-term Debt Amount by which the notes' if-converted value exceeds their principal amount: Debt Instrument, Convertible, If-converted Value in Excess of Principal Organization and Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Debt Instrument Conversion Term [Axis] Debt Instrument Conversion Term [Axis] Debt Instrument Conversion Term [Axis] Debt Instrument Conversion Term [Domain] Debt Instrument Conversion Term [Domain] [Domain] for Debt Instrument Conversion Term [Axis] Term of at least 20 trading days during a period of 30 consecutive trading days Debt Instrument Conversion Term One [Member] Debt Instrument Conversion Term One [Member] Term of five business day period after any five consecutive trading day period Debt Instrument Conversion Term Two [Member] Debt Instrument Conversion Term Two [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Interest rate on convertible notes Aggregate principal amount Proceeds from convertible debt Proceeds from Convertible Debt Initial conversion price of convertible notes (in dollars per share) Debt Instrument, Convertible, Conversion Price Amount reclassified to stockholders' equity Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity Contractual coupon interest rate Interest Expense, Debt, Excluding Amortization Amortization of debt issuance costs Amortization of Debt Issuance Costs Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Conversion price in event of fundamental change Debt Instrument, Covenant Repurchase Price, Percentage Debt Instrument, Covenant Repurchase Price, Percentage Conversion multiple Debt Instrument, Convertible, Terms of Conversion Feature, Conversion Amount Debt Instrument, Convertible, Terms of Conversion Feature, Conversion Amount Threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Conversion percentage based on last reported sale price Debt Instrument, Redemption Covenant, Percent of Conversion Price, Last Reported Sale Price of Common Stock Debt Instrument, Redemption Covenant, Percent of Conversion Price, Last Reported Sale Price of Common Stock Debt instrument, redemption price, percentage Debt Instrument, Redemption Price, Percentage Debt instrument, convertible, conversion ratio Debt Instrument, Convertible, Conversion Ratio Convertible note hedge, number of shares Debt Instrument, Convertible, Associated Derivative Transactions, Number of Shares Debt Instrument, Convertible, Associated Derivative Transactions, Number of Shares1 Cost of convertible note hedge recognized in additional paid-in capital Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Warrants sold to counterparties Debt Conversion, Converted Instrument, Shares Issued Proceeds from issuance of warrants Proceeds from Issuance of Warrants Strike price of warrant Class of Warrant or Right, Exercise Price of Warrants or Rights Components of lease expense Lease, Cost [Table Text Block] Future minimum lease payments, operating leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Future minimum lease payments, finance leases Finance Lease, Liability, Maturity [Table Text Block] EX-101.PRE 11 dxcm-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2019
Apr. 25, 2019
Document Documentand Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
Trading Symbol DXCM  
Entity Registrant Name DEXCOM INC  
Entity Central Index Key 0001093557  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth false  
Entity Common Stock, Shares Outstanding   91,050,405
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 1,285.1 $ 1,137.0
Short-term marketable securities 72.9 248.6
Accounts receivable, net 204.7 226.7
Inventory 101.1 70.7
Prepaid and other current assets 27.0 16.5
Total current assets 1,690.8 1,699.5
Property and equipment, net 221.4 183.1
Operating lease right-of-use assets 27.7 0.0
Goodwill 18.6 18.7
Other assets 15.5 14.7
Total assets 1,974.0 1,916.0
Current liabilities:    
Accounts payable and accrued liabilities 169.1 147.1
Accrued payroll and related expenses 51.3 72.4
Short-term portion of operating lease liabilities 12.3 0.0
Deferred revenue 2.7 2.9
Total current liabilities 235.4 222.4
Long-term senior convertible notes 1,022.4 1,010.3
Operating lease liabilities, net of current portion 29.5 0.0
Other long-term liabilities 18.1 20.0
Total liabilities 1,305.4 1,252.7
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at March 31, 2019 and December 31, 2018 0.0 0.0
Common stock, $0.001 par value, 200.0 million shares authorized; 92.1 million and 91.0 million shares issued and outstanding, respectively, at March 31, 2019; and 91.1 million and 90.0 million shares issued and outstanding, respectively, at December 31, 2018 0.1 0.1
Additional paid-in capital 1,590.6 1,560.6
Accumulated other comprehensive income 1.6 1.5
Accumulated deficit (823.7) (798.9)
Treasury stock, at cost; 0.8 million shares at March 31, 2019 and December 31, 2018 (100.0) (100.0)
Total stockholders’ equity 668.6 663.3
Total liabilities and stockholders’ equity $ 1,974.0 $ 1,916.0
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 92,100,000 91,100,000
Common stock, shares outstanding 91,000,000 90,000,000
Treasury Stock, Shares 800,000 800,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenues $ 280.5 $ 184.4
Cost of sales 111.7 65.5
Gross profit 168.8 118.9
Operating expenses:    
Research and development 59.0 44.8
Selling, general and administrative 124.2 104.8
Total operating expenses 183.2 149.6
Operating loss (14.4) (30.7)
Interest expense (14.9) (4.8)
Income (loss) from equity investments (4.2) 7.4
Interest and other income (expense), net 6.9 4.1
Loss before income taxes (26.6) (24.0)
Income tax expense 0.3 0.2
Net loss $ (26.9) $ (24.2)
Basic and diluted net loss per share $ (0.30) $ (0.28)
Shares used to compute basic and diluted net loss per share 90.3 87.3
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Statement of Comprehensive Income [Abstract]    
Net loss $ (26.9) $ (24.2)
Other comprehensive income (loss), net of income taxes:    
Foreign currency translation loss 0.0 (2.3)
Unrealized income on marketable debt securities 0.1 0.0
Total other comprehensive income (loss), net 0.1 (2.3)
Comprehensive loss $ (26.8) $ (26.5)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2017   87.0        
Beginning Balance at Dec. 31, 2017 $ 419.4 $ 0.1 $ 1,093.7 $ (2.6) $ (671.8) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under equity incentive plans (in shares)   1.0        
Issuance of common stock under equity incentive plans 0.1   0.1      
Issuance of common stock for Employee Stock Purchase Plan (in shares)   0.1        
Issuance of common stock for Employee Stock Purchase Plan 4.1   4.1      
Share-based compensation expense 24.6   24.6      
Net loss (24.2)       (24.2)  
Net loss (2.3)     (2.3)    
Ending Balance (in shares) at Mar. 31, 2018   88.1        
Ending Balance at Mar. 31, 2018 421.7 $ 0.1 1,122.5 (4.9) (696.0) 0.0
Beginning Balance (in shares) at Dec. 31, 2018   90.0        
Beginning Balance at Dec. 31, 2018 663.3 $ 0.1 1,560.6 1.5 (798.9) (100.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock under equity incentive plans (in shares)   0.9        
Issuance of common stock under equity incentive plans 0.2   0.2      
Issuance of common stock for Employee Stock Purchase Plan (in shares)   0.1        
Issuance of common stock for Employee Stock Purchase Plan 4.8   4.8      
Share-based compensation expense 25.0   25.0      
Cumulative-effect adjustment from adoption of new lease accounting standard (Note 2) 2.1          
Cumulative-effect adjustment from adoption of new lease accounting standard (Note 2) | Accounting Standards Update 2016-02         2.1  
Net loss (26.9)       (26.9)  
Net loss 0.1     0.1    
Ending Balance (in shares) at Mar. 31, 2019   91.0        
Ending Balance at Mar. 31, 2019 $ 668.6 $ 0.1 $ 1,590.6 $ 1.6 $ (823.7) $ (100.0)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating activities    
Net loss $ (26.9) $ (24.2)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 9.9 6.0
Share-based compensation 25.0 24.6
Non-cash interest expense 12.2 3.7
Income (loss) from equity investments 4.2 (7.4)
Other non-cash income and expenses 0.3 (0.9)
Changes in operating assets and liabilities:    
Accounts receivable, net 21.5 10.7
Inventory (30.4) (6.4)
Prepaid and other assets (5.4) (2.7)
Accounts payable and accrued liabilities 25.5 2.2
Accrued payroll and related expenses (21.1) (14.4)
Deferred revenue, deferred rent, and other liabilities (3.0) 0.1
Net cash provided by (used in) operating activities 11.8 (8.7)
Investing activities    
Purchase of marketable securities (50.7) (32.0)
Proceeds from sale and maturity of marketable securities 222.5 32.9
Purchase of other equity investments (1.2) (1.0)
Purchase of property and equipment (39.3) (15.3)
Net cash provided by (used in) investing activities 131.3 (15.4)
Financing activities    
Net proceeds from issuance of common stock 5.0 4.2
Other financing activities (0.1) 0.0
Net cash provided by financing activities 4.9 4.2
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0.6 (0.9)
Increase (decrease) in cash, cash equivalents and restricted cash 148.6 (20.8)
Cash, cash equivalents and restricted cash, beginning of period 1,137.1 441.5
Cash, cash equivalents and restricted cash, end of period 1,285.7 420.7
Reconciliation of cash, cash equivalents and restricted cash, end of period:    
Cash and cash equivalents 1,285.1 420.4
Restricted cash 0.6 0.3
Supplemental disclosure of non-cash investing and financing transactions:    
Acquisition of property and equipment included in accounts payable and accrued liabilities 10.1 $ 4.3
Right-of-use assets obtained in exchange for lease liabilities $ 45.2  
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Significant Accounting Policies
 3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Significant Accounting Policies
Organization and Significant Accounting Policies
Organization and Business
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.
Basis of Presentation and Principles of Consolidation
We have prepared the accompanying unaudited consolidated financial statements (the financial statements) in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.
Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We experience seasonality that is typical in our industry, with lower sales in the first quarter of each year compared to the fourth quarter.
These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2018 included in the Annual Report on Form 10-K that we filed with the SEC on February 21, 2019.
These financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.
Concentration of Credit Risk and Significant Customers
Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.
Two of our distributors are significant customers. Each of them accounted for more than 10% of revenue in each of the past three fiscal years and each of them accounted for more than 10% of accounts receivable as of the end of the past two fiscal years. Distributor A accounted for 15% and 13% of our revenues for the three months ended March 31, 2019 and 2018, respectively. Distributor B accounted for 11% and 14% of our revenues for the three months ended March 31, 2019 and 2018, respectively. Distributor A and Distributor B accounted for 17% and 11%, respectively, of our accounts receivable as of March 31, 2019 and for 19% and 15%, respectively, of our accounts receivable as of December 31, 2018.
Revenue Recognition
We generate our revenue from the sale of our durable CGM systems and disposable sensors (the Components). Our durable systems include a reusable transmitter and receiver. Disposable sensors are sold separately. We also provide free-of-charge software and mobile applications for use with our durable systems and disposable sensors. The initial durable system price is generally not dependent upon the subsequent purchase of any amount of disposable sensors.
We sell our durable systems and disposable sensors through two main sales channels: 1) directly to customers who use our products or organizations (the Direct Channel) and 2) to distribution partners who resell our products (the Distributor Channel).
In the Direct Channel, we sell the Components to customers and we receive payment directly from customers, organizations and third-party payors. Third-party payors primarily include commercial insurance companies and federal and state agencies (under Medicare and Medicaid programs).
Policy elections and ASC Topic 606 practical expedients taken
•
We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;
•
We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;
•
We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and
•
If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.
Contracts and performance obligations
We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. Components are individually priced and can be purchased separately or bundled in a contract. We also provide free-of-charge software, mobile applications and updates for our DexCom Share® remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are based on an expected cost plus a margin approach.
Transaction price
Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on contracted rates less any estimates of claim denials and historical reimbursement experience, which would include current and future expectations regarding reimbursement contracts, guidelines and payor mix, and less estimated variable consideration adjustments.
Variable consideration
Rebates. We estimate reductions to our revenues for rebates paid to payors, healthcare providers and distributors. Rebates are based on contractual arrangements or statutory requirements, which may vary by product, payor and individual payor plans. Our estimates are based on products sold, historical payor mix and, as available, known market events or trends and channel inventory data. We also take into consideration, as available, new information regarding changes in programs’ regulations and guidelines that would impact the amount of the actual rebates and/or our expectations regarding future payor mix for these programs.
Product Returns. We generally provide a “30-day money back guarantee” program whereby first-time end-user customers may return the durable system. In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. Our returns have historically been immaterial.
Revenue recognition
We recognize revenue when control is transferred to our customers. The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with the Components are satisfied at a point in time, which typically occurs at shipment. Terms of direct and distributor orders are generally Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer.
In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the durable system.
Our sales of the receiver and transmitter components of our CGM systems include an assurance-type warranty which is accounted for based on the cost accrual method recognized as expense when the products are sold and is not considered a separate performance obligation.
Contract balances
The timing of revenue recognition, billing and cash collections results in the recording of trade receivables and deferred revenue in our balance sheets. We recognize a receivable in the period in which our right to the consideration is unconditional. We generally do not have any contracts or performance obligations with a term of more than one year.
Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.
Accounts receivable as of March 31, 2019 and December 31, 2018 included unbilled accounts receivable of $4.7 million and $5.1 million. Unbilled accounts receivable consist of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months.
Substantially all of our deferred revenue as of March 31, 2019 is associated with certain of our free-of-charge software and mobile applications and will be recognized during 2019. During the three months ended March 31, 2019, we recognized revenue of $2.4 million that was recorded as deferred revenue as of December 31, 2018. During the three months ended March 31, 2018, we recognized revenue of $1.5 million that was recorded as deferred revenue as of December 31, 2017.
Deferred cost of sales
Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. These costs are recognized in cost of sales when the associated revenue is recognized. Deferred cost of sales are included in prepaid and other current assets in our balance sheets.
Incentive compensation costs
We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been one year or less. We record these costs in selling, general and administrative expense in our statement of operations.
Leases
We adopted Accounting Standards Codification Topic 842 (ASC 842) utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. Under ASC 842, we determine if an arrangement is a lease at inception. We record operating lease right-of-use assets and liabilities based on the present value of the lease payments over the lease term. In determining the present value of the lease payments, we use our incremental borrowing rate at the lease commencement date. We define the initial lease term to include the construction build-out period but to exclude lease extension periods when we are not reasonably certain to exercise our extension option. We record lease expense on a straight-line basis over the expected lease term. Lease costs which are variable and dependent on a rate, an index, or on usage of the asset are expensed in the period they are incurred.
We have facilities lease agreements with lease and non-lease components, such as common area maintenance. We generally account for the lease and non-lease components of these agreements as a single lease component.
We account for short-term lease expense on a straight-line basis over the lease term.
Net Income (Loss) Per Share
Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.
Common share equivalents that we calculate using the treasury stock method include outstanding stock options and unvested RSUs that are settleable in shares of common stock and potential common shares from convertible securities that we intend to settle using a combination of shares of our common stock and cash. Common share equivalents that we calculate using the if-converted method include potential common shares from convertible securities that we intend to settle using only shares of our common stock.
Because we reported net losses for the three months ended March 31, 2019 and 2018, all potentially dilutive common shares have been excluded from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.
Outstanding anti-dilutive securities not included in the diluted net loss per share attributable to common stockholders calculations were as follows:
 
Three Months Ended 
 March 31,
 (In millions)
2019
 
2018
Options outstanding to purchase common stock
—

 
0.4

Unvested restricted stock units
2.3

 
3.1

Senior convertible notes due 2022
4.0

 
4.0

Senior convertible notes due 2023
5.2

 
—

Warrants
5.2

 
—

Total
16.7

 
7.5


Recent Accounting Guidance
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) (ASU 2016-02), which requires a lessee to recognize most leases on the balance sheet as lease liabilities with corresponding right-of-use assets. We adopted ASU 2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. See Note 2, “Leases,” for more information on the impact of our adoption of ASU 2016-02 and related disclosures.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (ASU 2017-12), which is intended to more closely align hedge accounting with companies’ risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (ASU 2016-13), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. ASU 2016-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-14). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. ASU 2017-14 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other – Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-05). This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-05 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We are currently evaluating the impact that this guidance will have on our financial statements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Leases
 3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Leases
Leases
Impact of Adoption of ASC 842
We adopted ASU No. 2016-02, Leases (Topic 842) (ASU 2016-02) utilizing the modified retrospective transition method through a $2.1 million cumulative-effect adjustment to retained earnings at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards. We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019.
Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.
In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $26.7 million, finance lease right-of-use assets of $15.3 million, operating lease liabilities of $40.4 million and finance lease liabilities of $15.9 million at the beginning of the first quarter of 2019, with no material impact to our statement of operations.
Information About Our Leases
Our corporate headquarters and primary manufacturing facilities are located in San Diego, California. We lease approximately 219,000 square feet of space in San Diego under leases that expire in February and March 2022. We have the option to renew each of these leases for two additional five-year terms. In San Diego we also lease approximately 87,000 square feet of space under a lease that expires in February 2022 with no renewal options and approximately 132,600 square feet of space under a sublease that expires in January 2022. We lease approximately 148,800 square feet of space in Mesa, Arizona under a lease that expires in March 2028. We have the option to renew this lease for four additional five-year terms. We have also entered into other domestic and international operating lease agreements, primarily for office and warehouse space, that expire at various times through July 2026.
The components of lease expense for the three months ended March 31, 2019 were as follows:
(In millions)
Three Months Ended 
 March 31, 2019
Finance lease cost:
 
Amortization of right-of-use assets
$
0.3

Interest on lease liabilities
0.2

Operating lease cost
2.5

Short-term lease cost
1.3

Variable lease cost(1)
$
0.8

Total lease cost
$
5.1

(1) Variable lease costs represent payments that are dependent on a rate or index, or on usage of our facility leases and are primarily related to common area maintenance charges and property taxes.  

Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.
(Dollars in millions)
Three Months Ended 
 March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
4.6

Operating cash flows from finance leases
$
0.2

Financing cash flows from finance leases
$
0.1

Right-of-use assets obtained in exchange for lease liabilities:
 
Operating leases
$
29.9

Finance leases
$
15.3

Weighted average remaining lease term in years:
 
Operating leases
3.3

Finance leases
14.0

Weighted average discount rate:
 
Operating leases
5.0
%
Finance leases
5.0
%

Future minimum lease payments under non-cancellable leases as of March 31, 2019 were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of March 31, 2019.
(In millions)
Operating Leases
 
Finance Leases
2019
$
11.3

 
$
1.0

2020
14.2

 
1.3

2021
14.5

 
1.3

2022
3.7

 
1.4

2023
1.6

 
1.4

Thereafter
1.0

 
15.4

Total future lease cost
46.3

 
21.8

Less: Amount representing interest
(3.6
)
 
(6.1
)
Present value of future payments
42.7

 
15.7

Less: Short-term leases not recorded as a liability
(0.9
)
 
—

Revised present value of future lease payments
41.8
 
15.7

Less: Current portion
(12.3
)
 
(0.5
)
Long-term portion
$
29.5

 
$
15.2
Leases
Leases
Impact of Adoption of ASC 842
We adopted ASU No. 2016-02, Leases (Topic 842) (ASU 2016-02) utilizing the modified retrospective transition method through a $2.1 million cumulative-effect adjustment to retained earnings at the beginning of the first quarter of 2019. We will continue to report financial information for fiscal years prior to 2019 under the previous lease accounting standards. We elected the package of practical expedients permitted under the transition guidance in the new standard, which allowed us to carry forward the historical classification of leases that were in place as of January 1, 2019.
Under the previous lease accounting standards we were deemed the owner of our Mesa, Arizona building during the construction period. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell and the related lease liability as of December 31, 2018 and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019.
In addition, as a result of our adoption of ASC 842 we recorded operating lease right-of-use assets of $26.7 million, finance lease right-of-use assets of $15.3 million, operating lease liabilities of $40.4 million and finance lease liabilities of $15.9 million at the beginning of the first quarter of 2019, with no material impact to our statement of operations.
Information About Our Leases
Our corporate headquarters and primary manufacturing facilities are located in San Diego, California. We lease approximately 219,000 square feet of space in San Diego under leases that expire in February and March 2022. We have the option to renew each of these leases for two additional five-year terms. In San Diego we also lease approximately 87,000 square feet of space under a lease that expires in February 2022 with no renewal options and approximately 132,600 square feet of space under a sublease that expires in January 2022. We lease approximately 148,800 square feet of space in Mesa, Arizona under a lease that expires in March 2028. We have the option to renew this lease for four additional five-year terms. We have also entered into other domestic and international operating lease agreements, primarily for office and warehouse space, that expire at various times through July 2026.
The components of lease expense for the three months ended March 31, 2019 were as follows:
(In millions)
Three Months Ended 
 March 31, 2019
Finance lease cost:
 
Amortization of right-of-use assets
$
0.3

Interest on lease liabilities
0.2

Operating lease cost
2.5

Short-term lease cost
1.3

Variable lease cost(1)
$
0.8

Total lease cost
$
5.1

(1) Variable lease costs represent payments that are dependent on a rate or index, or on usage of our facility leases and are primarily related to common area maintenance charges and property taxes.  

Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.
(Dollars in millions)
Three Months Ended 
 March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
4.6

Operating cash flows from finance leases
$
0.2

Financing cash flows from finance leases
$
0.1

Right-of-use assets obtained in exchange for lease liabilities:
 
Operating leases
$
29.9

Finance leases
$
15.3

Weighted average remaining lease term in years:
 
Operating leases
3.3

Finance leases
14.0

Weighted average discount rate:
 
Operating leases
5.0
%
Finance leases
5.0
%

Future minimum lease payments under non-cancellable leases as of March 31, 2019 were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of March 31, 2019.
(In millions)
Operating Leases
 
Finance Leases
2019
$
11.3

 
$
1.0

2020
14.2

 
1.3

2021
14.5

 
1.3

2022
3.7

 
1.4

2023
1.6

 
1.4

Thereafter
1.0

 
15.4

Total future lease cost
46.3

 
21.8

Less: Amount representing interest
(3.6
)
 
(6.1
)
Present value of future payments
42.7

 
15.7

Less: Short-term leases not recorded as a liability
(0.9
)
 
—

Revised present value of future lease payments
41.8
 
15.7

Less: Current portion
(12.3
)
 
(0.5
)
Long-term portion
$
29.5

 
$
15.2
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurement
Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.
We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market-related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values of our Level 2 marketable securities portfolio balance provided by our investment managers.
The following table summarizes financial assets that we measured at fair value on a recurring basis as of March 31, 2019, classified in accordance with the fair value hierarchy. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.
 
Fair Value Measurements Using
(In millions)
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents
$
309.9

 
$
49.6

 
$
—

 
$
359.5

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
—

 
54.8

 
—

 
54.8

Commercial paper
—

 
3.0

 
—

 
3.0

Corporate debt
—

 
15.1

 
—

 
15.1

Total debt securities, available for sale
—

 
72.9

 
—

 
72.9

 
 
 
 
 
 
 
 
Total assets measured at fair value on a recurring basis
$
309.9

 
$
122.5

 
$
—

 
$
432.4

The following table summarizes financial assets that we measured at fair value on a recurring basis as of December 31, 2018, classified in accordance with the fair value hierarchy.
 
Fair Value Measurements Using
(In millions)
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents
$
199.3

 
$
66.7

 
$
—

 
$
266.0

 
 
 
 
 
 
 
 
Equity investment in Tandem Diabetes Care, Inc.
38.0

 
—

 
—

 
38.0

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
—

 
173.1

 
—

 
173.1

Commercial paper
—

 
36.2

 
—

 
36.2

Corporate debt
—

 
1.3

 
—

 
1.3

Total debt securities, available for sale
—

 
210.6

 
—

 
210.6

 
 
 
 
 
 
 
 
Total assets measured at fair value on a recurring basis
$
237.3

 
$
277.3

 
$
—

 
$
514.6


There were no transfers between Level 1 and Level 2 securities during the three months ended March 31, 2019 and 2018. There were no transfers into or out of Level 3 securities during the three months ended March 31, 2019 and 2018.
We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments are not significant and we include them in other assets in our balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are often privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant adverse effect on the fair values.
Financial liabilities whose fair values we measure on a recurring basis using Level 1 inputs consist of our outstanding 2022 Notes and 2023 Notes. We measure the fair value of the 2022 Notes and 2023 Notes based on their trading prices. The fair value of the 2022 Notes was $537.5 million as of March 31, 2019 and $540.2 million as of December 31, 2018. The fair value of the 2023 Notes was $876.3 million as of March 31, 2019 and $859.6 million as of December 31, 2018. For more information on the carrying values and fair values of our 2022 Notes and 2023 Notes, see Note 5, “Debt.”
Foreign Currency and Derivative Financial Instruments
From time to time we engage in limited hedging transactions to reduce foreign currency risks on certain intercompany balances. The fair values of these derivatives are based on quoted market prices, which are Level 1 inputs. As of March 31, 2019, we had no outstanding currency hedging transactions.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details
 3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Details
Balance Sheet Details
Short-Term Marketable Securities
Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.
 
March 31, 2019
(In millions)
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
$
54.8

 
$
—

 
$
—

 
$
54.8

Commercial paper
3.0

 
—

 
—

 
3.0

Corporate debt
15.1

 
—

 
—

 
15.1

Total debt securities, available for sale
72.9

 
—

 
—

 
72.9

 
 
 
 
 
 
 
 
Total marketable securities
$
72.9

 
$
—

 
$
—

 
$
72.9


 
December 31, 2018
(In millions)
Cost or Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
Equity investment in Tandem Diabetes Care, Inc.
$
2.0

 
$
36.0

 
$
—

 
$
38.0

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
173.2

 
—

 
(0.1
)
 
173.1

Commercial paper
36.2

 
—

 
—

 
36.2

Corporate debt
1.3

 
—

 
—

 
1.3

Total debt securities, available for sale
210.7

 
—

 
(0.1
)
 
210.6

 
 
 
 
 
 
 
 
Total marketable securities
$
212.7

 
$
36.0

 
$
(0.1
)
 
$
248.6


As of March 31, 2019 and December 31, 2018, all of our debt securities had contractual maturities of less than 12 months. Gross realized gains and losses on sales of our debt securities during the three months ended March 31, 2019 and 2018 were not significant.
We periodically review our portfolio of debt securities to determine if any investment is other-than-temporarily impaired due to changes in credit risk or other potential valuation concerns. We believe that the investments we held at March 31, 2019 were not other-than-temporarily impaired. Unrealized losses on available-for-sale debt securities at that date were not significant and were due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.

Inventory
(In millions)
March 31, 2019
 
December 31, 2018
Raw materials
$
52.7

 
$
30.8

Work-in-process
10.0

 
11.2

Finished goods
38.4

 
28.7

Total inventory
$
101.1

 
$
70.7


During the three months ended March 31, 2019 we recorded excess and obsolete inventory charges of $1.6 million in cost of goods sold as a result of our ongoing assessment of sales demand and inventory on hand.
Property and Equipment
(In millions)
March 31, 2019
 
December 31, 2018
Building and land
$
15.3

 
$
6.0

Furniture and fixtures
9.1

 
9.0

Computer software and hardware
31.6

 
29.2

Machinery and equipment
82.5

 
80.7

Leasehold improvements
83.2

 
80.7

Construction in progress
88.1

 
57.3

Total cost
309.8

 
262.9

Less accumulated depreciation and amortization
(88.4
)
 
(79.8
)
Total property and equipment, net
$
221.4

 
$
183.1


Building and Land. Although we do not legally own these premises, under previous lease accounting standards we were deemed the owner of the construction project during the construction period of our manufacturing facility in Mesa, Arizona under a build-to-suit lease arrangement. As a result of our adoption of ASC 842, we have de-recognized the estimated fair value of the building shell that was included in Building in our balance sheet as of December 31, 2018 and the related lease liability and recorded the difference between the asset and liability as an adjustment to retained earnings at the beginning of the first quarter of 2019. See Note 2, “Leases,” for more information on our adoption of ASC 842.
Construction in Progress. The increase in construction in progress as of March 31, 2019 compared to December 31, 2018 is primarily due to continued investment in the expansion and automation of our production capabilities.
Accounts Payable and Accrued Liabilities
(In millions)
March 31, 2019
 
December 31, 2018
Accounts payable trade
$
90.3

 
$
75.5

Accrued tax, audit, and legal fees
12.3

 
11.7

Accrued rebates
40.9

 
36.1

Accrued warranty
6.0

 
6.8

Restructuring reserve
1.1

 
—

Other accrued liabilities
18.5

 
17.0

Total accounts payable and accrued liabilities
$
169.1

 
$
147.1


Restructuring Reserve. In February 2019, our Board of Directors approved a restructuring plan that will result in the transition of certain of our operations to the Philippines. We estimate that we will incur total pre-tax charges and costs of approximately $9 million, primarily for employee severance benefits under both ongoing and one-time benefit arrangements. We expect to incur these costs throughout 2019 but primarily in the first half of 2019, and we expect the restructuring activities to be substantially complete by the end of 2019.

Other Long-Term Liabilities
(In millions)
March 31, 2019
 
December 31, 2018
Finance lease liabilities
$
15.2

 
$
7.3

Deferred rent
—

 
9.4

Other liabilities
2.9

 
3.3

Total other long-term liabilities
$
18.1

 
$
20.0


Our adoption of ASC 842 during the first quarter of 2019 affected the balances of finance lease liabilities and deferred rent as of March 31, 2019. See Note 2, “Leases,” for more information.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Debt
 3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
Debt
Debt
Senior Convertible Notes
(In millions)
March 31, 2019
 
December 31, 2018
0.75% Senior Convertible Notes due 2022:
 
 
 
Principal amount
$
400.0

 
$
400.0

Unamortized debt discount
(47.7
)
 
(51.1
)
Unamortized debt issuance costs
(5.9
)
 
(6.3
)
Net carrying amount of Senior Convertible Notes due 2022
346.4

 
342.6

 
 
 
 
0.75% Senior Convertible Notes due 2023:
 
 
 
Principal amount
850.0

 
850.0

Unamortized debt discount
(164.0
)
 
(171.8
)
Unamortized debt issuance costs
(10.0
)
 
(10.5
)
Net carrying amount of Senior Convertible Notes due 2023
676.0

 
667.7

 
 
 
 
Total net carrying amount of senior convertible notes
$
1,022.4

 
$
1,010.3

 
 
 
 
Fair value of outstanding senior convertible notes:
 
 
 
Senior Convertible Notes due 2022
$
537.5

 
$
540.2

Senior Convertible Notes due 2023
876.3

 
859.6

Total fair value of outstanding senior convertible notes
$
1,413.8

 
$
1,399.8

 
 
 
 
Amount by which the notes' if-converted value exceeds their principal amount:
 
 
 
Senior Convertible Notes due 2022
$
121.7

 
$
125.4

Senior Convertible Notes due 2023
—

 
—

Total by which the notes' if-converted value exceeds their principal amount
$
121.7

 
$
125.4



0.75% Senior Convertible Notes due 2022
In June 2017, we completed an offering of $400.0 million aggregate principal amount of unsecured senior convertible senior notes with a stated interest rate of 0.75% and a maturity date of May 15, 2022 (the 2022 Notes). The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $389.0 million. The 2022 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all 2022 Notes conversions in shares of our common stock. The initial conversion rate of the 2022 Notes is 10.0918 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $99.09 per share, subject to adjustments. We use the if-converted method for assumed conversion of the 2022 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.
Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders’ equity. As a result, we recognized $72.6 million in additional paid-in-capital during 2017.
The interest expense recognized on the 2022 Notes during the three months ended March 31, 2019 includes $0.7 million, $3.5 million and $0.4 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2022 Notes during the three months ended March 31, 2018 includes $0.8 million, $3.3 million and $0.4 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2022 Notes is 5.1%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. The discount on the 2022 Notes is amortized through May 15, 2022. Interest on the 2022 Notes began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.
In the event of a fundamental change (as defined in the indenture related to the 2022 Notes), holders of the 2022 Notes have the right to require us to repurchase for cash all or a portion of their notes at a price equal to 100% of the principal amount of the 2022 Notes, plus any accrued and unpaid interest. Holders of the 2022 Notes who convert their notes in connection with a make-whole fundamental change (as defined in the indenture) or following the delivery by DexCom of a notice of redemption are, under certain circumstances, entitled to an increase in the conversion rate.
Prior to 5:00 p.m., New York City time, on the business day immediately preceding February 15, 2022, holders of the 2022 Notes may convert all or a portion of their notes, in multiples of $1,000 principal amount, only under the following circumstances:
(1)
during any calendar quarter commencing after September 30, 2017 (and only during such calendar quarter), if the last reported sale price of common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the Notes on each such trading day;
(2)
during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each day of that five day consecutive trading day period was less than 98% of the product of the last reported sale price of common stock and the applicable conversion rate of the Notes on such trading day;
(3)
if we call any or all of the Notes for redemption, at any time prior to the close on business on the scheduled trading day immediately preceding the redemption date; or
(4)
upon the occurrence of specified corporate transactions.
 On or after February 15, 2022, until 5:00 p.m., New York City time, on the business day immediately preceding the maturity date, holders of the 2022 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.
DexCom may not redeem the 2022 Notes prior to May 15, 2020. On or after May 15, 2020, DexCom may redeem for cash all or part of the 2022 Notes, at its option, if the last reported sale price of our common stock has been at least 140% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.
No principal payments are due on the 2022 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2022 Notes includes customary terms and covenants, including certain events of default after which the 2022 Notes may be due and payable immediately.
Circumstance (1) listed above occurred during the last 30 trading days of the quarter ended March 31, 2019. As a result, the 2022 Notes are convertible at the option of the holders from April 1, 2019 and will remain convertible until June 30, 2019. We continue to classify the carrying value of the liability component of the 2022 Notes as long-term debt, and the equity component of the 2022 Notes as permanent equity in our balance sheet as of March 31, 2019.
0.75% Senior Convertible Notes due 2023
In November 2018, we completed an offering of $850.0 million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 0.75% and a maturity date of December 1, 2023 (the 2023 Notes). The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $836.6 million. The 2023 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all 2023 Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any note conversion value in excess of the principal amount in shares of our common stock. The initial conversion rate of the 2023 Notes is 6.0869 shares per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $164.29 per share, subject to adjustments. We use the treasury stock method for assumed conversion of the 2023 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. We entered into transactions for a convertible note hedge (the 2023 Note Hedge) and warrants (the 2023 Warrants) concurrently with the issuance of the 2023 Notes.
Since upon conversion by the holders we may elect to settle such conversion in shares of our common stock, cash, or a combination thereof, we accounted for the cash conversion option as an equity instrument classified to stockholders’ equity. As a result, we recognized $174.4 million in additional paid-in capital during 2018.
The interest expense recognized on the 2023 Notes during the three months ended March 31, 2019 includes $1.6 million, $7.8 million and $0.5 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2023 Notes is 5.6%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. The discount on the 2023 Notes is being amortized through December 1, 2023. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually on June 1 and December 1 of each year.
Holders of the 2023 Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the indenture relating to the notes). We will also be required to increase the conversion rate for holders who convert their 2023 Notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by DexCom of a notice of redemption.
Holders of the 2023 Notes may convert all or a portion of their notes at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding September 1, 2023, in multiples of $1,000 principal amount, only under the following circumstances:
(1)
during any calendar quarter commencing after March 31, 2019 (and only during such calendar quarter), if the last reported sale price of common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2023 Notes on each such trading day;
(2)
during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the 2023 Notes for each day of that five-day consecutive trading day period was less than 98% of the product of the last reported sale price of common stock and the applicable conversion rate of the 2023 Notes on such trading day;
(3)
if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or
(4)
upon the occurrence of specified corporate transactions.
On or after September 1, 2023, until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding the maturity date, holders of the 2023 Notes may convert all or a portion of their notes regardless of the foregoing circumstances.
DexCom may not redeem the 2023 Notes prior to December 1, 2021. On or after December 1, 2021 and prior to September 1, 2023, DexCom may redeem for cash all or part of the 2023 Notes, at its option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which DexCom provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the 2023 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date.
No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indenture relating to the 2023 Notes includes customary terms and covenants, including certain events of default after which the 2023 Notes may be due and payable immediately. As of the date of these financial statements, we are unaware of any current events or market conditions that would allow holders to convert the 2023 Notes.
2023 Note Hedge
In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions with two of the initial purchasers of the 2023 Notes (the 2023 Counterparties) entitling us to purchase up to 5.2 million shares of our common stock at an initial price of $164.29 per share, each of which is subject to adjustment. The cost of the 2023 Note Hedge was $218.9 million and we accounted for it as an equity instrument by recognizing $218.9 million in additional paid-in capital during 2018. The 2023 Note Hedge will expire on December 1, 2023. The 2023 Note Hedge is expected to reduce the potential equity dilution upon any conversion of the 2023 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Note Hedge. The strike price of the 2023 Note Hedge initially corresponds to the conversion price of the 2023 Notes and is subject to certain adjustments under the terms of the 2023 Note Hedge. An assumed exercise of the 2023 Note Hedge by us is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.
2023 Warrants
In November 2018, we also sold warrants to the 2023 Counterparties to acquire up to 5.2 million shares of our common stock. The 2023 Warrants require net share settlement and a pro rated number of warrants will expire on each of the 60 scheduled trading days starting on March 1, 2024. We received $183.8 million in cash proceeds from the sale of the 2023 Warrants, which we recorded in additional paid-in capital during 2018. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants. The strike price of the 2023 Warrants is initially $198.38 per share and is subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.
Revolving Credit Agreement
In December 2018, we entered into a five-year $200.0 million revolving credit agreement (the Credit Agreement) with JPMorgan Chase Bank, NA, as administrative agent, Bank of America, Silicon Valley Bank, Union Bank and Bank of the West. The Credit Agreement provides a $50.0 million sublimit for borrowings in Canadian Dollars, Euros, British Pounds, Swedish Krona, Japanese Yen and any other currency that is subsequently approved by the lenders and a sub-facility of up to $10.0 million for letters of credit. Subject to customary conditions and the approval of any lender whose commitment would be increased, we have the option to increase the maximum principal amount available under the Credit Agreement by up to an additional $300.0 million, resulting in a maximum available principal amount of $500.0 million. However, at this time none of the lenders have committed to provide any such increase in their commitments.
Revolving loans under the Credit Agreement bear interest at our choice of one of two base rates plus a range of applicable margin rates that are based on our leverage ratio. The first base rate is the highest of (a) the publicly announced JPMorgan Chase prime rate, (b) the federal funds rate, or (c) the overnight bank funding rate, and the applicable margin rate ranges from 0.375% to 1.000%. The second base rate is a LIBOR-based rate, and the applicable margin rate ranges from 1.375% to 2.000%. We will also pay a commitment fee of between 0.2% and 0.3%, payable quarterly in arrears, on the average daily unused amount of the revolving facility based on our leverage ratio.
The Credit Agreement requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of March 31, 2019.
We drew no loans under the Credit Agreement during the three months ended March 31, 2019. As of March 31, 2019, we had no outstanding borrowings, letters of credit totaling $4.4 million, and a total available balance of $195.6 million under the Credit Agreement.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Contingencies
 3 Months Ended
Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
Contingencies
Litigation
On March 28, 2016, AgaMatrix, Inc., or AgaMatrix, filed a patent infringement lawsuit against us in the United States District Court for the District of Oregon, asserting that certain of our products infringe certain patents held by AgaMatrix. On June 6, 2016, AgaMatrix filed a First Amended Complaint asserting the same three patents. On February 24, 2017, the Court granted AgaMatrix’s motion to substitute WaveForm Technologies, Inc., or WaveForm, as the new plaintiff following AgaMatrix’s transfer of the three patents to its newly formed entity. On August 25, 2016, we filed petitions for inter partes review with the Patent Trial and Appeal Board, or PTAB, of the U.S. Patent and Trademark Office seeking a determination that two of the three asserted patents are invalid under U.S. patent law and those petitions were granted on March 6, 2017. On March 8, 2017, we filed a petition for inter partes review with the PTAB seeking a determination that the third of the three asserted patents is invalid under U.S. patent law. This petition was granted on September 15, 2017. The PTAB issued a Final Written Decision for each of the first two patents on February 28, 2018, where the PTAB found the majority of asserted claims from the first patent unpatentable and the remaining claims under review not unpatentable. The PTAB found all claims under review from the second patent not unpatentable. On April 3, 2019, the Federal Circuit affirmed the PTAB’s finding that certain claims were not unpatentable. The PTAB issued a Final Written Decision for the third patent on September 12, 2018, where the PTAB found all claims of the third patent asserted against us in the District of Oregon litigation unpatentable. WaveForm did not appeal this decision. Most activity in the patent infringement lawsuit against us in the District of Oregon was stayed until the PTAB completed the inter partes review proceedings. That stay was lifted on October 10, 2018. The remaining claims and counterclaims will continue with an estimated date of trial in February 2020. It is our position that Waveform’s assertions of infringement have no merit.
We have also filed several lawsuits against AgaMatrix. We filed a patent infringement lawsuit against Agamatrix in the United States District Court for the Central District of California, or C.D. Cal., in which a Final Judgment of non-infringement was entered by the C.D. Cal judge on February 23, 2018 and affirmed on appeal by the Federal Circuit on April 15, 2019. AgaMatrix sought attorneys' fees for this lawsuit and as of March 31, 2019 we have accrued an immaterial amount for those fees. The fee decision is currently on appeal to the Federal Circuit. On September 15, 2017, we filed a patent infringement lawsuit against AgaMatrix in the United States District Court for the District of Delaware, asserting certain single-point blood glucose monitoring products of AgaMatrix infringe two patents held by us. In addition, on September 18, 2017, we filed a Complaint against AgaMatrix in the International Trade Commission, referred to as the ITC, requesting that the ITC institute an investigation and issue an order excluding certain products of AgaMatrix from importation into or sale in the United States based on AgaMatrix’s infringement of the same two patents asserted in the Delaware litigation. The investigation was terminated by the Commission on April 4, 2019 with a finding of non-infringement. On September 14, 2018, AgaMatrix filed two petitions for inter partes review for each of the same two patents we asserted in the District of Delaware and the ITC. These petitions were denied.
Neither the outcome of these lawsuits nor the amount and range of potential loss associated with the lawsuits can be assessed at this time. Other than the attorneys’ fees described above, as of March 31, 2019 we have accrued no amounts for contingent losses associated with these suits.
We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability and employment related matters. In addition, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters. We do not expect that the resolution of these matters would, or will, have a material adverse effect or material impact on our financial position or results of operations.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes
 3 Months Ended
Mar. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
Our effective tax rate for the three months ended March 31, 2019 and 2018 was a negative rate of 1%. The negative effective tax rate in the current period resulted from recording foreign income tax in jurisdictions with current taxable income. The negative effective tax rate in the prior period resulted from recording state income and foreign withholding taxes. In both periods, no income tax benefit was recorded on losses in jurisdictions where valuation allowances are recorded against net deferred tax assets.
We maintain a full valuation allowance against our net deferred tax assets as of March 31, 2019 based on our assessment that it is not more likely than not these future benefits will be realized before expiration.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Business Segment and Geographic Information
 3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Business Segment and Geographic Information
Business Segment and Geographic Information
Reportable Segments
An operating segment is identified as a component of a business that has discrete financial information available and for which the chief operating decision maker must decide the level of resource allocation. In addition, the guidance for segment reporting indicates certain quantitative materiality thresholds.
We currently consider our operations to be, and manage our business globally within, one reportable segment, which is consistent with how our President and Chief Executive Officer, who is our chief operating decision maker, reviews our business, makes investment and resource allocation decisions, and assesses operating performance.
Disaggregation of Revenue
DexCom is domiciled in the United States. We sell our durable systems and disposable sensors through a direct sales force in the United States, Canada and some countries in Europe, and through distribution arrangements in the United States, Canada, Australia, New Zealand, and in some countries in Europe, Asia, Latin America, the Middle East and Africa. We disaggregate our revenue from contracts by major sales channel and geography as we believe they best depict how the nature, amount and timing of revenues and cash flows are affected by economic factors.
Revenues by geographic region
During the three months ended March 31, 2019 and 2018, no country outside of the United States generated revenue that represented more than 10% of our total revenue.
The following table sets forth revenues by our two primary geographical markets, United States and outside of the United States, based on the geographic location to which we deliver the product:
 
Three Months Ended 
 March 31, 2019
 
Three Months Ended 
 March 31, 2018
(In millions)
Amount
 
% of Total
 
Amount
 
% of Total
Revenues:
 
 
 
 
 
 
 
United States
$
210.5

 
75
%
 
$
145.4

 
79
%
Outside of the United States
70.0

 
25
%
 
39.0

 
21
%
Total
$
280.5

 
100
%
 
$
184.4

 
100
%

Revenues by customer sales channel
The following table sets forth revenues disaggregated by customer sales channel:
 
Three Months Ended 
 March 31, 2019
 
Three Months Ended 
 March 31, 2018
(In millions)
Amount
 
% of Total
 
Amount
 
% of Total
Revenues:
 
 
 
 
 
 
 
Distributor
$
187.8

 
67
%
 
$
118.3

 
64
%
Direct
92.7

 
33
%
 
66.1

 
36
%
Total
$
280.5

 
100
%
 
$
184.4

 
100
%
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stockholder's Equity
Stockholders’ Equity

Share-Based Compensation Expense
The following table summarizes share-based compensation expense for the periods shown:
 
Three Months Ended 
 March 31,
(In millions)
2019
 
2018
Cost of sales
$
2.3

 
$
2.2

Research and development
8.5

 
8.5

Selling, general and administrative
14.2

 
13.9

Total share-based compensation expense included in net loss
$
25.0

 
$
24.6


As of March 31, 2019, unrecognized estimated compensation costs related to unvested restricted stock units, or RSUs, and performance stock units, or PSUs, totaled $188.3 million and is expected to be recognized through 2021.
Restricted Stock Units
A summary of our RSU and PSU activity for the three months ended March 31, 2019 is as follows:
 
 
 
Weighted
 
 
 
 
 
Average
 
Aggregate
 
 
 
Grant Date
 
Intrinsic
(In millions, except weighted average grant date fair values)
Shares
 
Fair Value
 
Value
Nonvested at December 31, 2018
2.7

 
$
69.19

 
$
319.0

Granted
0.6

 
143.24

 
 
Vested
(0.9
)
 
65.77

 
 
Forfeited
(0.1
)
 
95.68

 
 
Nonvested at March 31, 2019
2.3

 
$
89.57

 
$
277.4



The total vest date fair value of RSUs that vested during the three months ended March 31, 2019 was $132.3 million. No PSUs vested during that period.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Organization and Business
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for use by people with diabetes and by healthcare providers. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.
Basis of Presentation and Principles of Consolidation
We have prepared the accompanying unaudited consolidated financial statements (the financial statements) in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.
Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We experience seasonality that is typical in our industry, with lower sales in the first quarter of each year compared to the fourth quarter.
These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2018 included in the Annual Report on Form 10-K that we filed with the SEC on February 21, 2019.
These financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Principles of Consolidation
Basis of Presentation and Principles of Consolidation
We have prepared the accompanying unaudited consolidated financial statements (the financial statements) in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, all adjustments, which include only normal recurring adjustments considered necessary for a fair presentation, have been included.
Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. We expect that revenues we generate from the sales of our products will fluctuate from quarter to quarter. We experience seasonality that is typical in our industry, with lower sales in the first quarter of each year compared to the fourth quarter.
These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2018 included in the Annual Report on Form 10-K that we filed with the SEC on February 21, 2019.
These financial statements include the accounts of DexCom, Inc. and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Reclassification
We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.
Concentration of Credit Risk and Significant Customers
Concentration of Credit Risk and Significant Customers
Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.
Revenue Recognition
Revenue Recognition
We generate our revenue from the sale of our durable CGM systems and disposable sensors (the Components). Our durable systems include a reusable transmitter and receiver. Disposable sensors are sold separately. We also provide free-of-charge software and mobile applications for use with our durable systems and disposable sensors. The initial durable system price is generally not dependent upon the subsequent purchase of any amount of disposable sensors.
We sell our durable systems and disposable sensors through two main sales channels: 1) directly to customers who use our products or organizations (the Direct Channel) and 2) to distribution partners who resell our products (the Distributor Channel).
In the Direct Channel, we sell the Components to customers and we receive payment directly from customers, organizations and third-party payors. Third-party payors primarily include commercial insurance companies and federal and state agencies (under Medicare and Medicaid programs).
Policy elections and ASC Topic 606 practical expedients taken
•
We report revenue net of taxes collected from customers, which are subsequently remitted to governmental authorities;
•
We account for shipping and handling activities that are performed after a customer has obtained control of a good as fulfillment costs rather than as separate performance obligations;
•
We do not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer; and
•
If we expect, at contract inception, that the period between the transfer of control and corresponding payment from the customer will be one year or less, we do not adjust the amount of consideration for the effects of a significant financing component.
Contracts and performance obligations
We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations. Components are individually priced and can be purchased separately or bundled in a contract. We also provide free-of-charge software, mobile applications and updates for our DexCom Share® remote monitoring system. The standalone selling prices of our free-of-charge software, mobile applications and updates are based on an expected cost plus a margin approach.
Transaction price
Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on contracted rates less any estimates of claim denials and historical reimbursement experience, which would include current and future expectations regarding reimbursement contracts, guidelines and payor mix, and less estimated variable consideration adjustments.
Variable consideration
Rebates. We estimate reductions to our revenues for rebates paid to payors, healthcare providers and distributors. Rebates are based on contractual arrangements or statutory requirements, which may vary by product, payor and individual payor plans. Our estimates are based on products sold, historical payor mix and, as available, known market events or trends and channel inventory data. We also take into consideration, as available, new information regarding changes in programs’ regulations and guidelines that would impact the amount of the actual rebates and/or our expectations regarding future payor mix for these programs.
Product Returns. We generally provide a “30-day money back guarantee” program whereby first-time end-user customers may return the durable system. In accordance with the terms of their distribution agreements, most distributors do not have rights of return outside of our limited warranty. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. Our returns have historically been immaterial.
Revenue recognition
We recognize revenue when control is transferred to our customers. The timing of revenue recognition is based on the satisfaction of performance obligations. Substantially all of the performance obligations associated with the Components are satisfied at a point in time, which typically occurs at shipment. Terms of direct and distributor orders are generally Freight on Board (FOB) shipping point for U.S. orders or Free Carrier (FCA) shipping point for international orders. For certain of our distributors, control transfers at delivery of the product to the customer.
In cases where our free-of-charge software, mobile applications and updates are deemed to be separate performance obligations, revenue is recognized over time on a ratable basis over the estimated life of the durable system.
Our sales of the receiver and transmitter components of our CGM systems include an assurance-type warranty which is accounted for based on the cost accrual method recognized as expense when the products are sold and is not considered a separate performance obligation.
Contract balances
The timing of revenue recognition, billing and cash collections results in the recording of trade receivables and deferred revenue in our balance sheets. We recognize a receivable in the period in which our right to the consideration is unconditional. We generally do not have any contracts or performance obligations with a term of more than one year.
Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.
Accounts receivable as of March 31, 2019 and December 31, 2018 included unbilled accounts receivable of $4.7 million and $5.1 million. Unbilled accounts receivable consist of revenue recognized for Components we have delivered but not yet invoiced to customers. We expect to invoice and collect all unbilled accounts receivable within twelve months.
Substantially all of our deferred revenue as of March 31, 2019 is associated with certain of our free-of-charge software and mobile applications and will be recognized during 2019. During the three months ended March 31, 2019, we recognized revenue of $2.4 million that was recorded as deferred revenue as of December 31, 2018. During the three months ended March 31, 2018, we recognized revenue of $1.5 million that was recorded as deferred revenue as of December 31, 2017.
Deferred cost of sales
Deferred cost of sales are associated with sales for which revenue recognition criteria are not met but product has shipped and released from inventory. These costs are recognized in cost of sales when the associated revenue is recognized. Deferred cost of sales are included in prepaid and other current assets in our balance sheets.
Incentive compensation costs
We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been one year or less. We record these costs in selling, general and administrative expense in our statement of operations.
Leases
Leases
We adopted Accounting Standards Codification Topic 842 (ASC 842) utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. Under ASC 842, we determine if an arrangement is a lease at inception. We record operating lease right-of-use assets and liabilities based on the present value of the lease payments over the lease term. In determining the present value of the lease payments, we use our incremental borrowing rate at the lease commencement date. We define the initial lease term to include the construction build-out period but to exclude lease extension periods when we are not reasonably certain to exercise our extension option. We record lease expense on a straight-line basis over the expected lease term. Lease costs which are variable and dependent on a rate, an index, or on usage of the asset are expensed in the period they are incurred.
We have facilities lease agreements with lease and non-lease components, such as common area maintenance. We generally account for the lease and non-lease components of these agreements as a single lease component.
We account for short-term lease expense on a straight-line basis over the lease term.
Net Income (Loss) Per Share
Net Income (Loss) Per Share
Basic net income (loss) per share attributable to common stockholders is calculated by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.
Common share equivalents that we calculate using the treasury stock method include outstanding stock options and unvested RSUs that are settleable in shares of common stock and potential common shares from convertible securities that we intend to settle using a combination of shares of our common stock and cash. Common share equivalents that we calculate using the if-converted method include potential common shares from convertible securities that we intend to settle using only shares of our common stock.
Because we reported net losses for the three months ended March 31, 2019 and 2018, all potentially dilutive common shares have been excluded from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.
Recent Accounting Guidance
Recent Accounting Guidance
Recently Adopted Accounting Pronouncements
In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) (ASU 2016-02), which requires a lessee to recognize most leases on the balance sheet as lease liabilities with corresponding right-of-use assets. We adopted ASU 2016-02 utilizing the modified retrospective transition method at the beginning of the first quarter of 2019. See Note 2, “Leases,” for more information on the impact of our adoption of ASU 2016-02 and related disclosures.
In August 2017, the FASB issued ASU No. 2017-12, Derivatives and Hedging (ASU 2017-12), which is intended to more closely align hedge accounting with companies’ risk management strategies, simplify the application of hedge accounting, and increase transparency regarding the scope and results of hedging programs. The guidance in this update is applied using a cumulative-effect adjustment to retained earnings at the beginning of the fiscal year of adoption. ASU 2017-12 is effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Our adoption of ASU 2017-12 at the beginning of the first quarter of 2019 did not have a significant impact on our financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (ASU 2016-13), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. ASU 2016-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In January 2017, the FASB issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (ASU 2017-14). This new guidance eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. ASU 2017-14 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public business entities will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. ASU 2018-13 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. We are currently evaluating the impact that this guidance will have on our financial statements.
In August 2018, the FASB issued ASU No. 2018-15, Intangibles - Goodwill and Other – Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract (ASU 2018-05). This new guidance requires a customer in a cloud computing arrangement to determine which implementation costs to capitalize as assets or expense as incurred. Capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. ASU 2018-05 is effective for public business entities for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and early adoption is permitted. Application of this guidance can be applied either prospectively or retrospectively. We are currently evaluating the impact that this guidance will have on our financial statements.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Outstanding anti-dilutive securities not included in diluted net loss per share
Outstanding anti-dilutive securities not included in the diluted net loss per share attributable to common stockholders calculations were as follows:
 
Three Months Ended 
 March 31,
 (In millions)
2019
 
2018
Options outstanding to purchase common stock
—

 
0.4

Unvested restricted stock units
2.3

 
3.1

Senior convertible notes due 2022
4.0

 
4.0

Senior convertible notes due 2023
5.2

 
—

Warrants
5.2

 
—

Total
16.7

 
7.5
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Components of lease expense
Other information related to leases was as shown in the table below. All figures include the leases recorded at the beginning of the first quarter of 2019 as a result of our adoption of ASC 842.
(Dollars in millions)
Three Months Ended 
 March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows from operating leases
$
4.6

Operating cash flows from finance leases
$
0.2

Financing cash flows from finance leases
$
0.1

Right-of-use assets obtained in exchange for lease liabilities:
 
Operating leases
$
29.9

Finance leases
$
15.3

Weighted average remaining lease term in years:
 
Operating leases
3.3

Finance leases
14.0

Weighted average discount rate:
 
Operating leases
5.0
%
Finance leases
5.0
%
The components of lease expense for the three months ended March 31, 2019 were as follows:
(In millions)
Three Months Ended 
 March 31, 2019
Finance lease cost:
 
Amortization of right-of-use assets
$
0.3

Interest on lease liabilities
0.2

Operating lease cost
2.5

Short-term lease cost
1.3

Variable lease cost(1)
$
0.8

Total lease cost
$
5.1

(1) Variable lease costs represent payments that are dependent on a rate or index, or on usage of our facility leases and are primarily related to common area maintenance charges and property taxes.  
Future minimum lease payments, operating leases
Future minimum lease payments under non-cancellable leases as of March 31, 2019 were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of March 31, 2019.
(In millions)
Operating Leases
 
Finance Leases
2019
$
11.3

 
$
1.0

2020
14.2

 
1.3

2021
14.5

 
1.3

2022
3.7

 
1.4

2023
1.6

 
1.4

Thereafter
1.0

 
15.4

Total future lease cost
46.3

 
21.8

Less: Amount representing interest
(3.6
)
 
(6.1
)
Present value of future payments
42.7

 
15.7

Less: Short-term leases not recorded as a liability
(0.9
)
 
—

Revised present value of future lease payments
41.8
 
15.7

Less: Current portion
(12.3
)
 
(0.5
)
Long-term portion
$
29.5

 
$
15.2
Future minimum lease payments, finance leases
Future minimum lease payments under non-cancellable leases as of March 31, 2019 were as shown in the table below. The current portion of finance leases are included in accounts payable and accrued liabilities and the long-term portion of finance leases are included in other long-term liabilities on our balance sheet as of March 31, 2019.
(In millions)
Operating Leases
 
Finance Leases
2019
$
11.3

 
$
1.0

2020
14.2

 
1.3

2021
14.5

 
1.3

2022
3.7

 
1.4

2023
1.6

 
1.4

Thereafter
1.0

 
15.4

Total future lease cost
46.3

 
21.8

Less: Amount representing interest
(3.6
)
 
(6.1
)
Present value of future payments
42.7

 
15.7

Less: Short-term leases not recorded as a liability
(0.9
)
 
—

Revised present value of future lease payments
41.8
 
15.7

Less: Current portion
(12.3
)
 
(0.5
)
Long-term portion
$
29.5

 
$
15.2
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Hierarchy for Financial Assets
The following table summarizes financial assets that we measured at fair value on a recurring basis as of March 31, 2019, classified in accordance with the fair value hierarchy. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.
 
Fair Value Measurements Using
(In millions)
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents
$
309.9

 
$
49.6

 
$
—

 
$
359.5

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
—

 
54.8

 
—

 
54.8

Commercial paper
—

 
3.0

 
—

 
3.0

Corporate debt
—

 
15.1

 
—

 
15.1

Total debt securities, available for sale
—

 
72.9

 
—

 
72.9

 
 
 
 
 
 
 
 
Total assets measured at fair value on a recurring basis
$
309.9

 
$
122.5

 
$
—

 
$
432.4

The following table summarizes financial assets that we measured at fair value on a recurring basis as of December 31, 2018, classified in accordance with the fair value hierarchy.
 
Fair Value Measurements Using
(In millions)
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents
$
199.3

 
$
66.7

 
$
—

 
$
266.0

 
 
 
 
 
 
 
 
Equity investment in Tandem Diabetes Care, Inc.
38.0

 
—

 
—

 
38.0

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
—

 
173.1

 
—

 
173.1

Commercial paper
—

 
36.2

 
—

 
36.2

Corporate debt
—

 
1.3

 
—

 
1.3

Total debt securities, available for sale
—

 
210.6

 
—

 
210.6

 
 
 
 
 
 
 
 
Total assets measured at fair value on a recurring basis
$
237.3

 
$
277.3

 
$
—

 
$
514.6
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details (Tables)
 3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Short Term Marketable Securities, Available for Sale
Short-Term Marketable Securities
Short-term marketable securities, consisting of equity securities and debt securities, were as follows as of the dates indicated. We sold the equity investment in Tandem Diabetes Care, Inc. that we held as of December 31, 2018 during the first quarter of 2019.
 
March 31, 2019
(In millions)
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
$
54.8

 
$
—

 
$
—

 
$
54.8

Commercial paper
3.0

 
—

 
—

 
3.0

Corporate debt
15.1

 
—

 
—

 
15.1

Total debt securities, available for sale
72.9

 
—

 
—

 
72.9

 
 
 
 
 
 
 
 
Total marketable securities
$
72.9

 
$
—

 
$
—

 
$
72.9


 
December 31, 2018
(In millions)
Cost or Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Estimated
Market
Value
Equity investment in Tandem Diabetes Care, Inc.
$
2.0

 
$
36.0

 
$
—

 
$
38.0

 
 
 
 
 
 
 
 
Debt securities, available for sale:
 
 
 
 
 
 
 
U.S. government agencies
173.2

 
—

 
(0.1
)
 
173.1

Commercial paper
36.2

 
—

 
—

 
36.2

Corporate debt
1.3

 
—

 
—

 
1.3

Total debt securities, available for sale
210.7

 
—

 
(0.1
)
 
210.6

 
 
 
 
 
 
 
 
Total marketable securities
$
212.7

 
$
36.0

 
$
(0.1
)
 
$
248.6
Inventory
Inventory
(In millions)
March 31, 2019
 
December 31, 2018
Raw materials
$
52.7

 
$
30.8

Work-in-process
10.0

 
11.2

Finished goods
38.4

 
28.7

Total inventory
$
101.1

 
$
70.7
Property, Plant and Equipment
Property and Equipment
(In millions)
March 31, 2019
 
December 31, 2018
Building and land
$
15.3

 
$
6.0

Furniture and fixtures
9.1

 
9.0

Computer software and hardware
31.6

 
29.2

Machinery and equipment
82.5

 
80.7

Leasehold improvements
83.2

 
80.7

Construction in progress
88.1

 
57.3

Total cost
309.8

 
262.9

Less accumulated depreciation and amortization
(88.4
)
 
(79.8
)
Total property and equipment, net
$
221.4

 
$
183.1
Accounts Payable and Accrued Liabilities
Accounts Payable and Accrued Liabilities
(In millions)
March 31, 2019
 
December 31, 2018
Accounts payable trade
$
90.3

 
$
75.5

Accrued tax, audit, and legal fees
12.3

 
11.7

Accrued rebates
40.9

 
36.1

Accrued warranty
6.0

 
6.8

Restructuring reserve
1.1

 
—

Other accrued liabilities
18.5

 
17.0

Total accounts payable and accrued liabilities
$
169.1

 
$
147.1
Other Liabilities
Other Long-Term Liabilities
(In millions)
March 31, 2019
 
December 31, 2018
Finance lease liabilities
$
15.2

 
$
7.3

Deferred rent
—

 
9.4

Other liabilities
2.9

 
3.3

Total other long-term liabilities
$
18.1

 
$
20.0
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
(In millions)
March 31, 2019
 
December 31, 2018
0.75% Senior Convertible Notes due 2022:
 
 
 
Principal amount
$
400.0

 
$
400.0

Unamortized debt discount
(47.7
)
 
(51.1
)
Unamortized debt issuance costs
(5.9
)
 
(6.3
)
Net carrying amount of Senior Convertible Notes due 2022
346.4

 
342.6

 
 
 
 
0.75% Senior Convertible Notes due 2023:
 
 
 
Principal amount
850.0

 
850.0

Unamortized debt discount
(164.0
)
 
(171.8
)
Unamortized debt issuance costs
(10.0
)
 
(10.5
)
Net carrying amount of Senior Convertible Notes due 2023
676.0

 
667.7

 
 
 
 
Total net carrying amount of senior convertible notes
$
1,022.4

 
$
1,010.3

 
 
 
 
Fair value of outstanding senior convertible notes:
 
 
 
Senior Convertible Notes due 2022
$
537.5

 
$
540.2

Senior Convertible Notes due 2023
876.3

 
859.6

Total fair value of outstanding senior convertible notes
$
1,413.8

 
$
1,399.8

 
 
 
 
Amount by which the notes' if-converted value exceeds their principal amount:
 
 
 
Senior Convertible Notes due 2022
$
121.7

 
$
125.4

Senior Convertible Notes due 2023
—

 
—

Total by which the notes' if-converted value exceeds their principal amount
$
121.7

 
$
125.4
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Business Segment and Geographic Information (Tables)
 3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Revenue from External Customers by Geographic Areas
The following table sets forth revenues by our two primary geographical markets, United States and outside of the United States, based on the geographic location to which we deliver the product:
 
Three Months Ended 
 March 31, 2019
 
Three Months Ended 
 March 31, 2018
(In millions)
Amount
 
% of Total
 
Amount
 
% of Total
Revenues:
 
 
 
 
 
 
 
United States
$
210.5

 
75
%
 
$
145.4

 
79
%
Outside of the United States
70.0

 
25
%
 
39.0

 
21
%
Total
$
280.5

 
100
%
 
$
184.4

 
100
%
Disaggregation of Revenue
The following table sets forth revenues disaggregated by customer sales channel:
 
Three Months Ended 
 March 31, 2019
 
Three Months Ended 
 March 31, 2018
(In millions)
Amount
 
% of Total
 
Amount
 
% of Total
Revenues:
 
 
 
 
 
 
 
Distributor
$
187.8

 
67
%
 
$
118.3

 
64
%
Direct
92.7

 
33
%
 
66.1

 
36
%
Total
$
280.5

 
100
%
 
$
184.4

 
100
%
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share based compensation expense
Share-Based Compensation Expense
The following table summarizes share-based compensation expense for the periods shown:
 
Three Months Ended 
 March 31,
(In millions)
2019
 
2018
Cost of sales
$
2.3

 
$
2.2

Research and development
8.5

 
8.5

Selling, general and administrative
14.2

 
13.9

Total share-based compensation expense included in net loss
$
25.0

 
$
24.6
Restricted Stock Units
Restricted Stock Units
A summary of our RSU and PSU activity for the three months ended March 31, 2019 is as follows:
 
 
 
Weighted
 
 
 
 
 
Average
 
Aggregate
 
 
 
Grant Date
 
Intrinsic
(In millions, except weighted average grant date fair values)
Shares
 
Fair Value
 
Value
Nonvested at December 31, 2018
2.7

 
$
69.19

 
$
319.0

Granted
0.6

 
143.24

 
 
Vested
(0.9
)
 
65.77

 
 
Forfeited
(0.1
)
 
95.68

 
 
Nonvested at March 31, 2019
2.3

 
$
89.57

 
$
277.4
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Summary of Significant Accounting Policies - Additional Information (Detail)
$ in Millions
 3 Months Ended
Mar. 31, 2019
USD ($)
customer
Mar. 31, 2018
USD ($)
Dec. 31, 2018
USD ($)
Organization And Summary Of Significant Accounting Policies [Line Items]      
Number of customers | customer 2    
Percentage of revenue 10.00%    
Percentage of accounts receivable 10.00%    
Sales returns coverage period 30 days    
Unbilled accounts receivable $ 4.7   $ 5.1
Deferred revenue recognized $ 2.4 $ 1.5  
Amortization period for incentive compensation costs 1 year    
Distributor A      
Organization And Summary Of Significant Accounting Policies [Line Items]      
Percentage of revenue 15.00% 13.00%  
Percentage of accounts receivable 17.00%   19.00%
Distributor B      
Organization And Summary Of Significant Accounting Policies [Line Items]      
Percentage of revenue 11.00% 14.00%  
Percentage of accounts receivable 11.00%   15.00%
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Significant Accounting Policies Anti-dilutive securities not included in calculation of net loss per share (Details) - shares
shares in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of net loss per share 16.7 7.5
Options outstanding to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of net loss per share 0.0 0.4
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of net loss per share 2.3 3.1
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of net loss per share 5.2 0.0
Senior convertible notes due 2022 | Senior convertible notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of net loss per share 4.0 4.0
Senior convertible notes due 2023 | Senior convertible notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of net loss per share 5.2 0.0
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2019
USD ($)
ft²
renewal_term
Jan. 01, 2019
USD ($)
Dec. 31, 2018
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Operating lease right-of-use assets $ 27.7 $ 26.7 $ 0.0
Finance lease right-of-use asset   15.3  
Operating lease liabilities 42.7 40.4  
Finance lease liability $ 15.7 15.9  
Accumulated Deficit | Accounting Standards Update 2016-02      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Cumulative-effect adjustment to retained earnings   $ 2.1  
Building      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Leased square footage | ft² 87,000    
Lessee leasing arrangements, operating leases, number of renewal terms | renewal_term 0    
Leased Buildings -6350 Sequence Drive      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Leased square footage | ft² 132,600    
Leased Buildings -6340 Sequence Drive, 6310 Sequence Drive, 6290 Sequence drive      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Leased square footage | ft² 219,000    
Lessee leasing arrangements, operating leases, number of renewal terms | renewal_term 2    
Leased Buildings -232 South Dobson Road      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Leased square footage | ft² 148,800    
Lessee leasing arrangements, operating leases, number of renewal terms | renewal_term 4    
Lessee, operating lease, renewal term 5 years    
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Components of lease expense (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2019
USD ($)
Finance lease cost:  
Amortization of right-of-use assets $ 0.3
Interest on lease liabilities 0.2
Operating lease cost 2.5
Short-term lease cost 1.3
Variable lease cost(1) 0.8
Total lease cost $ 5.1
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Other information related to leases (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2019
USD ($)
Leases [Abstract]  
Operating Lease, Payments $ 4.6
Finance Lease, Interest Payment on Liability 0.2
Finance Lease, Principal Payments 0.1
Right-of-use assets obtained in exchange for lease liabilities 29.9
Finance Lease, Right-of-Use Asset $ 15.3
Operating Lease, Weighted Average Remaining Lease Term 3 years 4 months 2 days
Finance Lease, Weighted Average Remaining Lease Term 14 years
Operating Lease, Weighted Average Discount Rate, Percent 5.00%
Finance Lease, Weighted Average Discount Rate, Percent 5.00%
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Future minimum lease payments under non-cancellable leases (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Jan. 01, 2019
Dec. 31, 2018
Operating Leases      
2019 $ 11.3    
2020 14.2    
2021 14.5    
2022 3.7    
2023 1.6    
Thereafter 1.0    
Total future lease cost 46.3    
Less: Amount representing interest (3.6)    
Present value of future payments 42.7 $ 40.4  
Less: Short-term leases not recorded as a liability (0.9)    
Revised present value of future lease payments 41.8    
Less: Current portion (12.3)   $ 0.0
Long-term portion 29.5   $ 0.0
Finance Leases      
2019 1.0    
2020 1.3    
2021 1.3    
2022 1.4    
2023 1.4    
Thereafter 15.4    
Total future lease cost 21.8    
Less: Amount representing interest (6.1)    
Present value of future payments 15.7 $ 15.9  
Less: Short-term leases not recorded as a liability 0.0    
Revised present value of future lease payments 15.7    
Less: Current portion (0.5)    
Long-term portion $ 15.2    
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents $ 359,500,000   $ 266,000,000
Debt securities, available-for-sale 72,900,000 $ 210,600,000 210,600,000
Transfers between Level 1 and Level 2 securities 0   0
Transfers into or out of Level 3 securities 0   0
Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents 309,900,000   199,300,000
Debt securities, available-for-sale 0   0
Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents 49,600,000   66,700,000
Debt securities, available-for-sale 72,900,000   210,600,000
Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Cash equivalents 0   0
Debt securities, available-for-sale 0   0
U.S. government agencies      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 54,800,000 173,100,000 173,100,000
U.S. government agencies | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
U.S. government agencies | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 54,800,000   173,100,000
U.S. government agencies | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Corporate debt      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 15,100,000 1,300,000 1,300,000
Corporate debt | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Corporate debt | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 15,100,000   1,300,000
Corporate debt | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Commercial paper      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 3,000,000 36,200,000 36,200,000
Commercial paper | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Commercial paper | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 3,000,000   36,200,000
Commercial paper | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Debt securities, available-for-sale 0   0
Equity investment in Tandem Diabetes Care, Inc      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     38,000,000
Equity investment in Tandem Diabetes Care, Inc | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     38,000,000
Equity investment in Tandem Diabetes Care, Inc | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     0
Equity investment in Tandem Diabetes Care, Inc | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Equity investment in Tandem Diabetes Care, Inc.     0
Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Fair value of outstanding senior convertible notes: 1,413,800,000 1,399,800,000  
Senior convertible notes due 2023 | Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Fair value of outstanding senior convertible notes: 876,300,000 859,600,000  
Senior convertible notes due 2022 | Senior Notes      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Fair value of outstanding senior convertible notes: 537,500,000 $ 540,200,000  
Foreign Exchange Forward | Designated as Hedging Instrument      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Outstanding currency hedging transactions 0    
Fair Value, Measurements, Recurring      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis 432,400,000   514,600,000
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis 309,900,000   237,300,000
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis 122,500,000   277,300,000
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]      
Total assets measured at fair value on a recurring basis $ 0   $ 0
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Short Term Marketable Securities, Available for Sale (Detail) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Debt securities, available for sale:      
Amortized Cost $ 72.9   $ 210.7
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   (0.1)
Estimated Market Value 72.9 $ 210.6 210.6
Total marketable securities      
Cost or Amortized Cost     212.7
Gross Unrealized Gains     36.0
Gross Unrealized Losses     (0.1)
Estimated Market Value 72.9   248.6
Equity Securities Net Gain      
Net gains recognized during the period on equity securities (4.2) 7.4  
U.S. government agencies      
Debt securities, available for sale:      
Amortized Cost 54.8   173.2
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   (0.1)
Estimated Market Value 54.8 173.1 173.1
Commercial paper      
Debt securities, available for sale:      
Amortized Cost 3.0   36.2
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   0.0
Estimated Market Value 3.0 36.2 36.2
Corporate debt      
Debt securities, available for sale:      
Amortized Cost 15.1   1.3
Gross Unrealized Gains 0.0   0.0
Gross Unrealized Losses 0.0   0.0
Estimated Market Value $ 15.1 $ 1.3 1.3
Equity investment in Tandem Diabetes Care, Inc      
Equity investment in Tandem Diabetes Care, Inc.      
Cost or Amortized Cost     2.0
Gross Unrealized Gains     36.0
Gross Unrealized Losses     0.0
Estimated Market Value     $ 38.0
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Inventory (Detail) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Raw materials $ 52.7 $ 30.8
Work-in-process 10.0 11.2
Finished goods 38.4 28.7
Total inventory 101.1 $ 70.7
Customer Notification Related Inventory Reserve    
Inventory write-down $ 1.6  
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Property and Equipment (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 309.8 $ 262.9
Less accumulated depreciation and amortization (88.4) (79.8)
Total property and equipment, net 221.4 183.1
Building    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 15.3 6.0
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 9.1 9.0
Computer software and hardware    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 31.6 29.2
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 82.5 80.7
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 83.2 80.7
Construction in progress    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 88.1 $ 57.3
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Accounts Payable and Accrued Liabilities (Detail) - USD ($)
$ in Millions
 1 Months Ended
Feb. 28, 2019
Mar. 31, 2019
Dec. 31, 2018
Accounts Payable and Accrued Liabilities [Abstract]      
Accounts payable trade   $ 90.3 $ 75.5
Accrued tax, audit, and legal fees   12.3 11.7
Accrued rebates   40.9 36.1
Accrued warranty   6.0 6.8
Restructuring reserve   1.1 0.0
Other accrued liabilities   18.5 17.0
Total accounts payable and accrued liabilities   $ 169.1 $ 147.1
Restructuring charges $ 9.0    
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheet Details - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Finance lease liabilities $ 15.2 $ 7.3
Deferred rent 0.0 9.4
Other liabilities 2.9 3.3
Total other long-term liabilities $ 18.1 $ 20.0
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Debt Schedule of senior convertible notes (Details) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Nov. 30, 2018
Jun. 30, 2017
Senior Notes [Abstract]          
Net carrying amount of Senior Convertible Notes due 2022 $ 1,022,400,000   $ 1,010,300,000    
Senior Notes          
Senior Notes [Abstract]          
Fair value of outstanding senior convertible notes: 1,413,800,000   1,399,800,000    
Amount by which the notes' if-converted value exceeds their principal amount: 121,700,000 $ 125,400,000      
Senior Notes | Zero Point Seven Five Percent Senior Convertible Notes          
Senior Notes [Abstract]          
Total net carrying amount of senior convertible notes 1,022,400,000   1,010,300,000    
Senior Notes | Senior convertible notes due 2022          
Senior Notes [Abstract]          
Principal amount 400,000,000.0   400,000,000.0   $ 400,000,000.0
Unamortized debt discount (47,700,000)   (51,100,000)    
Unamortized debt issuance costs (5,900,000)   (6,300,000)    
Net carrying amount of Senior Convertible Notes due 2022 346,400,000   342,600,000    
Fair value of outstanding senior convertible notes: 537,500,000   540,200,000    
Amount by which the notes' if-converted value exceeds their principal amount: 121,700,000 125,400,000      
Senior Notes | Senior convertible notes due 2023          
Senior Notes [Abstract]          
Principal amount 850,000,000.0   850,000,000.0 $ 850,000,000  
Unamortized debt discount (164,000,000)   (171,800,000)    
Unamortized debt issuance costs (10,000,000)   (10,500,000)    
Net carrying amount of Senior Convertible Notes due 2022 676,000,000   667,700,000    
Fair value of outstanding senior convertible notes: 876,300,000   $ 859,600,000    
Amount by which the notes' if-converted value exceeds their principal amount: $ 0 $ 0      
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Debt 0.75% Senior convertible notes (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 30, 2018
USD ($)
d
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
Mar. 31, 2019
USD ($)
d
Mar. 31, 2018
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Debt Instrument [Line Items]            
Non-cash interest expense     $ 12,200,000 $ 3,700,000    
Senior Notes | Senior convertible notes due 2022            
Debt Instrument [Line Items]            
Interest rate on convertible notes   0.75%        
Aggregate principal amount   $ 400,000,000.0 400,000,000.0   $ 400,000,000.0  
Proceeds from convertible debt   $ 389,000,000        
Initial conversion price of convertible notes (in dollars per share) | $ / shares   $ 99.09        
Contractual coupon interest rate     700,000 800,000    
Non-cash interest expense     3,500,000 3,300,000    
Amortization of debt issuance costs     $ 400,000 $ 400,000    
Effective interest rate     5.14%      
Conversion price in event of fundamental change     100.00%      
Conversion multiple     $ 1,000      
Conversion percentage based on last reported sale price     140.00%      
Debt instrument, redemption price, percentage     100.00%      
Senior Notes | Senior convertible notes due 2023            
Debt Instrument [Line Items]            
Interest rate on convertible notes 0.75%          
Aggregate principal amount $ 850,000,000   $ 850,000,000.0   850,000,000.0  
Proceeds from convertible debt $ 836,600,000          
Initial conversion price of convertible notes (in dollars per share) | $ / shares $ 164.29          
Contractual coupon interest rate     1,600,000      
Non-cash interest expense     7,800,000      
Amortization of debt issuance costs     $ 500,000      
Effective interest rate     5.63%      
Conversion price in event of fundamental change     100.00%      
Conversion multiple     $ 1,000      
Threshold consecutive trading days | d 60          
Conversion percentage based on last reported sale price     130.00%      
Debt instrument, redemption price, percentage     100.00%      
Debt instrument, convertible, conversion ratio 0.0060869 0.0100918        
Warrants sold to counterparties | shares 5,200,000          
Proceeds from issuance of warrants $ 183,800,000          
Strike price of warrant | $ / shares $ 198.3840          
Senior Notes | Additional Paid-In Capital | Senior convertible notes due 2022            
Debt Instrument [Line Items]            
Amount reclassified to stockholders' equity           $ 72,600,000
Senior Notes | Additional Paid-In Capital | Senior convertible notes due 2023            
Debt Instrument [Line Items]            
Amount reclassified to stockholders' equity         $ 174,400,000  
Senior Notes | Term of at least 20 trading days during a period of 30 consecutive trading days | Minimum | Senior convertible notes due 2022            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     20      
Threshold percentage of stock price trigger     130.00%      
Senior Notes | Term of at least 20 trading days during a period of 30 consecutive trading days | Minimum | Senior convertible notes due 2023            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     20      
Threshold percentage of stock price trigger     130.00%      
Senior Notes | Term of at least 20 trading days during a period of 30 consecutive trading days | Maximum | Senior convertible notes due 2022            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     30      
Senior Notes | Term of at least 20 trading days during a period of 30 consecutive trading days | Maximum | Senior convertible notes due 2023            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     30      
Senior Notes | Term of five business day period after any five consecutive trading day period | Senior convertible notes due 2022            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     5      
Senior Notes | Term of five business day period after any five consecutive trading day period | Senior convertible notes due 2023            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     5      
Senior Notes | Term of five business day period after any five consecutive trading day period | Maximum | Senior convertible notes due 2022            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     5      
Threshold percentage of stock price trigger     98.00%      
Senior Notes | Term of five business day period after any five consecutive trading day period | Maximum | Senior convertible notes due 2023            
Debt Instrument [Line Items]            
Threshold consecutive trading days | d     5      
Threshold percentage of stock price trigger     98.00%      
Designated as Hedging Instrument | Senior Notes | Senior convertible notes due 2023            
Debt Instrument [Line Items]            
Convertible note hedge, number of shares | shares 5,173,865          
Cost of convertible note hedge recognized in additional paid-in capital $ 218,900,000          
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Debt Revolving Credit Agreement (Details) - USD ($)
 1 Months Ended
Dec. 31, 2018
Mar. 31, 2019
Line of Credit Facility [Line Items]    
Line of credit, current   $ 0
Line of credit facility, remaining borrowing capacity   195,600,000
Letter of Credit    
Line of Credit Facility [Line Items]    
Long-term line of credit   $ 4,400,000
Foreign Currency Line of Credit | Letter of Credit    
Line of Credit Facility [Line Items]    
Line of credit facility, maximum borrowing capacity $ 50,000,000  
Line of Credit    
Line of Credit Facility [Line Items]    
Debt Instrument, Term 5 years  
Long-term line of credit $ 200,000,000  
Line of credit facility, maximum borrowing capacity 500,000,000  
Line of Credit | Letter of Credit    
Line of Credit Facility [Line Items]    
Line of credit facility, maximum borrowing capacity 10,000,000  
Amount of option to increase the maximum available principal $ 300,000,000  
Minimum | Line of Credit    
Line of Credit Facility [Line Items]    
Debt instrument, interest rate, stated percentage 0.375%  
Line of credit facility, unused capacity, commitment fee percentage 0.20%  
Maximum | Line of Credit    
Line of Credit Facility [Line Items]    
Debt instrument, interest rate, stated percentage 1.00%  
Line of credit facility, unused capacity, commitment fee percentage 0.30%  
London Interbank Offered Rate (LIBOR) | Minimum | Line of Credit    
Line of Credit Facility [Line Items]    
Margin on variable rate 1.375%  
London Interbank Offered Rate (LIBOR) | Maximum | Line of Credit    
Line of Credit Facility [Line Items]    
Margin on variable rate 2.00%  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Contingencies Litigation (Details)
Sep. 14, 2018
number_patents
Petition
Mar. 30, 2018
number_patents
Feb. 28, 2018
number_patents
Sep. 15, 2017
number_patents
Mar. 08, 2017
number_patents
Feb. 24, 2017
number_patents
Aug. 25, 2016
number_patents
Jun. 06, 2016
number_patents
Mar. 31, 2019
USD ($)
Loss Contingencies [Line Items]                  
Loss contingencies, patents allegedly infringed, number of inter partes review requested | Petition 2                
Loss contingency accrual | $                 $ 0
Estimated litigation liability | $                 $ 0
AgaMatrix                  
Loss Contingencies [Line Items]                  
Loss contingency, patents allegedly infringed, number               3  
Loss contingencies, patents allegedly infringed, number of inter partes review requested 2                
WaveForm Technologies, Inc.                  
Loss Contingencies [Line Items]                  
Loss contingency, patents allegedly infringed, number transferred to new plaintiff           3      
Loss contingencies, patents allegedly infringed, number of inter partes review requested   2 2   3   2    
AgaMatrix                  
Loss Contingencies [Line Items]                  
Gain contingency, patents allegedly infringed upon, number       2          
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Details)
 3 Months Ended
Mar. 31, 2019
USD ($)
Income Tax Disclosure [Abstract]  
Effective tax rate (1.00%)
Tax benefit for refunds of foreign withholding tax, partially offset by state and foreign tax expense $ 0
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.19.1
Business Segment and Geographic Information - Additional Information (Detail)
$ in Millions
 3 Months Ended
Mar. 31, 2019
USD ($)
segment
Mar. 31, 2018
USD ($)
Disaggregation of Revenue [Line Items]    
Number of Reportable Segments | segment 1  
Revenues $ 280.5 $ 184.4
Revenue, Percentage 100.00% 100.00%
United States    
Disaggregation of Revenue [Line Items]    
Revenues $ 210.5 $ 145.4
Revenue, Percentage 75.00% 79.00%
Outside of the United States    
Disaggregation of Revenue [Line Items]    
Revenues $ 70.0 $ 39.0
Revenue, Percentage 25.00% 21.00%
Distributor    
Disaggregation of Revenue [Line Items]    
Revenues $ 187.8 $ 118.3
Revenue, Percentage 67.00% 64.00%
Direct    
Disaggregation of Revenue [Line Items]    
Revenues $ 92.7 $ 66.1
Revenue, Percentage 33.00% 36.00%
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity Share-Based Compensation Expense (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Unrecognized estimated compensation costs $ 188.3  
Allocated Share-based Compensation Expense 25.0 $ 24.6
Cost of Sales    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Allocated Share-based Compensation Expense 2.3 2.2
Research and Development Expense    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Allocated Share-based Compensation Expense 8.5 8.5
Selling General And Administrative    
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]    
Allocated Share-based Compensation Expense $ 14.2 $ 13.9
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity Restricted Stock Units (Details) - USD ($)
$ / shares in Units, shares in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Unvested restricted stock units      
Shares      
Nonvested beginning balance, shares 2.3 2.3 2.7
Granted 0.6    
Vested (0.9)    
Forfeited (0.1)    
Nonvested ending balance, shares 2.3    
Weighted Average Grant Date Fair Value      
Weighted average grant date fair value, in dollars per share   $ 89.57 $ 69.19
Granted $ 143.24    
Vested 65.77    
Forfeited $ 95.68    
Aggregate intrinsic value   $ 277,400,000 $ 319,000,000
Total vest date fair value $ 132,300,000    
Performance Shares [Member]      
Weighted Average Grant Date Fair Value      
Total vest date fair value $ 0    
EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 195 278 1 false 58 0 false 11 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.dexcom.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.dexcom.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Operations Sheet http://www.dexcom.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1003000 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.dexcom.com/role/ConsolidatedStatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 1004000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.dexcom.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.dexcom.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Organization and Significant Accounting Policies Sheet http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies Organization and Significant Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - Leases Sheet http://www.dexcom.com/role/Leases Leases Notes 9 false false R10.htm 2103100 - Disclosure - Fair Value Measurements Sheet http://www.dexcom.com/role/FairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 2104100 - Disclosure - Balance Sheet Details Sheet http://www.dexcom.com/role/BalanceSheetDetails Balance Sheet Details Notes 11 false false R12.htm 2105100 - Disclosure - Debt Sheet http://www.dexcom.com/role/Debt Debt Notes 12 false false R13.htm 2106100 - Disclosure - Contingencies Sheet http://www.dexcom.com/role/Contingencies Contingencies Notes 13 false false R14.htm 2107100 - Disclosure - Income Taxes Sheet http://www.dexcom.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 2108100 - Disclosure - Business Segment and Geographic Information Sheet http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation Business Segment and Geographic Information Notes 15 false false R16.htm 2108100 - Disclosure - Stockholders' Equity Sheet http://www.dexcom.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 2201201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://www.dexcom.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://www.dexcom.com/role/OrganizationAndSignificantAccountingPolicies 17 false false R18.htm 2301302 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) Sheet http://www.dexcom.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables Organization and Summary of Significant Accounting Policies (Tables) Tables 18 false false R19.htm 2302301 - Disclosure - Leases (Tables) Sheet http://www.dexcom.com/role/LeasesTables Leases (Tables) Tables http://www.dexcom.com/role/Leases 19 false false R20.htm 2303301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.dexcom.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.dexcom.com/role/FairValueMeasurements 20 false false R21.htm 2304301 - Disclosure - Balance Sheet Details (Tables) Sheet http://www.dexcom.com/role/BalanceSheetDetailsTables Balance Sheet Details (Tables) Tables http://www.dexcom.com/role/BalanceSheetDetails 21 false false R22.htm 2305301 - Disclosure - Debt (Tables) Sheet http://www.dexcom.com/role/DebtTables Debt (Tables) Tables http://www.dexcom.com/role/Debt 22 false false R23.htm 2308301 - Disclosure - Business Segment and Geographic Information (Tables) Sheet http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationTables Business Segment and Geographic Information (Tables) Tables http://www.dexcom.com/role/BusinessSegmentAndGeographicInformation 23 false false R24.htm 2308301 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.dexcom.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.dexcom.com/role/StockholdersEquity 24 false false R25.htm 2401403 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.dexcom.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Organization and Summary of Significant Accounting Policies - Additional Information (Detail) Details 25 false false R26.htm 2401404 - Disclosure - Organization and Significant Accounting Policies Anti-dilutive securities not included in calculation of net loss per share (Details) Sheet http://www.dexcom.com/role/OrganizationAndSignificantAccountingPoliciesAntiDilutiveSecuritiesNotIncludedInCalculationOfNetLossPerShareDetails Organization and Significant Accounting Policies Anti-dilutive securities not included in calculation of net loss per share (Details) Details 26 false false R27.htm 2402402 - Disclosure - Leases - Narrative (Details) Sheet http://www.dexcom.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 27 false false R28.htm 2402403 - Disclosure - Leases - Components of lease expense (Details) Sheet http://www.dexcom.com/role/LeasesComponentsOfLeaseExpenseDetails Leases - Components of lease expense (Details) Details 28 false false R29.htm 2402404 - Disclosure - Leases - Other information related to leases (Details) Sheet http://www.dexcom.com/role/LeasesOtherInformationRelatedToLeasesDetails Leases - Other information related to leases (Details) Details 29 false false R30.htm 2402405 - Disclosure - Leases - Future minimum lease payments under non-cancellable leases (Details) Sheet http://www.dexcom.com/role/LeasesFutureMinimumLeasePaymentsUnderNonCancellableLeasesDetails Leases - Future minimum lease payments under non-cancellable leases (Details) Details 30 false false R31.htm 2403402 - Disclosure - Fair Value Measurements (Details) Sheet http://www.dexcom.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.dexcom.com/role/FairValueMeasurementsTables 31 false false R32.htm 2404402 - Disclosure - Balance Sheet Details - Short Term Marketable Securities, Available for Sale (Detail) Sheet http://www.dexcom.com/role/BalanceSheetDetailsShortTermMarketableSecuritiesAvailableForSaleDetail Balance Sheet Details - Short Term Marketable Securities, Available for Sale (Detail) Details 32 false false R33.htm 2404403 - Disclosure - Balance Sheet Details - Inventory (Detail) Sheet http://www.dexcom.com/role/BalanceSheetDetailsInventoryDetail Balance Sheet Details - Inventory (Detail) Details 33 false false R34.htm 2404404 - Disclosure - Balance Sheet Details - Property and Equipment (Details) Sheet http://www.dexcom.com/role/BalanceSheetDetailsPropertyAndEquipmentDetails Balance Sheet Details - Property and Equipment (Details) Details 34 false false R35.htm 2404405 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Detail) Sheet http://www.dexcom.com/role/BalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetail Balance Sheet Details - Accounts Payable and Accrued Liabilities (Detail) Details 35 false false R36.htm 2404406 - Disclosure - Balance Sheet Details - Other Long-Term Liabilities (Details) Sheet http://www.dexcom.com/role/BalanceSheetDetailsOtherLongTermLiabilitiesDetails Balance Sheet Details - Other Long-Term Liabilities (Details) Details 36 false false R37.htm 2405402 - Disclosure - Debt Schedule of senior convertible notes (Details) Notes http://www.dexcom.com/role/DebtScheduleOfSeniorConvertibleNotesDetails Debt Schedule of senior convertible notes (Details) Details 37 false false R38.htm 2405403 - Disclosure - Debt 0.75% Senior convertible notes (Details) Notes http://www.dexcom.com/role/Debt075SeniorConvertibleNotesDetails Debt 0.75% Senior convertible notes (Details) Details 38 false false R39.htm 2405404 - Disclosure - Debt Revolving Credit Agreement (Details) Sheet http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails Debt Revolving Credit Agreement (Details) Details 39 false false R40.htm 2406401 - Disclosure - Contingencies Litigation (Details) Sheet http://www.dexcom.com/role/ContingenciesLitigationDetails Contingencies Litigation (Details) Details 40 false false R41.htm 2407401 - Disclosure - Income Taxes (Details) Sheet http://www.dexcom.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.dexcom.com/role/IncomeTaxes 41 false false R42.htm 2408402 - Disclosure - Business Segment and Geographic Information - Additional Information (Detail) Sheet http://www.dexcom.com/role/BusinessSegmentAndGeographicInformationAdditionalInformationDetail Business Segment and Geographic Information - Additional Information (Detail) Details 42 false false R43.htm 2408402 - Disclosure - Stockholders' Equity Share-Based Compensation Expense (Details) Sheet http://www.dexcom.com/role/StockholdersEquityShareBasedCompensationExpenseDetails Stockholders' Equity Share-Based Compensation Expense (Details) Details 43 false false R44.htm 2408403 - Disclosure - Stockholders' Equity Restricted Stock Units (Details) Sheet http://www.dexcom.com/role/StockholdersEquityRestrictedStockUnitsDetails Stockholders' Equity Restricted Stock Units (Details) Details 44 false false All Reports Book All Reports dxcm-20190331.xml dxcm-20190331.xsd dxcm-20190331_cal.xml dxcm-20190331_def.xml dxcm-20190331_lab.xml dxcm-20190331_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 true true ZIP 61 0001093557-19-000119-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001093557-19-000119-xbrl.zip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`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end